WO2018096525A2 - Heteroaryl compounds and uses thereof - Google Patents

Heteroaryl compounds and uses thereof Download PDF

Info

Publication number
WO2018096525A2
WO2018096525A2 PCT/IB2018/052089 IB2018052089W WO2018096525A2 WO 2018096525 A2 WO2018096525 A2 WO 2018096525A2 IB 2018052089 W IB2018052089 W IB 2018052089W WO 2018096525 A2 WO2018096525 A2 WO 2018096525A2
Authority
WO
WIPO (PCT)
Prior art keywords
deuterium
compound
formula
hydrogen
compounds
Prior art date
Application number
PCT/IB2018/052089
Other languages
French (fr)
Other versions
WO2018096525A3 (en
Inventor
Peter Anthony CICALA
Original Assignee
Celgene Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corporation filed Critical Celgene Corporation
Priority to PCT/IB2018/052089 priority Critical patent/WO2018096525A2/en
Publication of WO2018096525A2 publication Critical patent/WO2018096525A2/en
Publication of WO2018096525A3 publication Critical patent/WO2018096525A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Definitions

  • the present invention provides compounds, and compositions thereof, useful as inhibitors of protein kinases.
  • Protein kinases constitute a large family of structurally related enzymes that are responsible for the control of a variety of signal transduction processes within the cell. Protein kinases are thought to have evolved from a common ancestral gene due to the conservation of their structure and catalytic function. Almost all kinases contain a similar 250-300 amino acid catalytic domain. The kinases may be categorized into families by the substrates they phosphorylate (e.g., protein-tyrosine, protein-serine/threonine, lipids, etc.).
  • protein kinases mediate intracellular signaling by effecting a phosphoryl transfer from a nucleoside triphosphate to a protein acceptor that is involved in a signaling pathway. These phosphorylation events act as molecular on/off switches that can modulate or regulate the target protein biological function. These phosphorylation events are ultimately triggered in response to a variety of extracellular and other stimuli.
  • Examples of such stimuli include environmental and chemical stress signals (e.g., osmotic shock, heat shock, ultraviolet radiation, bacterial endotoxin, and H 2 O 2 ), cytokines (e.g., interleukin-1 (IL-1) and tumor necrosis factor a (TNF-a)), and growth factors (e.g., granulocyte macrophage-colony-stimulating factor (GM-CSF), and fibroblast growth factor (FGF)).
  • IL-1 interleukin-1
  • TNF-a tumor necrosis factor a
  • growth factors e.g., granulocyte macrophage-colony-stimulating factor (GM-CSF), and fibroblast growth factor (FGF)
  • An extracellular stimulus may affect one or more cellular responses related to cell growth, migration, differentiation, secretion of hormones, activation of transcription factors, muscle contraction, glucose metabolism, control of protein synthesis, and regulation of the cell cycle.
  • R 7 , R 7' , R 8a , R 8a' , R 8 , R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R xa , R x , R x ' , R xc , R ya , R ya' , R y andR y ' is as defined herein.
  • Compounds of the present invention are useful for treating a variety of diseases, disorders or conditions, associated with abnormal cellular responses triggered by protein kinase-mediated events. Such diseases, disorders, or conditions include those described herein.
  • Compounds provided by this invention are also useful for the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.
  • the present invention provides certain compounds, and compositions thereof, useful as protein kinase inhibitors.
  • the present invention provides certain 2,4-disubstituted pyrimidine compounds which inhibit activity of one or more protein kinases, including Janus kinase ("JAK").
  • JNK Janus kinase
  • R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R xa , R x , R x ' , R xc , R ya , R ya' , R y andR y ' is independently selected from hydrogen or deuterium;
  • R 7 , R 7' , R 8a , R 8a' , R 8 , R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R xa , R x , R x ' , R xc , R ya , R ya' , R y andR y ' is deuterium.
  • the present invention provides a compound of Formula I, wherein the compound is a co
  • the term "pharmaceutically acceptable salt” refers to those salts which are, within the scope of sound medical judgment, suitable for use in contact with the tissues of humans and lower animals without undue toxicity, irritation, allergic response and the like, and are commensurate with a reasonable benefit/risk ratio.
  • Pharmaceutically acceptable salts are well known in the art. For example, S. M. Berge et al., describe pharmaceutically acceptable salts in detail in J. Pharmaceutical Sciences, 1977, 66, 1-19, incorporated herein by reference.
  • Pharmaceutically acceptable salts of the compounds of this invention include those derived from suitable inorganic and organic acids and bases.
  • Examples of pharmaceutically acceptable, nontoxic acid addition salts are salts of an amino group formed with inorganic acids such as hydrochloric acid, hydrobromic acid, phosphoric acid, sulfuric acid and perchloric acid or with organic acids such as acetic acid, oxalic acid, maleic acid, tartaric acid, citric acid, succinic acid or malonic acid or by using other methods used in the art such as ion exchange.
  • inorganic acids such as hydrochloric acid, hydrobromic acid, phosphoric acid, sulfuric acid and perchloric acid
  • organic acids such as acetic acid, oxalic acid, maleic acid, tartaric acid, citric acid, succinic acid or malonic acid or by using other methods used in the art such as ion exchange.
  • salts include adipate, alginate, ascorbate, aspartate, benzenesulfonate, benzoate, bisulfate, borate, butyrate, camphorate, camphorsulfonate, citrate, cyclopentanepropionate, digluconate, dodecylsulfate, ethanesulfonate, formate, fumarate, glucoheptonate, glycerophosphate, gluconate, hemisulfate, heptanoate, hexanoate, hydroiodide, 2-hydroxy-ethanesulfonate, lactobionate, lactate, laurate, lauryl sulfate, malate, maleate, malonate, methanesulfonate, 2-naphthalenesulfonate, nicotinate, nitrate, oleate, oxalate, palmitate, pamoate, pectinate,
  • Salts derived from appropriate bases include alkali metal, alkaline earth metal, ammonium and N + (Ci_ 4 alkyl)4 salts.
  • Representative alkali or alkaline earth metal salts include sodium, lithium, potassium, calcium, magnesium, and the like.
  • Further pharmaceutically acceptable salts include, when appropriate, nontoxic ammonium, quaternary ammonium, and amine cations formed using counterions such as halide, hydroxide, carboxylate, sulfate, phosphate, nitrate, loweralkyl sulfonate and aryl sulfonate.
  • structures depicted herein are also meant to include all isomeric (e.g., enantiomeric, diastereomeric, and geometric (or conformational)) forms of the structure; for example, the R and S configurations for each asymmetric center, Z and E double bond isomers, and Z and E conformational isomers. Therefore, single stereochemical isomers as well as enantiomeric, diastereomeric, and geometric (or conformational) mixtures of the present compounds are within the scope of the invention. Unless otherwise stated, all tautomeric forms of the compounds of the invention are within the scope of the invention.
  • an inhibitor is defined as a compound that binds to and /or inhibits the target protein kinase with measurable affinity.
  • an inhibitor has an IC 50 and/or binding constant of less about 50 ⁇ , less than about 1 ⁇ , less than about 500 nM, less than about 100 nM, or less than about 10 nM.
  • measurable affinity and “measurably inhibit,” as used herein, means a measurable change in JAK activity between a sample comprising a compound of the present invention, or composition thereof, and an equivalent sample comprising JAK, in the absence of said compound, or composition thereof.
  • Deuterium (D or 2 H) is a stable, non-radioactive isotope of hydrogen and has an atomic weight of 2.0144. Hydrogen naturally occurs as a mixture of the isotopes 1H (hydrogen or protium), D ( 2 H or deuterium), and T ( 3 H or tritium).
  • hydrogen in hydrogen-containing chemical compounds actually represents a mixture of hydrogen and about 0.015% deuterium.
  • deuterium-enriched compounds are prepared via synthesis utilizing appropriately enriched starting materials.
  • deuterium-enriched or deuterium enrichment refer to a compound, or a particular site of said compound, which comprises deuterium in an amount that is greater than its natural isotopic abundance (0.015%).
  • the present invention provides compounds comprising deuterium at a given site, wherein the percentage or level of deuterium incorporation is greater than its natural isotopic abundance. [0019] According to one aspect, the present invention provides a compound of Formula I:
  • R 2 is R 2c ;
  • R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R xa , R x , R x ' , R xc , R ya , R ya' , R y andR y ' is independently selected from hydrogen or deuterium;
  • R 7 , R 7' , R 8a , R 8a' , R 8 , R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R xa , R x , R x ' , R xc , R ya , R ya' , R y andR y ' is deuterium.
  • R la is deuterium. In some embodiments, R l is deuterium. In some embodiments, R lc is deuterium. In some embodiments, each of R la , R l , and R lc is deuterium. In some embodiments, each of R la , R l , and R lc is deuterium and each of R 2a , R 2 , T?2C ?3b ?3c ?4 ?4' ?4" ?5 T?6 ?6' ?7 TJV x?8a T?8a' ?8b ?8b' ?9a ?9a' ?9b ?9b' ?xa x j xb
  • R x ' , R xc , R ya , R ya' , R y andR y ' is hydrogen.
  • R 2a is deuterium. In some embodiments, R 2 is deuterium. In some embodiments, R 2c is deuterium. In some embodiments, each of R 2a , R 2 , and R 2c is deuterium. In some embodiments, each of R 2a , R 2 , and R 2c is deuterium and each of R la , R l ,
  • R x ' , R xc , R ya , R ya' , R y andR y ' is hydrogen.
  • R 3a is deuterium. In some embodiments, R 3 is deuterium. In some embodiments, R 3c is deuterium. In some embodiments, each of R 3a , R 3 , and R 3c is deuterium. In some embodiments, each of R 3a , R 3 , and R 3c is deuterium and each of R la , R l ,
  • R x ' , R xc , R ya , R ya' , R y andR y ' is hydrogen.
  • each of R la , R l , R lc , R 2a , R 2 , R 2c , R 3a , R 3 , and R 3c is deuterium.
  • R 4 is deuterium. In some embodiments, R 4 is deuterium. In some embodiments, R 4 is deuterium. In some embodiments, R 4 is deuterium. In some embodiments, each of each of R 4 , R 4 , and R 4 is deuterium and each of R la , R l , R lc , R 2a , R 2 , R 2c , R 3a , R 3 , R 3c , R 5 , R 6 , R 6' , R 7 , R 7' , R 8a , R 8a' , R 8 , R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R xa , R x , R x ' , R xc , R ya , R ya' , R y andR y ' is hydrogen.
  • R 6 is deuterium. In some embodiments, R 6 is deuterium. In some embodiments, each of R 6 and R 6 is deuterium. In some embodiments, each of R 6 and R 6 is deuterium and each of R la , R l , R lc , R 2a , R 2 , R 2c , R 3a , R 3 , R 3c , R 4 , R 4' , R 4" , R 5 , R 7 , R 7' , R 8a , R 8a' , R 8 , R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R 9 , R 9 ' , R xa , R x , R x ' , R xc , R ya , R ya' , R y andR y ' is hydrogen.
  • R 7 is deuterium. In some embodiments, R 7 is deuterium. In some embodiments, R 7 is deuterium.
  • each of R and R is deuterium. In some embodiments, each of R and R is deuterium and each of R la , R l , R lc , R 2a , R 2 , R 2c , R 3a , R 3 , R 3c , R 4 , R 4' , R 4" , R 5 , R 6 , R 6' , R 8a , R 8a' , R 8 , R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R 9 , R 9 ' , R xc , R ya , R ya' , R y andR y ' is hydrogen.
  • R 8a is deuterium. In some embodiments, R 8a is deuterium. In some embodiments, R 8 is deuterium. In some embodiments, R 8 is deuterium. In some embodiments, each of R 8a and R 8a is deuterium. In some embodiments, each of R 8 and R 8 is deuterium. In some embodiments, each of R 8a , R 8a , R 8 , and R 8 is deuterium and each of R la ,
  • R x ' , R xc , R ya , R ya' , R y andR y ' is hydrogen.
  • R 9a is deuterium. In some embodiments, R 9a is deuterium. In some embodiments, R 9 is deuterium. In some embodiments, R 9 is deuterium. In some embodiments, each of R 9a and R 9a is deuterium. In some embodiments, each of R 9 and R 9 is deuterium.
  • each of R 9a , R 9a , R 9 , and R 9 is deuterium and each of R la , x j lb ?lc ?2a ?2b ?2 ?3a ?3b ?3 ?4 4' ?4" ?5 ?6 6' ?7 V ?8a r j Sa' ?8b ?8b' x j xa x j xb
  • R x ' , R xc , R ya , R ya' , R y andR y ' is hydrogen.
  • R xa is deuterium. In some embodiments, R xa is deuterium and each of R la , R l , R lc , R 2a , R 2 , R 2c , R 3a , R 3 , R 3c , R 4 , R 4' , R 4" , R 5 , R 6 , R 6' , R 7 , R 7' , R 8a , R 8a' , R 8 , R 8 ' , R 9a , R 9a' , R 9 , R 9 , R 9 ' , R x , R x ' , R xc , R ya , R ya' , R y andR y ' is hydrogen.
  • R x is deuterium. In some embodiments, R x is deuterium. In some embodiments, each of R x and R x is deuterium and each of R la , R l , R lc , R 2a , R 2 , R 2c , R 3a ,
  • R y and R y is hydrogen.
  • R ya is deuterium. In some embodiments, R ya is deuterium. In some embodiments, each of R ya and R ya' is deuterium and each of R la , R l , R lc , R 2a , R 2 , R 2c , R 3a , n b 3 4 4' T?4" 5 TJ6 TJ6' TJV V x j 8a r?9a x j 9a' x j xa x j xb r j xb' , K
  • R y , and R y is hydrogen.
  • R y is deuterium. In some embodiments, R y is deuterium. In some embodiments, each of R y and R y ' is deuterium and each of R la , R l , R lc , R 2a , R 2 , R 2c , R 3a ,
  • R ya , and R ya' is hydrogen.
  • each of R 4 , R 4 , R 4 is hydrogen and each of R 1 , R 2 and R 3 is -C3 ⁇ 4. Accordingly, in some embodiments, the present invention provides a compound of Formula Il-a:
  • each of R 6 , R 6' , R 7 , R 7' , R 8a , R 8a' , R 8 , R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R xa , R x , R x ' , R xc , R ya , R ya' , R y and R y is independently selected from hydrogen or deuterium;
  • R 6 , R 6' , R 7 , R 7' , R 8a , R 8a' , R 8 , R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R xa , R x , R x ' , R xc , R ya , R ya' , R y andR y ' is deuterium.
  • each of R 4 , R 4 , R 4 is hydrogen and each of R 1 , R 2 and R 3 is -CH 3 . Accordingly, in some embodiments, the present invention provides a compound of Formula Ill-a:
  • each of R 6 , R 6' , R 7 , R 7' , R 8a , R 8a' , R 8 , R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R xa , R x , R x ' , R xc , R ya , R ya' , R y and R y is independently selected from hydrogen or deuterium.
  • each of R 4 , R 4 , R 4 is hydrogen and each of R 1 , R 2 and R 3 is -CD 3 . Accordingly, in some embodiments, the present invention provides a compound of Formula Il-b or Formula Ill-b:
  • each of R 6 , R 6' , R 7 , R 7' , R 8a , R 8a' , R 8 , R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R xa , R x , R x ' , R xc , R ya , R ya' , R y and R y is independently selected from hydrogen or deuterium.
  • each of R 4 , R 4 , R 4 is deuterium and each of R 1 , R 2 and R 3 is -C3 ⁇ 4. Accordingly, in some embodiments, the present invention provides a compound of Formula II-c or Formula III-c:
  • each of R 6 , R 6' , R 7 , R 7' , R 8a , R 8a' , R 8 , R 8 ' , R 9a , R 9a' , R 9 , R 9 ' , R xa , R x , R x ' , R xc , R ya , R ya' , R y and R y is independently selected from hydrogen or deuterium.
  • each of R 4 , R 4 , R 4 is deuterium and each of R 1 , R 2 and R 3 is -CD 3 . Accordingly, in some embodiments, the present invention provides a compound of Formula Il-d or Formula Ill-d:
  • each of R 66 ,, R 6 ', R 7 R 7 ', R 8a , R 8a ', R 8 , R 8 ', R 9a , R 9a ', R 9 , R 9 ', R xa , R x , R x ', R xc , R ya , R ya ', R y and R y is independently selected from hydrogen or deuterium
  • Table 1 sets forth compounds of Formula Il-a, Il-b, II-c, and II-d wherein each of R 6 , R 6 , R 7 and R 7 is hydrogen.
  • Table 2 sets forth compounds of Formula Il-a, Il-b, II-c, and ⁇ - d wherein each of R 6 and R 6 is hydrogen and each of R 7 and R 7 is deuterium.
  • Table 3 sets forth compounds of Formula Il-a, Il-b, II-c, and II-d wherein each of R 6 and R 6 is deuterium and each of R 7 and R 7 is hydrogen.
  • Table 4 sets forth compounds of Formula Il-a, Il-b, II-c, and II- d wherein each of R 6 , R 6 , R 7 and R 7 is deuterium. It will be appreciated that each row in Table 1 , Table 2, Table 3, and Table 4 represents four discrete compounds. For example, row 1 in Table 1 represents compounds II-a-1, ⁇ -b-l, II-c-1 and II-d-1:
  • R 7 is hydrogen

Abstract

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Description

HETEROARYL COMPOUNDS AND USES THEREOF
FIELD OF THE INVENTION
[0001] The present invention provides compounds, and compositions thereof, useful as inhibitors of protein kinases.
BACKGROUND OF THE INVENTION
[0002] The search for new therapeutic agents has been greatly aided in recent years by a better understanding of the structure of enzymes and other biomolecules associated with diseases. One important class of enzymes that has been the subject of extensive study is protein kinases.
[0003] Protein kinases constitute a large family of structurally related enzymes that are responsible for the control of a variety of signal transduction processes within the cell. Protein kinases are thought to have evolved from a common ancestral gene due to the conservation of their structure and catalytic function. Almost all kinases contain a similar 250-300 amino acid catalytic domain. The kinases may be categorized into families by the substrates they phosphorylate (e.g., protein-tyrosine, protein-serine/threonine, lipids, etc.).
[0004] In general, protein kinases mediate intracellular signaling by effecting a phosphoryl transfer from a nucleoside triphosphate to a protein acceptor that is involved in a signaling pathway. These phosphorylation events act as molecular on/off switches that can modulate or regulate the target protein biological function. These phosphorylation events are ultimately triggered in response to a variety of extracellular and other stimuli. Examples of such stimuli include environmental and chemical stress signals (e.g., osmotic shock, heat shock, ultraviolet radiation, bacterial endotoxin, and H2O2), cytokines (e.g., interleukin-1 (IL-1) and tumor necrosis factor a (TNF-a)), and growth factors (e.g., granulocyte macrophage-colony-stimulating factor (GM-CSF), and fibroblast growth factor (FGF)). An extracellular stimulus may affect one or more cellular responses related to cell growth, migration, differentiation, secretion of hormones, activation of transcription factors, muscle contraction, glucose metabolism, control of protein synthesis, and regulation of the cell cycle. [0005] Many diseases are associated with abnormal cellular responses triggered by protein kinase-mediated events as described above. These diseases include, but are not limited to, autoimmune diseases, inflammatory diseases, bone diseases, metabolic diseases, neurological and neurodegenerative diseases, cancer, cardiovascular diseases, allergies and asthma, Alzheimer's disease, and hormone-related diseases. Accordingly, there remains a need to find protein kinase inhibitors useful as therapeutic agents.
SUMMARY OF THE I VENTION
[0006] It has now been found that compounds of the present invention, and compositions thereof, are useful as inhibitors of one or more protein kinases and exhibit desirable characteristics for the same. Such compounds have general Formula I:
Figure imgf000003_0001
I or a pharmaceutically acceptable salt thereof, wherein each of R1, R2, R3, R4, R4 , R4 , R5, R6, R6,
R7, R7', R8a, R8a', R8 , R8 ', R9a, R9a', R9 , R9 ', Rxa, Rx , Rx ', Rxc, Rya, Rya', Ry andRy ' is as defined herein.
[0007] Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful for treating a variety of diseases, disorders or conditions, associated with abnormal cellular responses triggered by protein kinase-mediated events. Such diseases, disorders, or conditions include those described herein.
[0008] Compounds provided by this invention are also useful for the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.
DETAILED DESCRIPTION OF THE INVENTION
1. General Description of Certain Aspects of the Invention
[0009] As described above, the present invention provides certain compounds, and compositions thereof, useful as protein kinase inhibitors. In particular, the present invention provides certain 2,4-disubstituted pyrimidine compounds which inhibit activity of one or more protein kinases, including Janus kinase ("JAK"). Such compounds have the structure of Formula I:
Figure imgf000004_0001
I or a harmaceutically acceptable salt thereof, wherein:
Figure imgf000004_0002
Figure imgf000005_0001
each of Rla, Rl , Rlc, R2a, R2 , R2c, R3a, R3 , R3c, R4, R4', R4", R5, R6, R6', R7, R7', R8a, R8a', R8 ,
R8 ', R9a, R9a', R9 , R9 ', Rxa, Rx , Rx ', Rxc, Rya, Rya', Ry andRy ' is independently selected from hydrogen or deuterium;
provided that at least one of Rla, Rl , Rlc, R2a, R2 , R2c, R3a, R3 , R3c, R4, R4', R4", R5, R6, R6',
R7, R7', R8a, R8a', R8 , R8 ', R9a, R9a', R9 , R9 ', Rxa, Rx , Rx ', Rxc, Rya, Rya', Ry andRy ' is deuterium.
[0010] In some embodiments, the present invention provides a compound of Formula I, wherein the compound is a co
Figure imgf000005_0002
2. Compounds and Definitions
[0011] Compounds of this invention include those described generally above, and are further illustrated by the classes, subclasses, and species disclosed herein. As used herein, the following definitions shall apply unless otherwise indicated. For purposes of this invention, the chemical elements are identified in accordance with the Periodic Table of the Elements, CAS version, Handbook of Chemistry and Physics, 75th Ed. Additionally, general principles of organic chemistry are described in "Organic Chemistry", Thomas Sorrell, University Science Books, Sausalito: 1999, and "March's Advanced Organic Chemistry", 5th Ed., Ed.: Smith, M.B. and March, J., John Wiley & Sons, New York: 2001, the entire contents of which are hereby incorporated by reference.
[0012] As used herein, the term "pharmaceutically acceptable salt" refers to those salts which are, within the scope of sound medical judgment, suitable for use in contact with the tissues of humans and lower animals without undue toxicity, irritation, allergic response and the like, and are commensurate with a reasonable benefit/risk ratio. Pharmaceutically acceptable salts are well known in the art. For example, S. M. Berge et al., describe pharmaceutically acceptable salts in detail in J. Pharmaceutical Sciences, 1977, 66, 1-19, incorporated herein by reference. Pharmaceutically acceptable salts of the compounds of this invention include those derived from suitable inorganic and organic acids and bases. Examples of pharmaceutically acceptable, nontoxic acid addition salts are salts of an amino group formed with inorganic acids such as hydrochloric acid, hydrobromic acid, phosphoric acid, sulfuric acid and perchloric acid or with organic acids such as acetic acid, oxalic acid, maleic acid, tartaric acid, citric acid, succinic acid or malonic acid or by using other methods used in the art such as ion exchange. Other pharmaceutically acceptable salts include adipate, alginate, ascorbate, aspartate, benzenesulfonate, benzoate, bisulfate, borate, butyrate, camphorate, camphorsulfonate, citrate, cyclopentanepropionate, digluconate, dodecylsulfate, ethanesulfonate, formate, fumarate, glucoheptonate, glycerophosphate, gluconate, hemisulfate, heptanoate, hexanoate, hydroiodide, 2-hydroxy-ethanesulfonate, lactobionate, lactate, laurate, lauryl sulfate, malate, maleate, malonate, methanesulfonate, 2-naphthalenesulfonate, nicotinate, nitrate, oleate, oxalate, palmitate, pamoate, pectinate, persulfate, 3-phenylpropionate, phosphate, pivalate, propionate, stearate, succinate, sulfate, tartrate, thiocyanate, p-toluenesulfonate, undecanoate, valerate salts, and the like.
[0013] Salts derived from appropriate bases include alkali metal, alkaline earth metal, ammonium and N+(Ci_4alkyl)4 salts. Representative alkali or alkaline earth metal salts include sodium, lithium, potassium, calcium, magnesium, and the like. Further pharmaceutically acceptable salts include, when appropriate, nontoxic ammonium, quaternary ammonium, and amine cations formed using counterions such as halide, hydroxide, carboxylate, sulfate, phosphate, nitrate, loweralkyl sulfonate and aryl sulfonate.
[0014] Unless otherwise stated, structures depicted herein are also meant to include all isomeric (e.g., enantiomeric, diastereomeric, and geometric (or conformational)) forms of the structure; for example, the R and S configurations for each asymmetric center, Z and E double bond isomers, and Z and E conformational isomers. Therefore, single stereochemical isomers as well as enantiomeric, diastereomeric, and geometric (or conformational) mixtures of the present compounds are within the scope of the invention. Unless otherwise stated, all tautomeric forms of the compounds of the invention are within the scope of the invention.
[0015] As used herein, the term "inhibitor" is defined as a compound that binds to and /or inhibits the target protein kinase with measurable affinity. In certain embodiments, an inhibitor has an IC50 and/or binding constant of less about 50 μΜ, less than about 1 μΜ, less than about 500 nM, less than about 100 nM, or less than about 10 nM.
[0016] The terms "measurable affinity" and "measurably inhibit," as used herein, means a measurable change in JAK activity between a sample comprising a compound of the present invention, or composition thereof, and an equivalent sample comprising JAK, in the absence of said compound, or composition thereof.
3. Description of Exemplary Compounds
[0017] Deuterium (D or 2H) is a stable, non-radioactive isotope of hydrogen and has an atomic weight of 2.0144. Hydrogen naturally occurs as a mixture of the isotopes 1H (hydrogen or protium), D (2H or deuterium), and T (3H or tritium). One skilled in the art appreciates that the designation "hydrogen" in hydrogen-containing chemical compounds actually represents a mixture of hydrogen and about 0.015% deuterium.
[0018] Complete deuteration, or 100% deuteration, at any one site can be difficult to achieve in the laboratory. When a deuterium atom is indicated at a given site on any compound described herein, it is understood that a small percentage of hydrogen may still be present. Such compounds are said to be enriched with deuterium. Deuterium-enriched compounds are prepared via synthesis utilizing appropriately enriched starting materials. As used herein, the terms "deuterium-enriched" or "deuterium enrichment" refer to a compound, or a particular site of said compound, which comprises deuterium in an amount that is greater than its natural isotopic abundance (0.015%). Accordingly, in some embodiments, the present invention provides compounds comprising deuterium at a given site, wherein the percentage or level of deuterium incorporation is greater than its natural isotopic abundance. [0019] According to one aspect, the present invention provides a compound of Formula I:
Figure imgf000008_0001
I or a harmaceutically acceptable salt thereof, wherein:
Figure imgf000008_0002
R2a
-H~R2B
R2is R2c ;
Figure imgf000008_0003
each of Rla, Rl , Rlc, R2a, R2, R2c, R3a, R3 , R3c, R4, R4', R4", R5, R6, R6', R7, R7', R8a, R8a', R8,
R8 ', R9a, R9a', R9, R9 ', Rxa, Rx, Rx ', Rxc, Rya, Rya', Ry andRy ' is independently selected from hydrogen or deuterium;
provided that at least one of Rla, Rl , Rlc, R2a, R2, R2c, R3a, R3 , R3c, R4, R4', R4", R5, R6, R6',
R7, R7', R8a, R8a', R8, R8 ', R9a, R9a', R9, R9 ', Rxa, Rx, Rx ', Rxc, Rya, Rya', Ry andRy ' is deuterium.
[0020] In some embodiments, Rla is deuterium. In some embodiments, Rl is deuterium. In some embodiments, Rlc is deuterium. In some embodiments, each of Rla, Rl , and Rlc is deuterium. In some embodiments, each of Rla, Rl , and Rlc is deuterium and each of R2a, R2, T?2C ?3b ?3c ?4 ?4' ?4" ?5 T?6 ?6' ?7 TJV x?8a T?8a' ?8b ?8b' ?9a ?9a' ?9b ?9b' ?xa xjxb
Rx ', Rxc, Rya, Rya', Ry andRy ' is hydrogen.
[0021] In some embodiments, R2a is deuterium. In some embodiments, R2 is deuterium. In some embodiments, R2c is deuterium. In some embodiments, each of R2a, R2, and R2c is deuterium. In some embodiments, each of R2a, R2, and R2c is deuterium and each of Rla, Rl ,
Tjlc T?3a Tj3b ?3C ?4 ?4' ?4" T?5 ?6 ?6' ?7 TJV x?8a ?8a' ?8b ?8b' ?9a xj9a' ?9b ?9b' ?xa xjxb
Rx ', Rxc, Rya, Rya', Ry andRy ' is hydrogen.
[0022] In some embodiments, R3a is deuterium. In some embodiments, R3 is deuterium. In some embodiments, R3c is deuterium. In some embodiments, each of R3a, R3 , and R3c is deuterium. In some embodiments, each of R3a, R3 , and R3c is deuterium and each of Rla, Rl ,
TJIC T?2a T?2b T?2C T?4 TJ4' T?4" T?5 T?6 n& T?V TJV T?8a xjSa' T?8b T?8b' T?9a τ?93' T?9b T?9b' xjxa xjxb
Rx ', Rxc, Rya, Rya', Ry andRy ' is hydrogen.
[0023] In some embodiments, each of Rla, Rl, Rlc, R2a, R2, R2c, R3a, R3, and R3c is deuterium. In some embodiments, each of Rla, Rl , Rlc, R2a, R2, R2c, R3a, R3 , and R3c is deuterium and each of R4, R4', R4", R5, R6, R6', R7, R7', R8a, R8a', R8, R8 ', R9a, R9a', R9, R9 ', Rxa, Rx, Rx ', Rxc, Rya, Rya', Ry andRy ' is hydrogen.
[0024] In some embodiments, R4 is deuterium. In some embodiments, R4 is deuterium. In some embodiments, R4 is deuterium. In some embodiments, each of each of R4, R4 , and R4 is deuterium and each of Rla, Rl , Rlc, R2a, R2, R2c, R3a, R3 , R3c, R5, R6, R6', R7, R7', R8a, R8a', R8, R8 ', R9a, R9a', R9, R9 ', Rxa, Rx, Rx ', Rxc, Rya, Rya', Ry andRy ' is hydrogen.
[0025] In some embodiments, R5 is deuterium. In some embodiments, R5 is deuterium and each of Rla, Rl , Rlc, R2a, R2, R2c, R3a, R3, R3c, R4, R4', R4", R6, R6', R7, R7', R8a, R8a', R8, R8 ', R9a, R9a', R9, R9 ', Rxa, Rx, Rx ', Rxc, Rya, Rya', Ry andRy ' is hydrogen.
[0026] In some embodiments, R6 is deuterium. In some embodiments, R6 is deuterium. In some embodiments, each of R6 and R6 is deuterium. In some embodiments, each of R6 and R6 is deuterium and each of Rla, Rl , Rlc, R2a, R2, R2c, R3a, R3 , R3c, R4, R4', R4", R5, R7, R7', R8a, R8a', R8, R8 ', R9a, R9a', R9, R9 ', Rxa, Rx, Rx ', Rxc, Rya, Rya', Ry andRy ' is hydrogen.
[0027] In some embodiments, R7 is deuterium. In some embodiments, R7 is deuterium. In
1 1' 1 1' some embodiments, each of R and R is deuterium. In some embodiments, each of R and R is deuterium and each of Rla, Rl , Rlc, R2a, R2, R2c, R3a, R3 , R3c, R4, R4', R4", R5, R6, R6', R8a, R8a', R8, R8 ', R9a, R9a', R9, R9 ', Rxa, Rx, Rx ', Rxc, Rya, Rya', Ry andRy ' is hydrogen. [0028] In some embodiments, R8a is deuterium. In some embodiments, R8a is deuterium. In some embodiments, R8 is deuterium. In some embodiments, R8 is deuterium. In some embodiments, each of R8a and R8a is deuterium. In some embodiments, each of R8 and R8 is deuterium. In some embodiments, each of R8a, R8a , R8, and R8 is deuterium and each of Rla,
x?2b T?2 T?3a x?3b T?3 T?4 T?4' T?4" ?5 T?6 T?6' T?7 V x?9a T?9a' x?9b T?9b' T?xa xjxb
Rx ', Rxc, Rya, Rya', Ry andRy ' is hydrogen.
[0029] In some embodiments, R9a is deuterium. In some embodiments, R9a is deuterium. In some embodiments, R9 is deuterium. In some embodiments, R9 is deuterium. In some embodiments, each of R9a and R9a is deuterium. In some embodiments, each of R9 and R9 is deuterium. In some embodiments, each of R9a, R9a , R9, and R9 is deuterium and each of Rla, xjlb ?lc ?2a ?2b ?2 ?3a ?3b ?3 ?4 4' ?4" ?5 ?6 6' ?7 V ?8a rjSa' ?8b ?8b' xjxa xjxb
Rx ', Rxc, Rya, Rya', Ry andRy ' is hydrogen.
[0030] In some embodiments, Rxa is deuterium. In some embodiments, Rxa is deuterium and each of Rla, Rl, Rlc, R2a, R2, R2c, R3a, R3 , R3c, R4, R4', R4", R5, R6, R6', R7, R7', R8a, R8a', R8, R8 ', R9a, R9a', R9, R9 ', Rx, Rx ', Rxc, Rya, Rya', Ry andRy ' is hydrogen.
[0031] In some embodiments, Rx is deuterium. In some embodiments, Rx is deuterium. In some embodiments, each of Rx and Rx is deuterium and each of Rla, Rl, Rlc, R2a, R2, R2c, R3a,
?ya ?ya'
Ry and Ry is hydrogen.
[0032] In some embodiments, Rxc is deuterium. In some embodiments, Rxc is deuterium and each of Rla, Rl, Rlc, R2a, R2, R2c, R3a, R3 , R3c, R4, R4', R4", R5, R6, R6', R7, R7', R8a, R8a', R8, R8 ', R9a, R9a', R9, R9 ', Rxa, Rx, Rx ', Rya, Rya', Ry andRy ' is hydrogen.
[0033] In some embodiments, Rya is deuterium. In some embodiments, Rya is deuterium. In some embodiments, each of Rya and Rya' is deuterium and each of Rla, Rl, Rlc, R2a, R2, R2c, R3a, n b 3 4 4' T?4" 5 TJ6 TJ6' TJV V xj8a r?9a xj9a' xjxa xjxb rjxb' , K
Ry, and Ry is hydrogen.
[0034] In some embodiments, Ry is deuterium. In some embodiments, Ry is deuterium. In some embodiments, each of Ry and Ry ' is deuterium and each of Rla, Rl, Rlc, R2a, R2, R2c, R3a,
T?3 T?3c ?8a xjSa' ?8b ?8b' ?9a τ?93' ?9b ?9b' xjxa xjxb xjxb'
Rya, and Rya' is hydrogen. [0035] In some embodiments of Formula I, each of R4, R4, R4 is hydrogen and each of R1, R2 and R3 is -C¾. Accordingly, in some embodiments, the present invention provides a compound of Formula Il-a:
Figure imgf000011_0001
II-a
or a pharmaceutically acceptable salt thereof, wherein:
each of R6, R6', R7, R7', R8a, R8a', R8 , R8 ', R9a, R9a', R9 , R9 ', Rxa, Rx, Rx ', Rxc, Rya, Rya', Ry and Ry is independently selected from hydrogen or deuterium;
provided that at least one of R6, R6', R7, R7', R8a, R8a', R8 , R8 ', R9a, R9a', R9, R9 ', Rxa, Rx, Rx ', Rxc, Rya, Rya', Ry andRy ' is deuterium.
[0036] In some embodiments of Formula I, each of R4, R4, R4 is hydrogen and each of R1, R2 and R3 is -CH3. Accordingly, in some embodiments, the present invention provides a compound of Formula Ill-a:
Figure imgf000012_0001
III-a
or a pharmaceutically acceptable salt thereof, wherein:
each of R6, R6', R7, R7', R8a, R8a', R8 , R8 ', R9a, R9a', R9 , R9 ', Rxa, Rx , Rx ', Rxc, Rya, Rya', Ry and Ry is independently selected from hydrogen or deuterium.
[0037] In some embodiments of Formula I, each of R4, R4 , R4 is hydrogen and each of R1, R2 and R3 is -CD3. Accordingly, in some embodiments, the present invention provides a compound of Formula Il-b or Formula Ill-b:
Figure imgf000012_0002
Il-b or a pharmaceutically acceptable salt thereof, wherein:
each of R6, R6', R7, R7', R8a, R8a', R8 , R8 ', R9a, R9a', R9 , R9 ', Rxa, Rx , Rx ', Rxc, Rya, Rya', Ry and Ry is independently selected from hydrogen or deuterium.
[0038] In some embodiments of Formula I, each of R4, R4, R4 is deuterium and each of R1, R2 and R3 is -C¾. Accordingly, in some embodiments, the present invention provides a compound of Formula II-c or Formula III-c:
Figure imgf000013_0001
or a pharmaceutically acceptable salt thereof, wherein:
each of R6, R6', R7, R7', R8a, R8a', R8 , R8 ', R9a, R9a', R9 , R9 ', Rxa, Rx , Rx ', Rxc, Rya, Rya', Ry and Ry is independently selected from hydrogen or deuterium.
[0039] In some embodiments of Formula I, each of R4, R4, R4 is deuterium and each of R1, R2 and R3 is -CD3. Accordingly, in some embodiments, the present invention provides a compound of Formula Il-d or Formula Ill-d:
Figure imgf000014_0001
II-d III-d
or a pharmaceutically acceptable salt thereof, wherein
each of R66,, R6', R7 R7', R8a, R8a', R8 , R8 ', R9a, R9a', R9 , R9 ', Rxa, Rx , Rx ', Rxc, Rya, Rya', Ry and Ry is independently selected from hydrogen or deuterium
[0040] Table 1 sets forth compounds of Formula Il-a, Il-b, II-c, and II-d wherein each of R6, R6 , R7 and R7 is hydrogen. Table 2 sets forth compounds of Formula Il-a, Il-b, II-c, and Π- d wherein each of R6 and R6 is hydrogen and each of R7 and R7 is deuterium. Table 3 sets forth compounds of Formula Il-a, Il-b, II-c, and II-d wherein each of R6 and R6 is deuterium and each of R7 and R7 is hydrogen. Table 4 sets forth compounds of Formula Il-a, Il-b, II-c, and II- d wherein each of R6, R6 , R7 and R7 is deuterium. It will be appreciated that each row in Table 1 , Table 2, Table 3, and Table 4 represents four discrete compounds. For example, row 1 in Table 1 represents compounds II-a-1, Π-b-l, II-c-1 and II-d-1:
Figure imgf000015_0001
II-a-1 II-b-1 II-c-1 II-d-1
Table 1. Compounds of Formulae Il-a, Il-b, II-c, and Il-d wherein each of R6, R6 , R7 and
R7 is hydrogen.
Figure imgf000015_0002
/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
H D D H H H H H H H
H D H D H H H H H H
H D D D H H H H H H
D D D H H H H H H H
D D H D H H H H H H
D D D D H H H H H H
D H H H D H H H H H
D H H H H D H H H H
D H H H H H D H H H
D H H H H H H D H H
D H H H D D H H H H
D H H H D H D H H H
D H H H D H H D H H
D H H H H D D H H H
D H H H H D H D H H
D H H H H H D D H H
D H H H D D D H H H
D H H H D D H D H H
D H H H D H D D H H
D H H H H D D D H H
D H H H D D D D H H
H D H H D H H H H H
H D H H H D H H H H
H D H H H H D H H H
H D H H H H H D H H
H D H H D D H H H H
H D H H D H D H H H
H D H H D H H D H H
H D H H H D D H H H
H D H H H D H D H H
H D H H H H D D H H
H D H H D D D H H H
H D H H D D H D H H
H D H H D H D D H H
H D H H H D D D H H
H D H H D D D D H H
D D H H D H H H H H
D D H H H D H H H H
D D H H H H D H H H
D D H H H H H D H H
D D H H D D H H H H
D D H H D H D H H H
D D H H D H H D H H
D D H H H D D H H H
Figure imgf000017_0001
Figure imgf000018_0001
Figure imgf000019_0001
Figure imgf000020_0001
Figure imgf000021_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
292 D D H D D H H H H H
293 D D H D H D H H H H
294 D D H D H H D H H H
295 D D H D H H H D H H
296 D D H D D D H H H H
297 D D H D D H D H H H
298 D D H D D H H D H H
299 D D H D H D D H H H
300 D D H D H D H D H H
301 D D H D H H D D H H
302 D D H D D D D H H H
303 D D H D D D H D H H
304 D D H D D H D D H H
305 D D H D H D D D H H
306 D D H D D D D D H H
307 D D D D D H H H H H
308 D D D D H D H H H H
309 D D D D H H D H H H
310 D D D D H H H D H H
31 1 D D D D D D H H H H
312 D D D D D H D H H H
313 D D D D D H H D H H
314 D D D D H D D H H H
315 D D D D H D H D H H
316 D D D D H H D D H H
317 D D D D D D D H H H
318 D D D D D D H D H H
319 D D D D D H D D H H
320 D D D D H D D D H H
321 D D D D D D D D H H
322 D H D H H H H H D H
323 D H H D H H H H D H
324 D H D D H H H H D H
325 H D D H H H H H D H
326 H D H D H H H H D H
327 H D D D H H H H D H
328 D D D H H H H H D H
329 D D H D H H H H D H
330 D D D D H H H H D H
331 D H D H H H H H H D
332 D H H D H H H H H D
333 D H D D H H H H H D
334 H D D H H H H H H D
335 H D H D H H H H H D No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
336 H D D D H H H H H D
337 D D D H H H H H H D
338 D D H D H H H H H D
339 D D D D H H H H H D
340 D H D H H H H H D D
341 D H H D H H H H D D
342 D H D D H H H H D D
343 H D D H H H H H D D
344 H D H D H H H H D D
345 H D D D H H H H D D
346 D D D H H H H H D D
347 D D H D H H H H D D
348 D D D D H H H H D D
349 D H H H D H H H D H
350 D H H H H D H H D H
351 D H H H H H D H D H
352 D H H H H H H D D H
353 D H H H D D H H D H
354 D H H H D H D H D H
355 D H H H D H H D D H
356 D H H H H D D H D H
357 D H H H H D H D D H
358 D H H H H H D D D H
359 D H H H D D D H D H
360 D H H H D D H D D H
361 D H H H D H D D D H
362 D H H H H D D D D H
363 D H H H D D D D D H
364 D H H H D H H H H D
365 D H H H H D H H H D
366 D H H H H H D H H D
367 D H H H H H H D H D
368 D H H H D D H H H D
369 D H H H D H D H H D
370 D H H H D H H D H D
371 D H H H H D D H H D
372 D H H H H D H D H D
373 D H H H H H D D H D
374 D H H H D D D H H D
375 D H H H D D H D H D
376 D H H H D H D D H D
377 D H H H H D D D H D
378 D H H H D D D D H D
379 D H H H D H H H D D
Figure imgf000024_0001
Figure imgf000025_0001
Figure imgf000026_0001
Figure imgf000027_0001
Figure imgf000028_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
600 H H D D D D H D H D
601 H H D D D H D D H D
602 H H D D H D D D H D
603 H H D D D D D D H D
604 H H D D D H H H D D
605 H H D D H D H H D D
606 H H D D H H D H D D
607 H H D D H H H D D D
608 H H D D D D H H D D
609 H H D D D H D H D D
610 H H D D D H H D D D
61 1 H H D D H D D H D D
612 H H D D H D H D D D
613 H H D D H H D D D D
614 H H D D D D D H D D
615 H H D D D D H D D D
616 H H D D D H D D D D
617 H H D D H D D D D D
618 H H D D D D D D D D
619 D H D H D H H H D H
620 D H D H H D H H D H
621 D H D H H H D H D H
622 D H D H H H H D D H
623 D H D H D D H H D H
624 D H D H D H D H D H
625 D H D H D H H D D H
626 D H D H H D D H D H
627 D H D H H D H D D H
628 D H D H H H D D D H
629 D H D H D D D H D H
630 D H D H D D H D D H
631 D H D H D H D D D H
632 D H D H H D D D D H
633 D H D H D D D D D H
634 D H H D D H H H D H
635 D H H D H D H H D H
636 D H H D H H D H D H
637 D H H D H H H D D H
638 D H H D D D H H D H
639 D H H D D H D H D H
640 D H H D D H H D D H
641 D H H D H D D H D H
642 D H H D H D H D D H
643 D H H D H H D D D H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
644 D H H D D D D H D H
645 D H H D D D H D D H
646 D H H D D H D D D H
647 D H H D H D D D D H
648 D H H D D D D D D H
649 D H D D D H H H D H
650 D H D D H D H H D H
651 D H D D H H D H D H
652 D H D D H H H D D H
653 D H D D D D H H D H
654 D H D D D H D H D H
655 D H D D D H H D D H
656 D H D D H D D H D H
657 D H D D H D H D D H
658 D H D D H H D D D H
659 D H D D D D D H D H
660 D H D D D D H D D H
661 D H D D D H D D D H
662 D H D D H D D D D H
663 D H D D D D D D D H
664 H D D H D H H H D H
665 H D D H H D H H D H
666 H D D H H H D H D H
667 H D D H H H H D D H
668 H D D H D D H H D H
669 H D D H D H D H D H
670 H D D H D H H D D H
671 H D D H H D D H D H
672 H D D H H D H D D H
673 H D D H H H D D D H
674 H D D H D D D H D H
675 H D D H D D H D D H
676 H D D H D H D D D H
677 H D D H H D D D D H
678 H D D H D D D D D H
679 H D H D D H H H D H
680 H D H D H D H H D H
681 H D H D H H D H D H
682 H D H D H H H D D H
683 H D H D D D H H D H
684 H D H D D H D H D H
685 H D H D D H H D D H
686 H D H D H D D H D H
687 H D H D H D H D D H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
688 H D H D H H D D D H
689 H D H D D D D H D H
690 H D H D D D H D D H
691 H D H D D H D D D H
692 H D H D H D D D D H
693 H D H D D D D D D H
694 H D D D D H H H D H
695 H D D D H D H H D H
696 H D D D H H D H D H
697 H D D D H H H D D H
698 H D D D D D H H D H
699 H D D D D H D H D H
700 H D D D D H H D D H
701 H D D D H D D H D H
702 H D D D H D H D D H
703 H D D D H H D D D H
704 H D D D D D D H D H
705 H D D D D D H D D H
706 H D D D D H D D D H
707 H D D D H D D D D H
708 H D D D D D D D D H
709 D D D H D H H H D H
710 D D D H H D H H D H
71 1 D D D H H H D H D H
712 D D D H H H H D D H
713 D D D H D D H H D H
714 D D D H D H D H D H
715 D D D H D H H D D H
716 D D D H H D D H D H
717 D D D H H D H D D H
718 D D D H H H D D D H
719 D D D H D D D H D H
720 D D D H D D H D D H
721 D D D H D H D D D H
722 D D D H H D D D D H
723 D D D H D D D D D H
724 D D H D D H H H D H
725 D D H D H D H H D H
726 D D H D H H D H D H
727 D D H D H H H D D H
728 D D H D D D H H D H
729 D D H D D H D H D H
730 D D H D D H H D D H
731 D D H D H D D H D H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
732 D D H D H D H D D H
733 D D H D H H D D D H
734 D D H D D D D H D H
735 D D H D D D H D D H
736 D D H D D H D D D H
737 D D H D H D D D D H
738 D D H D D D D D D H
739 D D D D D H H H D H
740 D D D D H D H H D H
741 D D D D H H D H D H
742 D D D D H H H D D H
743 D D D D D D H H D H
744 D D D D D H D H D H
745 D D D D D H H D D H
746 D D D D H D D H D H
747 D D D D H D H D D H
748 D D D D H H D D D H
749 D D D D D D D H D H
750 D D D D D D H D D H
751 D D D D D H D D D H
752 D D D D H D D D D H
753 D D D D D D D D D H
754 D H D H D H H H H D
755 D H D H H D H H H D
756 D H D H H H D H H D
757 D H D H H H H D H D
758 D H D H D D H H H D
759 D H D H D H D H H D
760 D H D H D H H D H D
761 D H D H H D D H H D
762 D H D H H D H D H D
763 D H D H H H D D H D
764 D H D H D D D H H D
765 D H D H D D H D H D
766 D H D H D H D D H D
767 D H D H H D D D H D
768 D H D H D D D D H D
769 D H H D D H H H H D
770 D H H D H D H H H D
771 D H H D H H D H H D
772 D H H D H H H D H D
773 D H H D D D H H H D
774 D H H D D H D H H D
775 D H H D D H H D H D
Figure imgf000033_0001
Figure imgf000034_0001
Figure imgf000035_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
908 D H H D D D H H D D
909 D H H D D H D H D D
910 D H H D D H H D D D
91 1 D H H D H D D H D D
912 D H H D H D H D D D
913 D H H D H H D D D D
914 D H H D D D D H D D
915 D H H D D D H D D D
916 D H H D D H D D D D
917 D H H D H D D D D D
918 D H H D D D D D D D
919 D H D D D H H H D D
920 D H D D H D H H D D
921 D H D D H H D H D D
922 D H D D H H H D D D
923 D H D D D D H H D D
924 D H D D D H D H D D
925 D H D D D H H D D D
926 D H D D H D D H D D
927 D H D D H D H D D D
928 D H D D H H D D D D
929 D H D D D D D H D D
930 D H D D D D H D D D
931 D H D D D H D D D D
932 D H D D H D D D D D
933 D H D D D D D D D D
934 H D D H D H H H D D
935 H D D H H D H H D D
936 H D D H H H D H D D
937 H D D H H H H D D D
938 H D D H D D H H D D
939 H D D H D H D H D D
940 H D D H D H H D D D
941 H D D H H D D H D D
942 H D D H H D H D D D
943 H D D H H H D D D D
944 H D D H D D D H D D
945 H D D H D D H D D D
946 H D D H D H D D D D
947 H D D H H D D D D D
948 H D D H D D D D D D
949 H D H D D H H H D D
950 H D H D H D H H D D
951 H D H D H H D H D D No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
952 H D H D H H H D D D
953 H D H D D D H H D D
954 H D H D D H D H D D
955 H D H D D H H D D D
956 H D H D H D D H D D
957 H D H D H D H D D D
958 H D H D H H D D D D
959 H D H D D D D H D D
960 H D H D D D H D D D
961 H D H D D H D D D D
962 H D H D H D D D D D
963 H D H D D D D D D D
964 H D D D D H H H D D
965 H D D D H D H H D D
966 H D D D H H D H D D
967 H D D D H H H D D D
968 H D D D D D H H D D
969 H D D D D H D H D D
970 H D D D D H H D D D
971 H D D D H D D H D D
972 H D D D H D H D D D
973 H D D D H H D D D D
974 H D D D D D D H D D
975 H D D D D D H D D D
976 H D D D D H D D D D
977 H D D D H D D D D D
978 H D D D D D D D D D
979 D D D H D H H H D D
980 D D D H H D H H D D
981 D D D H H H D H D D
982 D D D H H H H D D D
983 D D D H D D H H D D
984 D D D H D H D H D D
985 D D D H D H H D D D
986 D D D H H D D H D D
987 D D D H H D H D D D
988 D D D H H H D D D D
989 D D D H D D D H D D
990 D D D H D D H D D D
991 D D D H D H D D D D
992 D D D H H D D D D D
993 D D D H D D D D D D
994 D D H D D H H H D D
995 D D H D H D H H D D
Figure imgf000038_0001
Table 2. Compounds of Formulae Il-a, Il-b, Π-c, and Il-d wherein each of R6 and R6 is hydrogen and each of R 7 and R 7' is deuterium.
Figure imgf000038_0002
Figure imgf000039_0001
Figure imgf000040_0001
Figure imgf000041_0001
Figure imgf000042_0001
Figure imgf000043_0001
Figure imgf000044_0001
Figure imgf000045_0001
Figure imgf000046_0001
Figure imgf000047_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
1430 H D H H D H D D D H
1431 H D H H H D D D D H
1432 H D H H D D D D D H
1433 H D H H D H H H H D
1434 H D H H H D H H H D
1435 H D H H H H D H H D
1436 H D H H H H H D H D
1437 H D H H D D H H H D
1438 H D H H D H D H H D
1439 H D H H D H H D H D
1440 H D H H H D D H H D
1441 H D H H H D H D H D
1442 H D H H H H D D H D
1443 H D H H D D D H H D
1444 H D H H D D H D H D
1445 H D H H D H D D H D
1446 H D H H H D D D H D
1447 H D H H D D D D H D
1448 H D H H D H H H D D
1449 H D H H H D H H D D
1450 H D H H H H D H D D
1451 H D H H H H H D D D
1452 H D H H D D H H D D
1453 H D H H D H D H D D
1454 H D H H D H H D D D
1455 H D H H H D D H D D
1456 H D H H H D H D D D
1457 H D H H H H D D D D
1458 H D H H D D D H D D
1459 H D H H D D H D D D
1460 H D H H D H D D D D
1461 H D H H H D D D D D
1462 H D H H D D D D D D
1463 D D H H D H H H D H
1464 D D H H H D H H D H
1465 D D H H H H D H D H
1466 D D H H H H H D D H
1467 D D H H D D H H D H
1468 D D H H D H D H D H
1469 D D H H D H H D D H
1470 D D H H H D D H D H
1471 D D H H H D H D D H
1472 D D H H H H D D D H
1473 D D H H D D D H D H
Figure imgf000049_0001
Figure imgf000050_0001
Figure imgf000051_0001
Figure imgf000052_0001
Figure imgf000053_0001
Figure imgf000054_0001
Figure imgf000055_0001
Figure imgf000056_0001
Figure imgf000057_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
1870 D D D H H H D H H D
1871 D D D H H H H D H D
1872 D D D H D D H H H D
1873 D D D H D H D H H D
1874 D D D H D H H D H D
1875 D D D H H D D H H D
1876 D D D H H D H D H D
1877 D D D H H H D D H D
1878 D D D H D D D H H D
1879 D D D H D D H D H D
1880 D D D H D H D D H D
1881 D D D H H D D D H D
1882 D D D H D D D D H D
1883 D D H D D H H H H D
1884 D D H D H D H H H D
1885 D D H D H H D H H D
1886 D D H D H H H D H D
1887 D D H D D D H H H D
1888 D D H D D H D H H D
1889 D D H D D H H D H D
1890 D D H D H D D H H D
1891 D D H D H D H D H D
1892 D D H D H H D D H D
1893 D D H D D D D H H D
1894 D D H D D D H D H D
1895 D D H D D H D D H D
1896 D D H D H D D D H D
1897 D D H D D D D D H D
1898 D D D D D H H H H D
1899 D D D D H D H H H D
1900 D D D D H H D H H D
1901 D D D D H H H D H D
1902 D D D D D D H H H D
1903 D D D D D H D H H D
1904 D D D D D H H D H D
1905 D D D D H D D H H D
1906 D D D D H D H D H D
1907 D D D D H H D D H D
1908 D D D D D D D H H D
1909 D D D D D D H D H D
1910 D D D D D H D D H D
1911 D D D D H D D D H D
1912 D D D D D D D D H D
1913 D H D H D H H H D D
Figure imgf000059_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
1958 H D D H D H H H D D
1959 H D D H H D H H D D
1960 H D D H H H D H D D
1961 H D D H H H H D D D
1962 H D D H D D H H D D
1963 H D D H D H D H D D
1964 H D D H D H H D D D
1965 H D D H H D D H D D
1966 H D D H H D H D D D
1967 H D D H H H D D D D
1968 H D D H D D D H D D
1969 H D D H D D H D D D
1970 H D D H D H D D D D
1971 H D D H H D D D D D
1972 H D D H D D D D D D
1973 H D H D D H H H D D
1974 H D H D H D H H D D
1975 H D H D H H D H D D
1976 H D H D H H H D D D
1977 H D H D D D H H D D
1978 H D H D D H D H D D
1979 H D H D D H H D D D
1980 H D H D H D D H D D
1981 H D H D H D H D D D
1982 H D H D H H D D D D
1983 H D H D D D D H D D
1984 H D H D D D H D D D
1985 H D H D D H D D D D
1986 H D H D H D D D D D
1987 H D H D D D D D D D
1988 H D D D D H H H D D
1989 H D D D H D H H D D
1990 H D D D H H D H D D
1991 H D D D H H H D D D
1992 H D D D D D H H D D
1993 H D D D D H D H D D
1994 H D D D D H H D D D
1995 H D D D H D D H D D
1996 H D D D H D H D D D
1997 H D D D H H D D D D
1998 H D D D D D D H D D
1999 H D D D D D H D D D
2000 H D D D D H D D D D
2001 H D D D H D D D D D
Figure imgf000061_0001
No. R8a/R8a R8b/R8b' R9a/R9a' R9b/R9b' Rxa Rxb Rxb' Rxc Rya/Rya Ryl7Ryb'
2046 D D D D H D D D D D
2047 D D D D D D D D D D
Table 3. Compounds of Formulae Il-a i, Il-b, Π- c, and Il-d wherein each of R6 and R6 is deuterium and each of R 7 and R 7' is hydrogen.
No. R8a/R8a R8b/R8b' R9a/R9a' R9b/R9b' Rxa Rxb Rxb Rxc Rya/Rya Ryb/Ryb'
2048 H H H H H H H H H H
2049 D H H H H H H H H H
2050 H D H H H H H H H H
2051 D D H H H H H H H H
2052 H H D H H H H H H H
2053 H H H D H H H H H H
2054 H H D D H H H H H H
2055 H H H H D H H H H H
2056 H H H H H D H H H H
2057 H H H H H H D H H H
2058 H H H H H H H D H H
2059 H H H H D D H H H H
2060 H H H H D H D H H H
2061 H H H H D H H D H H
2062 H H H H H D D H H H
2063 H H H H H D H D H H
2064 H H H H H H D D H H
2065 H H H H D D D H H H
2066 H H H H D D H D H H
2067 H H H H D H D D H H
2068 H H H H H D D D H H
2069 H H H H D D D D H H
2070 H H H H H H H H D H
2071 H H H H H H H H H D
2072 H H H H H H H H D D
2073 D H D H H H H H H H
2074 D H H D H H H H H H
2075 D H D D H H H H H H
2076 H D D H H H H H H H
2077 H D H D H H H H H H
2078 H D D D H H H H H H
2079 D D D H H H H H H H
2080 D D H D H H H H H H
2081 D D D D H H H H H H
2082 D H H H D H H H H H
2083 D H H H H D H H H H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2084 D H H H H H D H H H
2085 D H H H H H H D H H
2086 D H H H D D H H H H
2087 D H H H D H D H H H
2088 D H H H D H H D H H
2089 D H H H H D D H H H
2090 D H H H H D H D H H
2091 D H H H H H D D H H
2092 D H H H D D D H H H
2093 D H H H D D H D H H
2094 D H H H D H D D H H
2095 D H H H H D D D H H
2096 D H H H D D D D H H
2097 H D H H D H H H H H
2098 H D H H H D H H H H
2099 H D H H H H D H H H
2100 H D H H H H H D H H
2101 H D H H D D H H H H
2102 H D H H D H D H H H
2103 H D H H D H H D H H
2104 H D H H H D D H H H
2105 H D H H H D H D H H
2106 H D H H H H D D H H
2107 H D H H D D D H H H
2108 H D H H D D H D H H
2109 H D H H D H D D H H
2110 H D H H H D D D H H
2111 H D H H D D D D H H
2112 D D H H D H H H H H
2113 D D H H H D H H H H
2114 D D H H H H D H H H
2115 D D H H H H H D H H
2116 D D H H D D H H H H
2117 D D H H D H D H H H
2118 D D H H D H H D H H
2119 D D H H H D D H H H
2120 D D H H H D H D H H
2121 D D H H H H D D H H
2122 D D H H D D D H H H
2123 D D H H D D H D H H
2124 D D H H D H D D H H
2125 D D H H H D D D H H
2126 D D H H D D D D H H
2127 D H H H H H H H D H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2128 D H H H H H H H H D
2129 D H H H H H H H D D
2130 H D H H H H H H D H
2131 H D H H H H H H H D
2132 H D H H H H H H D D
2133 D D H H H H H H D H
2134 D D H H H H H H H D
2135 D D H H H H H H D D
2136 H H D H D H H H H H
2137 H H D H H D H H H H
2138 H H D H H H D H H H
2139 H H D H H H H D H H
2140 H H D H D D H H H H
2141 H H D H D H D H H H
2142 H H D H D H H D H H
2143 H H D H H D D H H H
2144 H H D H H D H D H H
2145 H H D H H H D D H H
2146 H H D H D D D H H H
2147 H H D H D D H D H H
2148 H H D H D H D D H H
2149 H H D H H D D D H H
2150 H H D H D D D D H H
2151 H H H D D H H H H H
2152 H H H D H D H H H H
2153 H H H D H H D H H H
2154 H H H D H H H D H H
2155 H H H D D D H H H H
2156 H H H D D H D H H H
2157 H H H D D H H D H H
2158 H H H D H D D H H H
2159 H H H D H D H D H H
2160 H H H D H H D D H H
2161 H H H D D D D H H H
2162 H H H D D D H D H H
2163 H H H D D H D D H H
2164 H H H D H D D D H H
2165 H H H D D D D D H H
2166 H H D D D H H H H H
2167 H H D D H D H H H H
2168 H H D D H H D H H H
2169 H H D D H H H D H H
2170 H H D D D D H H H H
2171 H H D D D H D H H H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2172 H H D D D H H D H H
2173 H H D D H D D H H H
2174 H H D D H D H D H H
2175 H H D D H H D D H H
2176 H H D D D D D H H H
2177 H H D D D D H D H H
2178 H H D D D H D D H H
2179 H H D D H D D D H H
2180 H H D D D D D D H H
2181 H H D H H H H H D H
2182 H H D H H H H H H D
2183 H H D H H H H H D D
2184 H H H D H H H H D H
2185 H H H D H H H H H D
2186 H H H D H H H H D D
2187 H H D D H H H H D H
2188 H H D D H H H H H D
2189 H H D D H H H H D D
2190 H H H H D H H H D H
2191 H H H H H D H H D H
2192 H H H H H H D H D H
2193 H H H H H H H D D H
2194 H H H H D D H H D H
2195 H H H H D H D H D H
2196 H H H H D H H D D H
2197 H H H H H D D H D H
2198 H H H H H D H D D H
2199 H H H H H H D D D H
2200 H H H H D D D H D H
2201 H H H H D D H D D H
2202 H H H H D H D D D H
2203 H H H H H D D D D H
2204 H H H H D D D D D H
2205 H H H H D H H H H D
2206 H H H H H D H H H D
2207 H H H H H H D H H D
2208 H H H H H H H D H D
2209 H H H H D D H H H D
2210 H H H H D H D H H D
2211 H H H H D H H D H D
2212 H H H H H D D H H D
2213 H H H H H D H D H D
2214 H H H H H H D D H D
2215 H H H H D D D H H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2216 H H H H D D H D H D
2217 H H H H D H D D H D
2218 H H H H H D D D H D
2219 H H H H D D D D H D
2220 H H H H D H H H D D
2221 H H H H H D H H D D
2222 H H H H H H D H D D
2223 H H H H H H H D D D
2224 H H H H D D H H D D
2225 H H H H D H D H D D
2226 H H H H D H H D D D
2227 H H H H H D D H D D
2228 H H H H H D H D D D
2229 H H H H H H D D D D
2230 H H H H D D D H D D
2231 H H H H D D H D D D
2232 H H H H D H D D D D
2233 H H H H H D D D D D
2234 H H H H D D D D D D
2235 D H D H D H H H H H
2236 D H D H H D H H H H
2237 D H D H H H D H H H
2238 D H D H H H H D H H
2239 D H D H D D H H H H
2240 D H D H D H D H H H
2241 D H D H D H H D H H
2242 D H D H H D D H H H
2243 D H D H H D H D H H
2244 D H D H H H D D H H
2245 D H D H D D D H H H
2246 D H D H D D H D H H
2247 D H D H D H D D H H
2248 D H D H H D D D H H
2249 D H D H D D D D H H
2250 D H H D D H H H H H
2251 D H H D H D H H H H
2252 D H H D H H D H H H
2253 D H H D H H H D H H
2254 D H H D D D H H H H
2255 D H H D D H D H H H
2256 D H H D D H H D H H
2257 D H H D H D D H H H
2258 D H H D H D H D H H
2259 D H H D H H D D H H No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2260 D H H D D D D H H H
2261 D H H D D D H D H H
2262 D H H D D H D D H H
2263 D H H D H D D D H H
2264 D H H D D D D D H H
2265 D H D D D H H H H H
2266 D H D D H D H H H H
2267 D H D D H H D H H H
2268 D H D D H H H D H H
2269 D H D D D D H H H H
2270 D H D D D H D H H H
2271 D H D D D H H D H H
2272 D H D D H D D H H H
2273 D H D D H D H D H H
2274 D H D D H H D D H H
2275 D H D D D D D H H H
2276 D H D D D D H D H H
2277 D H D D D H D D H H
2278 D H D D H D D D H H
2279 D H D D D D D D H H
2280 H D D H D H H H H H
2281 H D D H H D H H H H
2282 H D D H H H D H H H
2283 H D D H H H H D H H
2284 H D D H D D H H H H
2285 H D D H D H D H H H
2286 H D D H D H H D H H
2287 H D D H H D D H H H
2288 H D D H H D H D H H
2289 H D D H H H D D H H
2290 H D D H D D D H H H
2291 H D D H D D H D H H
2292 H D D H D H D D H H
2293 H D D H H D D D H H
2294 H D D H D D D D H H
2295 H D H D D H H H H H
2296 H D H D H D H H H H
2297 H D H D H H D H H H
2298 H D H D H H H D H H
2299 H D H D D D H H H H
2300 H D H D D H D H H H
2301 H D H D D H H D H H
2302 H D H D H D D H H H
2303 H D H D H D H D H H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2304 H D H D H H D D H H
2305 H D H D D D D H H H
2306 H D H D D D H D H H
2307 H D H D D H D D H H
2308 H D H D H D D D H H
2309 H D H D D D D D H H
2310 H D D D D H H H H H
2311 H D D D H D H H H H
2312 H D D D H H D H H H
2313 H D D D H H H D H H
2314 H D D D D D H H H H
2315 H D D D D H D H H H
2316 H D D D D H H D H H
2317 H D D D H D D H H H
2318 H D D D H D H D H H
2319 H D D D H H D D H H
2320 H D D D D D D H H H
2321 H D D D D D H D H H
2322 H D D D D H D D H H
2323 H D D D H D D D H H
2324 H D D D D D D D H H
2325 D D D H D H H H H H
2326 D D D H H D H H H H
2327 D D D H H H D H H H
2328 D D D H H H H D H H
2329 D D D H D D H H H H
2330 D D D H D H D H H H
2331 D D D H D H H D H H
2332 D D D H H D D H H H
2333 D D D H H D H D H H
2334 D D D H H H D D H H
2335 D D D H D D D H H H
2336 D D D H D D H D H H
2337 D D D H D H D D H H
2338 D D D H H D D D H H
2339 D D D H D D D D H H
2340 D D H D D H H H H H
2341 D D H D H D H H H H
2342 D D H D H H D H H H
2343 D D H D H H H D H H
2344 D D H D D D H H H H
2345 D D H D D H D H H H
2346 D D H D D H H D H H
2347 D D H D H D D H H H No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2348 D D H D H D H D H H
2349 D D H D H H D D H H
2350 D D H D D D D H H H
2351 D D H D D D H D H H
2352 D D H D D H D D H H
2353 D D H D H D D D H H
2354 D D H D D D D D H H
2355 D D D D D H H H H H
2356 D D D D H D H H H H
2357 D D D D H H D H H H
2358 D D D D H H H D H H
2359 D D D D D D H H H H
2360 D D D D D H D H H H
2361 D D D D D H H D H H
2362 D D D D H D D H H H
2363 D D D D H D H D H H
2364 D D D D H H D D H H
2365 D D D D D D D H H H
2366 D D D D D D H D H H
2367 D D D D D H D D H H
2368 D D D D H D D D H H
2369 D D D D D D D D H H
2370 D H D H H H H H D H
2371 D H H D H H H H D H
2372 D H D D H H H H D H
2373 H D D H H H H H D H
2374 H D H D H H H H D H
2375 H D D D H H H H D H
2376 D D D H H H H H D H
2377 D D H D H H H H D H
2378 D D D D H H H H D H
2379 D H D H H H H H H D
2380 D H H D H H H H H D
2381 D H D D H H H H H D
2382 H D D H H H H H H D
2383 H D H D H H H H H D
2384 H D D D H H H H H D
2385 D D D H H H H H H D
2386 D D H D H H H H H D
2387 D D D D H H H H H D
2388 D H D H H H H H D D
2389 D H H D H H H H D D
2390 D H D D H H H H D D
2391 H D D H H H H H D D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2392 H D H D H H H H D D
2393 H D D D H H H H D D
2394 D D D H H H H H D D
2395 D D H D H H H H D D
2396 D D D D H H H H D D
2397 D H H H D H H H D H
2398 D H H H H D H H D H
2399 D H H H H H D H D H
2400 D H H H H H H D D H
2401 D H H H D D H H D H
2402 D H H H D H D H D H
2403 D H H H D H H D D H
2404 D H H H H D D H D H
2405 D H H H H D H D D H
2406 D H H H H H D D D H
2407 D H H H D D D H D H
2408 D H H H D D H D D H
2409 D H H H D H D D D H
2410 D H H H H D D D D H
2411 D H H H D D D D D H
2412 D H H H D H H H H D
2413 D H H H H D H H H D
2414 D H H H H H D H H D
2415 D H H H H H H D H D
2416 D H H H D D H H H D
2417 D H H H D H D H H D
2418 D H H H D H H D H D
2419 D H H H H D D H H D
2420 D H H H H D H D H D
2421 D H H H H H D D H D
2422 D H H H D D D H H D
2423 D H H H D D H D H D
2424 D H H H D H D D H D
2425 D H H H H D D D H D
2426 D H H H D D D D H D
2427 D H H H D H H H D D
2428 D H H H H D H H D D
2429 D H H H H H D H D D
2430 D H H H H H H D D D
2431 D H H H D D H H D D
2432 D H H H D H D H D D
2433 D H H H D H H D D D
2434 D H H H H D D H D D
2435 D H H H H D H D D D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2436 D H H H H H D D D D
2437 D H H H D D D H D D
2438 D H H H D D H D D D
2439 D H H H D H D D D D
2440 D H H H H D D D D D
2441 D H H H D D D D D D
2442 H D H H D H H H D H
2443 H D H H H D H H D H
2444 H D H H H H D H D H
2445 H D H H H H H D D H
2446 H D H H D D H H D H
2447 H D H H D H D H D H
2448 H D H H D H H D D H
2449 H D H H H D D H D H
2450 H D H H H D H D D H
2451 H D H H H H D D D H
2452 H D H H D D D H D H
2453 H D H H D D H D D H
2454 H D H H D H D D D H
2455 H D H H H D D D D H
2456 H D H H D D D D D H
2457 H D H H D H H H H D
2458 H D H H H D H H H D
2459 H D H H H H D H H D
2460 H D H H H H H D H D
2461 H D H H D D H H H D
2462 H D H H D H D H H D
2463 H D H H D H H D H D
2464 H D H H H D D H H D
2465 H D H H H D H D H D
2466 H D H H H H D D H D
2467 H D H H D D D H H D
2468 H D H H D D H D H D
2469 H D H H D H D D H D
2470 H D H H H D D D H D
2471 H D H H D D D D H D
2472 H D H H D H H H D D
2473 H D H H H D H H D D
2474 H D H H H H D H D D
2475 H D H H H H H D D D
2476 H D H H D D H H D D
2477 H D H H D H D H D D
2478 H D H H D H H D D D
2479 H D H H H D D H D D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2480 H D H H H D H D D D
2481 H D H H H H D D D D
2482 H D H H D D D H D D
2483 H D H H D D H D D D
2484 H D H H D H D D D D
2485 H D H H H D D D D D
2486 H D H H D D D D D D
2487 D D H H D H H H D H
2488 D D H H H D H H D H
2489 D D H H H H D H D H
2490 D D H H H H H D D H
2491 D D H H D D H H D H
2492 D D H H D H D H D H
2493 D D H H D H H D D H
2494 D D H H H D D H D H
2495 D D H H H D H D D H
2496 D D H H H H D D D H
2497 D D H H D D D H D H
2498 D D H H D D H D D H
2499 D D H H D H D D D H
2500 D D H H H D D D D H
2501 D D H H D D D D D H
2502 D D H H D H H H H D
2503 D D H H H D H H H D
2504 D D H H H H D H H D
2505 D D H H H H H D H D
2506 D D H H D D H H H D
2507 D D H H D H D H H D
2508 D D H H D H H D H D
2509 D D H H H D D H H D
2510 D D H H H D H D H D
2511 D D H H H H D D H D
2512 D D H H D D D H H D
2513 D D H H D D H D H D
2514 D D H H D H D D H D
2515 D D H H H D D D H D
2516 D D H H D D D D H D
2517 D D H H D H H H D D
2518 D D H H H D H H D D
2519 D D H H H H D H D D
2520 D D H H H H H D D D
2521 D D H H D D H H D D
2522 D D H H D H D H D D
2523 D D H H D H H D D D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2524 D D H H H D D H D D
2525 D D H H H D H D D D
2526 D D H H H H D D D D
2527 D D H H D D D H D D
2528 D D H H D D H D D D
2529 D D H H D H D D D D
2530 D D H H H D D D D D
2531 D D H H D D D D D D
2532 H H D H D H H H D H
2533 H H D H H D H H D H
2534 H H D H H H D H D H
2535 H H D H H H H D D H
2536 H H D H D D H H D H
2537 H H D H D H D H D H
2538 H H D H D H H D D H
2539 H H D H H D D H D H
2540 H H D H H D H D D H
2541 H H D H H H D D D H
2542 H H D H D D D H D H
2543 H H D H D D H D D H
2544 H H D H D H D D D H
2545 H H D H H D D D D H
2546 H H D H D D D D D H
2547 H H D H D H H H H D
2548 H H D H H D H H H D
2549 H H D H H H D H H D
2550 H H D H H H H D H D
2551 H H D H D D H H H D
2552 H H D H D H D H H D
2553 H H D H D H H D H D
2554 H H D H H D D H H D
2555 H H D H H D H D H D
2556 H H D H H H D D H D
2557 H H D H D D D H H D
2558 H H D H D D H D H D
2559 H H D H D H D D H D
2560 H H D H H D D D H D
2561 H H D H D D D D H D
2562 H H D H D H H H D D
2563 H H D H H D H H D D
2564 H H D H H H D H D D
2565 H H D H H H H D D D
2566 H H D H D D H H D D
2567 H H D H D H D H D D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2568 H H D H D H H D D D
2569 H H D H H D D H D D
2570 H H D H H D H D D D
2571 H H D H H H D D D D
2572 H H D H D D D H D D
2573 H H D H D D H D D D
2574 H H D H D H D D D D
2575 H H D H H D D D D D
2576 H H D H D D D D D D
2577 H H H D D H H H D H
2578 H H H D H D H H D H
2579 H H H D H H D H D H
2580 H H H D H H H D D H
2581 H H H D D D H H D H
2582 H H H D D H D H D H
2583 H H H D D H H D D H
2584 H H H D H D D H D H
2585 H H H D H D H D D H
2586 H H H D H H D D D H
2587 H H H D D D D H D H
2588 H H H D D D H D D H
2589 H H H D D H D D D H
2590 H H H D H D D D D H
2591 H H H D D D D D D H
2592 H H H D D H H H H D
2593 H H H D H D H H H D
2594 H H H D H H D H H D
2595 H H H D H H H D H D
2596 H H H D D D H H H D
2597 H H H D D H D H H D
2598 H H H D D H H D H D
2599 H H H D H D D H H D
2600 H H H D H D H D H D
2601 H H H D H H D D H D
2602 H H H D D D D H H D
2603 H H H D D D H D H D
2604 H H H D D H D D H D
2605 H H H D H D D D H D
2606 H H H D D D D D H D
2607 H H H D D H H H D D
2608 H H H D H D H H D D
2609 H H H D H H D H D D
2610 H H H D H H H D D D
2611 H H H D D D H H D D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2612 H H H D D H D H D D
2613 H H H D D H H D D D
2614 H H H D H D D H D D
2615 H H H D H D H D D D
2616 H H H D H H D D D D
2617 H H H D D D D H D D
2618 H H H D D D H D D D
2619 H H H D D H D D D D
2620 H H H D H D D D D D
2621 H H H D D D D D D D
2622 H H D D D H H H D H
2623 H H D D H D H H D H
2624 H H D D H H D H D H
2625 H H D D H H H D D H
2626 H H D D D D H H D H
2627 H H D D D H D H D H
2628 H H D D D H H D D H
2629 H H D D H D D H D H
2630 H H D D H D H D D H
2631 H H D D H H D D D H
2632 H H D D D D D H D H
2633 H H D D D D H D D H
2634 H H D D D H D D D H
2635 H H D D H D D D D H
2636 H H D D D D D D D H
2637 H H D D D H H H H D
2638 H H D D H D H H H D
2639 H H D D H H D H H D
2640 H H D D H H H D H D
2641 H H D D D D H H H D
2642 H H D D D H D H H D
2643 H H D D D H H D H D
2644 H H D D H D D H H D
2645 H H D D H D H D H D
2646 H H D D H H D D H D
2647 H H D D D D D H H D
2648 H H D D D D H D H D
2649 H H D D D H D D H D
2650 H H D D H D D D H D
2651 H H D D D D D D H D
2652 H H D D D H H H D D
2653 H H D D H D H H D D
2654 H H D D H H D H D D
2655 H H D D H H H D D D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2656 H H D D D D H H D D
2657 H H D D D H D H D D
2658 H H D D D H H D D D
2659 H H D D H D D H D D
2660 H H D D H D H D D D
2661 H H D D H H D D D D
2662 H H D D D D D H D D
2663 H H D D D D H D D D
2664 H H D D D H D D D D
2665 H H D D H D D D D D
2666 H H D D D D D D D D
2667 D H D H D H H H D H
2668 D H D H H D H H D H
2669 D H D H H H D H D H
2670 D H D H H H H D D H
2671 D H D H D D H H D H
2672 D H D H D H D H D H
2673 D H D H D H H D D H
2674 D H D H H D D H D H
2675 D H D H H D H D D H
2676 D H D H H H D D D H
2677 D H D H D D D H D H
2678 D H D H D D H D D H
2679 D H D H D H D D D H
2680 D H D H H D D D D H
2681 D H D H D D D D D H
2682 D H H D D H H H D H
2683 D H H D H D H H D H
2684 D H H D H H D H D H
2685 D H H D H H H D D H
2686 D H H D D D H H D H
2687 D H H D D H D H D H
2688 D H H D D H H D D H
2689 D H H D H D D H D H
2690 D H H D H D H D D H
2691 D H H D H H D D D H
2692 D H H D D D D H D H
2693 D H H D D D H D D H
2694 D H H D D H D D D H
2695 D H H D H D D D D H
2696 D H H D D D D D D H
2697 D H D D D H H H D H
2698 D H D D H D H H D H
2699 D H D D H H D H D H No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2700 D H D D H H H D D H
2701 D H D D D D H H D H
2702 D H D D D H D H D H
2703 D H D D D H H D D H
2704 D H D D H D D H D H
2705 D H D D H D H D D H
2706 D H D D H H D D D H
2707 D H D D D D D H D H
2708 D H D D D D H D D H
2709 D H D D D H D D D H
2710 D H D D H D D D D H
2711 D H D D D D D D D H
2712 H D D H D H H H D H
2713 H D D H H D H H D H
2714 H D D H H H D H D H
2715 H D D H H H H D D H
2716 H D D H D D H H D H
2717 H D D H D H D H D H
2718 H D D H D H H D D H
2719 H D D H H D D H D H
2720 H D D H H D H D D H
2721 H D D H H H D D D H
2722 H D D H D D D H D H
2723 H D D H D D H D D H
2724 H D D H D H D D D H
2725 H D D H H D D D D H
2726 H D D H D D D D D H
2727 H D H D D H H H D H
2728 H D H D H D H H D H
2729 H D H D H H D H D H
2730 H D H D H H H D D H
2731 H D H D D D H H D H
2732 H D H D D H D H D H
2733 H D H D D H H D D H
2734 H D H D H D D H D H
2735 H D H D H D H D D H
2736 H D H D H H D D D H
2737 H D H D D D D H D H
2738 H D H D D D H D D H
2739 H D H D D H D D D H
2740 H D H D H D D D D H
2741 H D H D D D D D D H
2742 H D D D D H H H D H
2743 H D D D H D H H D H No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2744 H D D D H H D H D H
2745 H D D D H H H D D H
2746 H D D D D D H H D H
2747 H D D D D H D H D H
2748 H D D D D H H D D H
2749 H D D D H D D H D H
2750 H D D D H D H D D H
2751 H D D D H H D D D H
2752 H D D D D D D H D H
2753 H D D D D D H D D H
2754 H D D D D H D D D H
2755 H D D D H D D D D H
2756 H D D D D D D D D H
2757 D D D H D H H H D H
2758 D D D H H D H H D H
2759 D D D H H H D H D H
2760 D D D H H H H D D H
2761 D D D H D D H H D H
2762 D D D H D H D H D H
2763 D D D H D H H D D H
2764 D D D H H D D H D H
2765 D D D H H D H D D H
2766 D D D H H H D D D H
2767 D D D H D D D H D H
2768 D D D H D D H D D H
2769 D D D H D H D D D H
2770 D D D H H D D D D H
2771 D D D H D D D D D H
2772 D D H D D H H H D H
2773 D D H D H D H H D H
2774 D D H D H H D H D H
2775 D D H D H H H D D H
2776 D D H D D D H H D H
2777 D D H D D H D H D H
2778 D D H D D H H D D H
2779 D D H D H D D H D H
2780 D D H D H D H D D H
2781 D D H D H H D D D H
2782 D D H D D D D H D H
2783 D D H D D D H D D H
2784 D D H D D H D D D H
2785 D D H D H D D D D H
2786 D D H D D D D D D H
2787 D D D D D H H H D H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2788 D D D D H D H H D H
2789 D D D D H H D H D H
2790 D D D D H H H D D H
2791 D D D D D D H H D H
2792 D D D D D H D H D H
2793 D D D D D H H D D H
2794 D D D D H D D H D H
2795 D D D D H D H D D H
2796 D D D D H H D D D H
2797 D D D D D D D H D H
2798 D D D D D D H D D H
2799 D D D D D H D D D H
2800 D D D D H D D D D H
2801 D D D D D D D D D H
2802 D H D H D H H H H D
2803 D H D H H D H H H D
2804 D H D H H H D H H D
2805 D H D H H H H D H D
2806 D H D H D D H H H D
2807 D H D H D H D H H D
2808 D H D H D H H D H D
2809 D H D H H D D H H D
2810 D H D H H D H D H D
2811 D H D H H H D D H D
2812 D H D H D D D H H D
2813 D H D H D D H D H D
2814 D H D H D H D D H D
2815 D H D H H D D D H D
2816 D H D H D D D D H D
2817 D H H D D H H H H D
2818 D H H D H D H H H D
2819 D H H D H H D H H D
2820 D H H D H H H D H D
2821 D H H D D D H H H D
2822 D H H D D H D H H D
2823 D H H D D H H D H D
2824 D H H D H D D H H D
2825 D H H D H D H D H D
2826 D H H D H H D D H D
2827 D H H D D D D H H D
2828 D H H D D D H D H D
2829 D H H D D H D D H D
2830 D H H D H D D D H D
2831 D H H D D D D D H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2832 D H D D D H H H H D
2833 D H D D H D H H H D
2834 D H D D H H D H H D
2835 D H D D H H H D H D
2836 D H D D D D H H H D
2837 D H D D D H D H H D
2838 D H D D D H H D H D
2839 D H D D H D D H H D
2840 D H D D H D H D H D
2841 D H D D H H D D H D
2842 D H D D D D D H H D
2843 D H D D D D H D H D
2844 D H D D D H D D H D
2845 D H D D H D D D H D
2846 D H D D D D D D H D
2847 H D D H D H H H H D
2848 H D D H H D H H H D
2849 H D D H H H D H H D
2850 H D D H H H H D H D
2851 H D D H D D H H H D
2852 H D D H D H D H H D
2853 H D D H D H H D H D
2854 H D D H H D D H H D
2855 H D D H H D H D H D
2856 H D D H H H D D H D
2857 H D D H D D D H H D
2858 H D D H D D H D H D
2859 H D D H D H D D H D
2860 H D D H H D D D H D
2861 H D D H D D D D H D
2862 H D H D D H H H H D
2863 H D H D H D H H H D
2864 H D H D H H D H H D
2865 H D H D H H H D H D
2866 H D H D D D H H H D
2867 H D H D D H D H H D
2868 H D H D D H H D H D
2869 H D H D H D D H H D
2870 H D H D H D H D H D
2871 H D H D H H D D H D
2872 H D H D D D D H H D
2873 H D H D D D H D H D
2874 H D H D D H D D H D
2875 H D H D H D D D H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2876 H D H D D D D D H D
2877 H D D D D H H H H D
2878 H D D D H D H H H D
2879 H D D D H H D H H D
2880 H D D D H H H D H D
2881 H D D D D D H H H D
2882 H D D D D H D H H D
2883 H D D D D H H D H D
2884 H D D D H D D H H D
2885 H D D D H D H D H D
2886 H D D D H H D D H D
2887 H D D D D D D H H D
2888 H D D D D D H D H D
2889 H D D D D H D D H D
2890 H D D D H D D D H D
2891 H D D D D D D D H D
2892 D D D H D H H H H D
2893 D D D H H D H H H D
2894 D D D H H H D H H D
2895 D D D H H H H D H D
2896 D D D H D D H H H D
2897 D D D H D H D H H D
2898 D D D H D H H D H D
2899 D D D H H D D H H D
2900 D D D H H D H D H D
2901 D D D H H H D D H D
2902 D D D H D D D H H D
2903 D D D H D D H D H D
2904 D D D H D H D D H D
2905 D D D H H D D D H D
2906 D D D H D D D D H D
2907 D D H D D H H H H D
2908 D D H D H D H H H D
2909 D D H D H H D H H D
2910 D D H D H H H D H D
2911 D D H D D D H H H D
2912 D D H D D H D H H D
2913 D D H D D H H D H D
2914 D D H D H D D H H D
2915 D D H D H D H D H D
2916 D D H D H H D D H D
2917 D D H D D D D H H D
2918 D D H D D D H D H D
2919 D D H D D H D D H D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2920 D D H D H D D D H D
2921 D D H D D D D D H D
2922 D D D D D H H H H D
2923 D D D D H D H H H D
2924 D D D D H H D H H D
2925 D D D D H H H D H D
2926 D D D D D D H H H D
2927 D D D D D H D H H D
2928 D D D D D H H D H D
2929 D D D D H D D H H D
2930 D D D D H D H D H D
2931 D D D D H H D D H D
2932 D D D D D D D H H D
2933 D D D D D D H D H D
2934 D D D D D H D D H D
2935 D D D D H D D D H D
2936 D D D D D D D D H D
2937 D H D H D H H H D D
2938 D H D H H D H H D D
2939 D H D H H H D H D D
2940 D H D H H H H D D D
2941 D H D H D D H H D D
2942 D H D H D H D H D D
2943 D H D H D H H D D D
2944 D H D H H D D H D D
2945 D H D H H D H D D D
2946 D H D H H H D D D D
2947 D H D H D D D H D D
2948 D H D H D D H D D D
2949 D H D H D H D D D D
2950 D H D H H D D D D D
2951 D H D H D D D D D D
2952 D H H D D H H H D D
2953 D H H D H D H H D D
2954 D H H D H H D H D D
2955 D H H D H H H D D D
2956 D H H D D D H H D D
2957 D H H D D H D H D D
2958 D H H D D H H D D D
2959 D H H D H D D H D D
2960 D H H D H D H D D D
2961 D H H D H H D D D D
2962 D H H D D D D H D D
2963 D H H D D D H D D D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2964 D H H D D H D D D D
2965 D H H D H D D D D D
2966 D H H D D D D D D D
2967 D H D D D H H H D D
2968 D H D D H D H H D D
2969 D H D D H H D H D D
2970 D H D D H H H D D D
2971 D H D D D D H H D D
2972 D H D D D H D H D D
2973 D H D D D H H D D D
2974 D H D D H D D H D D
2975 D H D D H D H D D D
2976 D H D D H H D D D D
2977 D H D D D D D H D D
2978 D H D D D D H D D D
2979 D H D D D H D D D D
2980 D H D D H D D D D D
2981 D H D D D D D D D D
2982 H D D H D H H H D D
2983 H D D H H D H H D D
2984 H D D H H H D H D D
2985 H D D H H H H D D D
2986 H D D H D D H H D D
2987 H D D H D H D H D D
2988 H D D H D H H D D D
2989 H D D H H D D H D D
2990 H D D H H D H D D D
2991 H D D H H H D D D D
2992 H D D H D D D H D D
2993 H D D H D D H D D D
2994 H D D H D H D D D D
2995 H D D H H D D D D D
2996 H D D H D D D D D D
2997 H D H D D H H H D D
2998 H D H D H D H H D D
2999 H D H D H H D H D D
3000 H D H D H H H D D D
3001 H D H D D D H H D D
3002 H D H D D H D H D D
3003 H D H D D H H D D D
3004 H D H D H D D H D D
3005 H D H D H D H D D D
3006 H D H D H H D D D D
3007 H D H D D D D H D D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
3008 H D H D D D H D D D
3009 H D H D D H D D D D
3010 H D H D H D D D D D
301 1 H D H D D D D D D D
3012 H D D D D H H H D D
3013 H D D D H D H H D D
3014 H D D D H H D H D D
3015 H D D D H H H D D D
3016 H D D D D D H H D D
3017 H D D D D H D H D D
3018 H D D D D H H D D D
3019 H D D D H D D H D D
3020 H D D D H D H D D D
3021 H D D D H H D D D D
3022 H D D D D D D H D D
3023 H D D D D D H D D D
3024 H D D D D H D D D D
3025 H D D D H D D D D D
3026 H D D D D D D D D D
3027 D D D H D H H H D D
3028 D D D H H D H H D D
3029 D D D H H H D H D D
3030 D D D H H H H D D D
3031 D D D H D D H H D D
3032 D D D H D H D H D D
3033 D D D H D H H D D D
3034 D D D H H D D H D D
3035 D D D H H D H D D D
3036 D D D H H H D D D D
3037 D D D H D D D H D D
3038 D D D H D D H D D D
3039 D D D H D H D D D D
3040 D D D H H D D D D D
3041 D D D H D D D D D D
3042 D D H D D H H H D D
3043 D D H D H D H H D D
3044 D D H D H H D H D D
3045 D D H D H H H D D D
3046 D D H D D D H H D D
3047 D D H D D H D H D D
3048 D D H D D H H D D D
3049 D D H D H D D H D D
3050 D D H D H D H D D D
3051 D D H D H H D D D D No. R*7R*a Rm/Rm' Rya/Rya' Ry|>/Ry|>' Rxa Rxb Rxb< Rxc Rya/Rya Ryl,/Ryb'
3052 D D H D D D D H D D
3053 D D H D D D H D D D
3054 D D H D D H D D D D
3055 D D H D H D D D D D
3056 D D H D D D D D D D
3057 D D D D D H H H D D
3058 D D D D H D H H D D
3059 D D D D H H D H D D
3060 D D D D H H H D D D
3061 D D D D D D H H D D
3062 D D D D D H D H D D
3063 D D D D D H H D D D
3064 D D D D H D D H D D
3065 D D D D H D H D D D
3066 D D D D H H D D D D
3067 D D D D D D D H D D
3068 D D D D D D H D D D
3069 D D D D D H D D D D
3070 D D D D H D D D D D
3071 D D D D D D D D D D
Table 4. Compounds of Formulae Il-a, Il-b, II-c, and Il-d wherein each of R6, R6 , R7 and R7 is deuterium.
Figure imgf000085_0001
Figure imgf000086_0001
Figure imgf000087_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3178 H H H D H H H D H H
3179 H H H D D D H H H H
3180 H H H D D H D H H H
3181 H H H D D H H D H H
3182 H H H D H D D H H H
3183 H H H D H D H D H H
3184 H H H D H H D D H H
3185 H H H D D D D H H H
3186 H H H D D D H D H H
3187 H H H D D H D D H H
3188 H H H D H D D D H H
3189 H H H D D D D D H H
3190 H H D D D H H H H H
3191 H H D D H D H H H H
3192 H H D D H H D H H H
3193 H H D D H H H D H H
3194 H H D D D D H H H H
3195 H H D D D H D H H H
3196 H H D D D H H D H H
3197 H H D D H D D H H H
3198 H H D D H D H D H H
3199 H H D D H H D D H H
3200 H H D D D D D H H H
3201 H H D D D D H D H H
3202 H H D D D H D D H H
3203 H H D D H D D D H H
3204 H H D D D D D D H H
3205 H H D H H H H H D H
3206 H H D H H H H H H D
3207 H H D H H H H H D D
3208 H H H D H H H H D H
3209 H H H D H H H H H D
3210 H H H D H H H H D D
3211 H H D D H H H H D H
3212 H H D D H H H H H D
3213 H H D D H H H H D D
3214 H H H H D H H H D H
3215 H H H H H D H H D H
3216 H H H H H H D H D H
3217 H H H H H H H D D H
3218 H H H H D D H H D H
3219 H H H H D H D H D H
3220 H H H H D H H D D H
3221 H H H H H D D H D H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3222 H H H H H D H D D H
3223 H H H H H H D D D H
3224 H H H H D D D H D H
3225 H H H H D D H D D H
3226 H H H H D H D D D H
3227 H H H H H D D D D H
3228 H H H H D D D D D H
3229 H H H H D H H H H D
3230 H H H H H D H H H D
3231 H H H H H H D H H D
3232 H H H H H H H D H D
3233 H H H H D D H H H D
3234 H H H H D H D H H D
3235 H H H H D H H D H D
3236 H H H H H D D H H D
3237 H H H H H D H D H D
3238 H H H H H H D D H D
3239 H H H H D D D H H D
3240 H H H H D D H D H D
3241 H H H H D H D D H D
3242 H H H H H D D D H D
3243 H H H H D D D D H D
3244 H H H H D H H H D D
3245 H H H H H D H H D D
3246 H H H H H H D H D D
3247 H H H H H H H D D D
3248 H H H H D D H H D D
3249 H H H H D H D H D D
3250 H H H H D H H D D D
3251 H H H H H D D H D D
3252 H H H H H D H D D D
3253 H H H H H H D D D D
3254 H H H H D D D H D D
3255 H H H H D D H D D D
3256 H H H H D H D D D D
3257 H H H H H D D D D D
3258 H H H H D D D D D D
3259 D H D H D H H H H H
3260 D H D H H D H H H H
3261 D H D H H H D H H H
3262 D H D H H H H D H H
3263 D H D H D D H H H H
3264 D H D H D H D H H H
3265 D H D H D H H D H H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3266 D H D H H D D H H H
3267 D H D H H D H D H H
3268 D H D H H H D D H H
3269 D H D H D D D H H H
3270 D H D H D D H D H H
3271 D H D H D H D D H H
3272 D H D H H D D D H H
3273 D H D H D D D D H H
3274 D H H D D H H H H H
3275 D H H D H D H H H H
3276 D H H D H H D H H H
3277 D H H D H H H D H H
3278 D H H D D D H H H H
3279 D H H D D H D H H H
3280 D H H D D H H D H H
3281 D H H D H D D H H H
3282 D H H D H D H D H H
3283 D H H D H H D D H H
3284 D H H D D D D H H H
3285 D H H D D D H D H H
3286 D H H D D H D D H H
3287 D H H D H D D D H H
3288 D H H D D D D D H H
3289 D H D D D H H H H H
3290 D H D D H D H H H H
3291 D H D D H H D H H H
3292 D H D D H H H D H H
3293 D H D D D D H H H H
3294 D H D D D H D H H H
3295 D H D D D H H D H H
3296 D H D D H D D H H H
3297 D H D D H D H D H H
3298 D H D D H H D D H H
3299 D H D D D D D H H H
3300 D H D D D D H D H H
3301 D H D D D H D D H H
3302 D H D D H D D D H H
3303 D H D D D D D D H H
3304 H D D H D H H H H H
3305 H D D H H D H H H H
3306 H D D H H H D H H H
3307 H D D H H H H D H H
3308 H D D H D D H H H H
3309 H D D H D H D H H H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3310 H D D H D H H D H H
331 1 H D D H H D D H H H
3312 H D D H H D H D H H
3313 H D D H H H D D H H
3314 H D D H D D D H H H
3315 H D D H D D H D H H
3316 H D D H D H D D H H
3317 H D D H H D D D H H
3318 H D D H D D D D H H
3319 H D H D D H H H H H
3320 H D H D H D H H H H
3321 H D H D H H D H H H
3322 H D H D H H H D H H
3323 H D H D D D H H H H
3324 H D H D D H D H H H
3325 H D H D D H H D H H
3326 H D H D H D D H H H
3327 H D H D H D H D H H
3328 H D H D H H D D H H
3329 H D H D D D D H H H
3330 H D H D D D H D H H
3331 H D H D D H D D H H
3332 H D H D H D D D H H
3333 H D H D D D D D H H
3334 H D D D D H H H H H
3335 H D D D H D H H H H
3336 H D D D H H D H H H
3337 H D D D H H H D H H
3338 H D D D D D H H H H
3339 H D D D D H D H H H
3340 H D D D D H H D H H
3341 H D D D H D D H H H
3342 H D D D H D H D H H
3343 H D D D H H D D H H
3344 H D D D D D D H H H
3345 H D D D D D H D H H
3346 H D D D D H D D H H
3347 H D D D H D D D H H
3348 H D D D D D D D H H
3349 D D D H D H H H H H
3350 D D D H H D H H H H
3351 D D D H H H D H H H
3352 D D D H H H H D H H
3353 D D D H D D H H H H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3354 D D D H D H D H H H
3355 D D D H D H H D H H
3356 D D D H H D D H H H
3357 D D D H H D H D H H
3358 D D D H H H D D H H
3359 D D D H D D D H H H
3360 D D D H D D H D H H
3361 D D D H D H D D H H
3362 D D D H H D D D H H
3363 D D D H D D D D H H
3364 D D H D D H H H H H
3365 D D H D H D H H H H
3366 D D H D H H D H H H
3367 D D H D H H H D H H
3368 D D H D D D H H H H
3369 D D H D D H D H H H
3370 D D H D D H H D H H
3371 D D H D H D D H H H
3372 D D H D H D H D H H
3373 D D H D H H D D H H
3374 D D H D D D D H H H
3375 D D H D D D H D H H
3376 D D H D D H D D H H
3377 D D H D H D D D H H
3378 D D H D D D D D H H
3379 D D D D D H H H H H
3380 D D D D H D H H H H
3381 D D D D H H D H H H
3382 D D D D H H H D H H
3383 D D D D D D H H H H
3384 D D D D D H D H H H
3385 D D D D D H H D H H
3386 D D D D H D D H H H
3387 D D D D H D H D H H
3388 D D D D H H D D H H
3389 D D D D D D D H H H
3390 D D D D D D H D H H
3391 D D D D D H D D H H
3392 D D D D H D D D H H
3393 D D D D D D D D H H
3394 D H D H H H H H D H
3395 D H H D H H H H D H
3396 D H D D H H H H D H
3397 H D D H H H H H D H
Figure imgf000093_0001
Figure imgf000094_0001
Figure imgf000095_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3530 D D H H D D H H H D
3531 D D H H D H D H H D
3532 D D H H D H H D H D
3533 D D H H H D D H H D
3534 D D H H H D H D H D
3535 D D H H H H D D H D
3536 D D H H D D D H H D
3537 D D H H D D H D H D
3538 D D H H D H D D H D
3539 D D H H H D D D H D
3540 D D H H D D D D H D
3541 D D H H D H H H D D
3542 D D H H H D H H D D
3543 D D H H H H D H D D
3544 D D H H H H H D D D
3545 D D H H D D H H D D
3546 D D H H D H D H D D
3547 D D H H D H H D D D
3548 D D H H H D D H D D
3549 D D H H H D H D D D
3550 D D H H H H D D D D
3551 D D H H D D D H D D
3552 D D H H D D H D D D
3553 D D H H D H D D D D
3554 D D H H H D D D D D
3555 D D H H D D D D D D
3556 H H D H D H H H D H
3557 H H D H H D H H D H
3558 H H D H H H D H D H
3559 H H D H H H H D D H
3560 H H D H D D H H D H
3561 H H D H D H D H D H
3562 H H D H D H H D D H
3563 H H D H H D D H D H
3564 H H D H H D H D D H
3565 H H D H H H D D D H
3566 H H D H D D D H D H
3567 H H D H D D H D D H
3568 H H D H D H D D D H
3569 H H D H H D D D D H
3570 H H D H D D D D D H
3571 H H D H D H H H H D
3572 H H D H H D H H H D
3573 H H D H H H D H H D No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3574 H H D H H H H D H D
3575 H H D H D D H H H D
3576 H H D H D H D H H D
3577 H H D H D H H D H D
3578 H H D H H D D H H D
3579 H H D H H D H D H D
3580 H H D H H H D D H D
3581 H H D H D D D H H D
3582 H H D H D D H D H D
3583 H H D H D H D D H D
3584 H H D H H D D D H D
3585 H H D H D D D D H D
3586 H H D H D H H H D D
3587 H H D H H D H H D D
3588 H H D H H H D H D D
3589 H H D H H H H D D D
3590 H H D H D D H H D D
3591 H H D H D H D H D D
3592 H H D H D H H D D D
3593 H H D H H D D H D D
3594 H H D H H D H D D D
3595 H H D H H H D D D D
3596 H H D H D D D H D D
3597 H H D H D D H D D D
3598 H H D H D H D D D D
3599 H H D H H D D D D D
3600 H H D H D D D D D D
3601 H H H D D H H H D H
3602 H H H D H D H H D H
3603 H H H D H H D H D H
3604 H H H D H H H D D H
3605 H H H D D D H H D H
3606 H H H D D H D H D H
3607 H H H D D H H D D H
3608 H H H D H D D H D H
3609 H H H D H D H D D H
3610 H H H D H H D D D H
361 1 H H H D D D D H D H
3612 H H H D D D H D D H
3613 H H H D D H D D D H
3614 H H H D H D D D D H
3615 H H H D D D D D D H
3616 H H H D D H H H H D
3617 H H H D H D H H H D
Figure imgf000098_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3662 H H D D H D H H H D
3663 H H D D H H D H H D
3664 H H D D H H H D H D
3665 H H D D D D H H H D
3666 H H D D D H D H H D
3667 H H D D D H H D H D
3668 H H D D H D D H H D
3669 H H D D H D H D H D
3670 H H D D H H D D H D
3671 H H D D D D D H H D
3672 H H D D D D H D H D
3673 H H D D D H D D H D
3674 H H D D H D D D H D
3675 H H D D D D D D H D
3676 H H D D D H H H D D
3677 H H D D H D H H D D
3678 H H D D H H D H D D
3679 H H D D H H H D D D
3680 H H D D D D H H D D
3681 H H D D D H D H D D
3682 H H D D D H H D D D
3683 H H D D H D D H D D
3684 H H D D H D H D D D
3685 H H D D H H D D D D
3686 H H D D D D D H D D
3687 H H D D D D H D D D
3688 H H D D D H D D D D
3689 H H D D H D D D D D
3690 H H D D D D D D D D
3691 D H D H D H H H D H
3692 D H D H H D H H D H
3693 D H D H H H D H D H
3694 D H D H H H H D D H
3695 D H D H D D H H D H
3696 D H D H D H D H D H
3697 D H D H D H H D D H
3698 D H D H H D D H D H
3699 D H D H H D H D D H
3700 D H D H H H D D D H
3701 D H D H D D D H D H
3702 D H D H D D H D D H
3703 D H D H D H D D D H
3704 D H D H H D D D D H
3705 D H D H D D D D D H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3706 D H H D D H H H D H
3707 D H H D H D H H D H
3708 D H H D H H D H D H
3709 D H H D H H H D D H
3710 D H H D D D H H D H
371 1 D H H D D H D H D H
3712 D H H D D H H D D H
3713 D H H D H D D H D H
3714 D H H D H D H D D H
3715 D H H D H H D D D H
3716 D H H D D D D H D H
3717 D H H D D D H D D H
3718 D H H D D H D D D H
3719 D H H D H D D D D H
3720 D H H D D D D D D H
3721 D H D D D H H H D H
3722 D H D D H D H H D H
3723 D H D D H H D H D H
3724 D H D D H H H D D H
3725 D H D D D D H H D H
3726 D H D D D H D H D H
3727 D H D D D H H D D H
3728 D H D D H D D H D H
3729 D H D D H D H D D H
3730 D H D D H H D D D H
3731 D H D D D D D H D H
3732 D H D D D D H D D H
3733 D H D D D H D D D H
3734 D H D D H D D D D H
3735 D H D D D D D D D H
3736 H D D H D H H H D H
3737 H D D H H D H H D H
3738 H D D H H H D H D H
3739 H D D H H H H D D H
3740 H D D H D D H H D H
3741 H D D H D H D H D H
3742 H D D H D H H D D H
3743 H D D H H D D H D H
3744 H D D H H D H D D H
3745 H D D H H H D D D H
3746 H D D H D D D H D H
3747 H D D H D D H D D H
3748 H D D H D H D D D H
3749 H D D H H D D D D H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3750 H D D H D D D D D H
3751 H D H D D H H H D H
3752 H D H D H D H H D H
3753 H D H D H H D H D H
3754 H D H D H H H D D H
3755 H D H D D D H H D H
3756 H D H D D H D H D H
3757 H D H D D H H D D H
3758 H D H D H D D H D H
3759 H D H D H D H D D H
3760 H D H D H H D D D H
3761 H D H D D D D H D H
3762 H D H D D D H D D H
3763 H D H D D H D D D H
3764 H D H D H D D D D H
3765 H D H D D D D D D H
3766 H D D D D H H H D H
3767 H D D D H D H H D H
3768 H D D D H H D H D H
3769 H D D D H H H D D H
3770 H D D D D D H H D H
3771 H D D D D H D H D H
3772 H D D D D H H D D H
3773 H D D D H D D H D H
3774 H D D D H D H D D H
3775 H D D D H H D D D H
3776 H D D D D D D H D H
3777 H D D D D D H D D H
3778 H D D D D H D D D H
3779 H D D D H D D D D H
3780 H D D D D D D D D H
3781 D D D H D H H H D H
3782 D D D H H D H H D H
3783 D D D H H H D H D H
3784 D D D H H H H D D H
3785 D D D H D D H H D H
3786 D D D H D H D H D H
3787 D D D H D H H D D H
3788 D D D H H D D H D H
3789 D D D H H D H D D H
3790 D D D H H H D D D H
3791 D D D H D D D H D H
3792 D D D H D D H D D H
3793 D D D H D H D D D H
Figure imgf000102_0001
Figure imgf000103_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3882 H D D H D D H D H D
3883 H D D H D H D D H D
3884 H D D H H D D D H D
3885 H D D H D D D D H D
3886 H D H D D H H H H D
3887 H D H D H D H H H D
3888 H D H D H H D H H D
3889 H D H D H H H D H D
3890 H D H D D D H H H D
3891 H D H D D H D H H D
3892 H D H D D H H D H D
3893 H D H D H D D H H D
3894 H D H D H D H D H D
3895 H D H D H H D D H D
3896 H D H D D D D H H D
3897 H D H D D D H D H D
3898 H D H D D H D D H D
3899 H D H D H D D D H D
3900 H D H D D D D D H D
3901 H D D D D H H H H D
3902 H D D D H D H H H D
3903 H D D D H H D H H D
3904 H D D D H H H D H D
3905 H D D D D D H H H D
3906 H D D D D H D H H D
3907 H D D D D H H D H D
3908 H D D D H D D H H D
3909 H D D D H D H D H D
3910 H D D D H H D D H D
391 1 H D D D D D D H H D
3912 H D D D D D H D H D
3913 H D D D D H D D H D
3914 H D D D H D D D H D
3915 H D D D D D D D H D
3916 D D D H D H H H H D
3917 D D D H H D H H H D
3918 D D D H H H D H H D
3919 D D D H H H H D H D
3920 D D D H D D H H H D
3921 D D D H D H D H H D
3922 D D D H D H H D H D
3923 D D D H H D D H H D
3924 D D D H H D H D H D
3925 D D D H H H D D H D No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3926 D D D H D D D H H D
3927 D D D H D D H D H D
3928 D D D H D H D D H D
3929 D D D H H D D D H D
3930 D D D H D D D D H D
3931 D D H D D H H H H D
3932 D D H D H D H H H D
3933 D D H D H H D H H D
3934 D D H D H H H D H D
3935 D D H D D D H H H D
3936 D D H D D H D H H D
3937 D D H D D H H D H D
3938 D D H D H D D H H D
3939 D D H D H D H D H D
3940 D D H D H H D D H D
3941 D D H D D D D H H D
3942 D D H D D D H D H D
3943 D D H D D H D D H D
3944 D D H D H D D D H D
3945 D D H D D D D D H D
3946 D D D D D H H H H D
3947 D D D D H D H H H D
3948 D D D D H H D H H D
3949 D D D D H H H D H D
3950 D D D D D D H H H D
3951 D D D D D H D H H D
3952 D D D D D H H D H D
3953 D D D D H D D H H D
3954 D D D D H D H D H D
3955 D D D D H H D D H D
3956 D D D D D D D H H D
3957 D D D D D D H D H D
3958 D D D D D H D D H D
3959 D D D D H D D D H D
3960 D D D D D D D D H D
3961 D H D H D H H H D D
3962 D H D H H D H H D D
3963 D H D H H H D H D D
3964 D H D H H H H D D D
3965 D H D H D D H H D D
3966 D H D H D H D H D D
3967 D H D H D H H D D D
3968 D H D H H D D H D D
3969 D H D H H D H D D D No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3970 D H D H H H D D D D
3971 D H D H D D D H D D
3972 D H D H D D H D D D
3973 D H D H D H D D D D
3974 D H D H H D D D D D
3975 D H D H D D D D D D
3976 D H H D D H H H D D
3977 D H H D H D H H D D
3978 D H H D H H D H D D
3979 D H H D H H H D D D
3980 D H H D D D H H D D
3981 D H H D D H D H D D
3982 D H H D D H H D D D
3983 D H H D H D D H D D
3984 D H H D H D H D D D
3985 D H H D H H D D D D
3986 D H H D D D D H D D
3987 D H H D D D H D D D
3988 D H H D D H D D D D
3989 D H H D H D D D D D
3990 D H H D D D D D D D
3991 D H D D D H H H D D
3992 D H D D H D H H D D
3993 D H D D H H D H D D
3994 D H D D H H H D D D
3995 D H D D D D H H D D
3996 D H D D D H D H D D
3997 D H D D D H H D D D
3998 D H D D H D D H D D
3999 D H D D H D H D D D
4000 D H D D H H D D D D
4001 D H D D D D D H D D
4002 D H D D D D H D D D
4003 D H D D D H D D D D
4004 D H D D H D D D D D
4005 D H D D D D D D D D
4006 H D D H D H H H D D
4007 H D D H H D H H D D
4008 H D D H H H D H D D
4009 H D D H H H H D D D
4010 H D D H D D H H D D
401 1 H D D H D H D H D D
4012 H D D H D H H D D D
4013 H D D H H D D H D D
Figure imgf000107_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
4058 D D D H H D D H D D
4059 D D D H H D H D D D
4060 D D D H H H D D D D
4061 D D D H D D D H D D
4062 D D D H D D H D D D
4063 D D D H D H D D D D
4064 D D D H H D D D D D
4065 D D D H D D D D D D
4066 D D H D D H H H D D
4067 D D H D H D H H D D
4068 D D H D H H D H D D
4069 D D H D H H H D D D
4070 D D H D D D H H D D
4071 D D H D D H D H D D
4072 D D H D D H H D D D
4073 D D H D H D D H D D
4074 D D H D H D H D D D
4075 D D H D H H D D D D
4076 D D H D D D D H D D
4077 D D H D D D H D D D
4078 D D H D D H D D D D
4079 D D H D H D D D D D
4080 D D H D D D D D D D
4081 D D D D D H H H D D
4082 D D D D H D H H D D
4083 D D D D H H D H D D
4084 D D D D H H H D D D
4085 D D D D D D H H D D
4086 D D D D D H D H D D
4087 D D D D D H H D D D
4088 D D D D H D D H D D
4089 D D D D H D H D D D
4090 D D D D H H D D D D
4091 D D D D D D D H D D
4092 D D D D D D H D D D
4093 D D D D D H D D D D
4094 D D D D H D D D D D
4095 D D D D D D D D D D
[0041] Table 5 sets forth compounds of Formula Ill-a, Ill-b, III-c, and Ill-d wherein each of R6, R6, R7 and R7 is hydrogen. Table 6 sets forth compounds of Formula Ill-a, Ill-b, III-c, and Ill-d wherein each of R6 and R6 is hydrogen and each of R7 and R7 is deuterium. Table 7 sets forth compounds of Formula Ill-a, Ill-b, III-c, and ΠΙ-d wherein each of R6 and R6 is deuterium and each of R7 and R7 is hydrogen. Table 8 sets forth compounds of Formula Ill-a, Ill-b, III-c, and Ill-d wherein each of R6, R6, R7 and R7 is deuterium. It will be appreciated that each row in Table 5, Table 6, Table 7, and Table 8 represents four discrete compounds. For example, row 2 in Table 5 represents compounds ni-a-2, III-b-2, III-c-2 and III-d-2:
Figure imgf000109_0001
III-a-2 III-b-2 III-c-2 III-d-2
Table 5. Compounds of Formulae Ill-a, Ill-b, III-c, and Ill-d wherein each of R6, R6 , R7 and R7 is hydrogen.
Figure imgf000109_0002
R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
H H H H H D D D H H
H H H H D D D D H H
H H H H H H H H D H
H H H H H H H H H D
H H H H H H H H D D
D H D H H H H H H H
D H H D H H H H H H
D H D D H H H H H H
H D D H H H H H H H
H D H D H H H H H H
H D D D H H H H H H
D D D H H H H H H H
D D H D H H H H H H
D D D D H H H H H H
D H H H D H H H H H
D H H H H D H H H H
D H H H H H D H H H
D H H H H H H D H H
D H H H D D H H H H
D H H H D H D H H H
D H H H D H H D H H
D H H H H D D H H H
D H H H H D H D H H
D H H H H H D D H H
D H H H D D D H H H
D H H H D D H D H H
D H H H D H D D H H
D H H H H D D D H H
D H H H D D D D H H
H D H H D H H H H H
H D H H H D H H H H
H D H H H H D H H H
H D H H H H H D H H
H D H H D D H H H H
H D H H D H D H H H
H D H H D H H D H H
H D H H H D D H H H
H D H H H D H D H H
H D H H H H D D H H
H D H H D D D H H H
H D H H D D H D H H
H D H H D H D D H H
H D H H H D D D H H
H D H H D D D D H H R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
D D H H D H H H H H
D D H H H D H H H H
D D H H H H D H H H
D D H H H H H D H H
D D H H D D H H H H
D D H H D H D H H H
D D H H D H H D H H
D D H H H D D H H H
D D H H H D H D H H
D D H H H H D D H H
D D H H D D D H H H
D D H H D D H D H H
D D H H D H D D H H
D D H H H D D D H H
D D H H D D D D H H
D H H H H H H H D H
D H H H H H H H H D
D H H H H H H H D D
H D H H H H H H D H
H D H H H H H H H D
H D H H H H H H D D
D D H H H H H H D H
D D H H H H H H H D
D D H H H H H H D D
H H D H D H H H H H
H H D H H D H H H H
H H D H H H D H H H
H H D H H H H D H H
H H D H D D H H H H
H H D H D H D H H H
H H D H D H H D H H
H H D H H D D H H H
H H D H H D H D H H
H H D H H H D D H H
H H D H D D D H H H
H H D H D D H D H H
H H D H D H D D H H
H H D H H D D D H H
H H D H D D D D H H
H H H D D H H H H H
H H H D H D H H H H
H H H D H H D H H H
H H H D H H H D H H
H H H D D D H H H H o. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
109 H H H D D H D H H H
110 H H H D D H H D H H
111 H H H D H D D H H H
112 H H H D H D H D H H
113 H H H D H H D D H H
114 H H H D D D D H H H
115 H H H D D D H D H H
116 H H H D D H D D H H
117 H H H D H D D D H H
118 H H H D D D D D H H
119 H H D D D H H H H H
120 H H D D H D H H H H
121 H H D D H H D H H H
122 H H D D H H H D H H
123 H H D D D D H H H H
124 H H D D D H D H H H
125 H H D D D H H D H H
126 H H D D H D D H H H
127 H H D D H D H D H H
128 H H D D H H D D H H
129 H H D D D D D H H H
130 H H D D D D H D H H
131 H H D D D H D D H H
132 H H D D H D D D H H
133 H H D D D D D D H H
134 H H D H H H H H D H
135 H H D H H H H H H D
136 H H D H H H H H D D
137 H H H D H H H H D H
138 H H H D H H H H H D
139 H H H D H H H H D D
140 H H D D H H H H D H
141 H H D D H H H H H D
142 H H D D H H H H D D
143 H H H H D H H H D H
144 H H H H H D H H D H
145 H H H H H H D H D H
146 H H H H H H H D D H
147 H H H H D D H H D H
148 H H H H D H D H D H
149 H H H H D H H D D H
150 H H H H H D D H D H
151 H H H H H D H D D H
152 H H H H H H D D D H o. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
153 H H H H D D D H D H
154 H H H H D D H D D H
155 H H H H D H D D D H
156 H H H H H D D D D H
157 H H H H D D D D D H
158 H H H H D H H H H D
159 H H H H H D H H H D
160 H H H H H H D H H D
161 H H H H H H H D H D
162 H H H H D D H H H D
163 H H H H D H D H H D
164 H H H H D H H D H D
165 H H H H H D D H H D
166 H H H H H D H D H D
167 H H H H H H D D H D
168 H H H H D D D H H D
169 H H H H D D H D H D
170 H H H H D H D D H D
171 H H H H H D D D H D
172 H H H H D D D D H D
173 H H H H D H H H D D
174 H H H H H D H H D D
175 H H H H H H D H D D
176 H H H H H H H D D D
177 H H H H D D H H D D
178 H H H H D H D H D D
179 H H H H D H H D D D
180 H H H H H D D H D D
181 H H H H H D H D D D
182 H H H H H H D D D D
183 H H H H D D D H D D
184 H H H H D D H D D D
185 H H H H D H D D D D
186 H H H H H D D D D D
187 H H H H D D D D D D
188 D H D H D H H H H H
189 D H D H H D H H H H
190 D H D H H H D H H H
191 D H D H H H H D H H
192 D H D H D D H H H H
193 D H D H D H D H H H
194 D H D H D H H D H H
195 D H D H H D D H H H
196 D H D H H D H D H H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
197 D H D H H H D D H H
198 D H D H D D D H H H
199 D H D H D D H D H H
200 D H D H D H D D H H
201 D H D H H D D D H H
202 D H D H D D D D H H
203 D H H D D H H H H H
204 D H H D H D H H H H
205 D H H D H H D H H H
206 D H H D H H H D H H
207 D H H D D D H H H H
208 D H H D D H D H H H
209 D H H D D H H D H H
210 D H H D H D D H H H
211 D H H D H D H D H H
212 D H H D H H D D H H
213 D H H D D D D H H H
214 D H H D D D H D H H
215 D H H D D H D D H H
216 D H H D H D D D H H
217 D H H D D D D D H H
218 D H D D D H H H H H
219 D H D D H D H H H H
220 D H D D H H D H H H
221 D H D D H H H D H H
222 D H D D D D H H H H
223 D H D D D H D H H H
224 D H D D D H H D H H
225 D H D D H D D H H H
226 D H D D H D H D H H
227 D H D D H H D D H H
228 D H D D D D D H H H
229 D H D D D D H D H H
230 D H D D D H D D H H
231 D H D D H D D D H H
232 D H D D D D D D H H
233 H D D H D H H H H H
234 H D D H H D H H H H
235 H D D H H H D H H H
236 H D D H H H H D H H
237 H D D H D D H H H H
238 H D D H D H D H H H
239 H D D H D H H D H H
240 H D D H H D D H H H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
241 H D D H H D H D H H
242 H D D H H H D D H H
243 H D D H D D D H H H
244 H D D H D D H D H H
245 H D D H D H D D H H
246 H D D H H D D D H H
247 H D D H D D D D H H
248 H D H D D H H H H H
249 H D H D H D H H H H
250 H D H D H H D H H H
251 H D H D H H H D H H
252 H D H D D D H H H H
253 H D H D D H D H H H
254 H D H D D H H D H H
255 H D H D H D D H H H
256 H D H D H D H D H H
257 H D H D H H D D H H
258 H D H D D D D H H H
259 H D H D D D H D H H
260 H D H D D H D D H H
261 H D H D H D D D H H
262 H D H D D D D D H H
263 H D D D D H H H H H
264 H D D D H D H H H H
265 H D D D H H D H H H
266 H D D D H H H D H H
267 H D D D D D H H H H
268 H D D D D H D H H H
269 H D D D D H H D H H
270 H D D D H D D H H H
271 H D D D H D H D H H
272 H D D D H H D D H H
273 H D D D D D D H H H
274 H D D D D D H D H H
275 H D D D D H D D H H
276 H D D D H D D D H H
277 H D D D D D D D H H
278 D D D H D H H H H H
279 D D D H H D H H H H
280 D D D H H H D H H H
281 D D D H H H H D H H
282 D D D H D D H H H H
283 D D D H D H D H H H
284 D D D H D H H D H H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
285 D D D H H D D H H H
286 D D D H H D H D H H
287 D D D H H H D D H H
288 D D D H D D D H H H
289 D D D H D D H D H H
290 D D D H D H D D H H
291 D D D H H D D D H H
292 D D D H D D D D H H
293 D D H D D H H H H H
294 D D H D H D H H H H
295 D D H D H H D H H H
296 D D H D H H H D H H
297 D D H D D D H H H H
298 D D H D D H D H H H
299 D D H D D H H D H H
300 D D H D H D D H H H
301 D D H D H D H D H H
302 D D H D H H D D H H
303 D D H D D D D H H H
304 D D H D D D H D H H
305 D D H D D H D D H H
306 D D H D H D D D H H
307 D D H D D D D D H H
308 D D D D D H H H H H
309 D D D D H D H H H H
310 D D D D H H D H H H
311 D D D D H H H D H H
312 D D D D D D H H H H
313 D D D D D H D H H H
314 D D D D D H H D H H
315 D D D D H D D H H H
316 D D D D H D H D H H
317 D D D D H H D D H H
318 D D D D D D D H H H
319 D D D D D D H D H H
320 D D D D D H D D H H
321 D D D D H D D D H H
322 D D D D D D D D H H
323 D H D H H H H H D H
324 D H H D H H H H D H
325 D H D D H H H H D H
326 H D D H H H H H D H
327 H D H D H H H H D H
328 H D D D H H H H D H No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
329 D D D H H H H H D H
330 D D H D H H H H D H
331 D D D D H H H H D H
332 D H D H H H H H H D
333 D H H D H H H H H D
334 D H D D H H H H H D
335 H D D H H H H H H D
336 H D H D H H H H H D
337 H D D D H H H H H D
338 D D D H H H H H H D
339 D D H D H H H H H D
340 D D D D H H H H H D
341 D H D H H H H H D D
342 D H H D H H H H D D
343 D H D D H H H H D D
344 H D D H H H H H D D
345 H D H D H H H H D D
346 H D D D H H H H D D
347 D D D H H H H H D D
348 D D H D H H H H D D
349 D D D D H H H H D D
350 D H H H D H H H D H
351 D H H H H D H H D H
352 D H H H H H D H D H
353 D H H H H H H D D H
354 D H H H D D H H D H
355 D H H H D H D H D H
356 D H H H D H H D D H
357 D H H H H D D H D H
358 D H H H H D H D D H
359 D H H H H H D D D H
360 D H H H D D D H D H
361 D H H H D D H D D H
362 D H H H D H D D D H
363 D H H H H D D D D H
364 D H H H D D D D D H
365 D H H H D H H H H D
366 D H H H H D H H H D
367 D H H H H H D H H D
368 D H H H H H H D H D
369 D H H H D D H H H D
370 D H H H D H D H H D
371 D H H H D H H D H D
372 D H H H H D D H H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
373 D H H H H D H D H D
374 D H H H H H D D H D
375 D H H H D D D H H D
376 D H H H D D H D H D
377 D H H H D H D D H D
378 D H H H H D D D H D
379 D H H H D D D D H D
380 D H H H D H H H D D
381 D H H H H D H H D D
382 D H H H H H D H D D
383 D H H H H H H D D D
384 D H H H D D H H D D
385 D H H H D H D H D D
386 D H H H D H H D D D
387 D H H H H D D H D D
388 D H H H H D H D D D
389 D H H H H H D D D D
390 D H H H D D D H D D
391 D H H H D D H D D D
392 D H H H D H D D D D
393 D H H H H D D D D D
394 D H H H D D D D D D
395 H D H H D H H H D H
396 H D H H H D H H D H
397 H D H H H H D H D H
398 H D H H H H H D D H
399 H D H H D D H H D H
400 H D H H D H D H D H
401 H D H H D H H D D H
402 H D H H H D D H D H
403 H D H H H D H D D H
404 H D H H H H D D D H
405 H D H H D D D H D H
406 H D H H D D H D D H
407 H D H H D H D D D H
408 H D H H H D D D D H
409 H D H H D D D D D H
410 H D H H D H H H H D
411 H D H H H D H H H D
412 H D H H H H D H H D
413 H D H H H H H D H D
414 H D H H D D H H H D
415 H D H H D H D H H D
416 H D H H D H H D H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
417 H D H H H D D H H D
418 H D H H H D H D H D
419 H D H H H H D D H D
420 H D H H D D D H H D
421 H D H H D D H D H D
422 H D H H D H D D H D
423 H D H H H D D D H D
424 H D H H D D D D H D
425 H D H H D H H H D D
426 H D H H H D H H D D
427 H D H H H H D H D D
428 H D H H H H H D D D
429 H D H H D D H H D D
430 H D H H D H D H D D
431 H D H H D H H D D D
432 H D H H H D D H D D
433 H D H H H D H D D D
434 H D H H H H D D D D
435 H D H H D D D H D D
436 H D H H D D H D D D
437 H D H H D H D D D D
438 H D H H H D D D D D
439 H D H H D D D D D D
440 D D H H D H H H D H
441 D D H H H D H H D H
442 D D H H H H D H D H
443 D D H H H H H D D H
444 D D H H D D H H D H
445 D D H H D H D H D H
446 D D H H D H H D D H
447 D D H H H D D H D H
448 D D H H H D H D D H
449 D D H H H H D D D H
450 D D H H D D D H D H
451 D D H H D D H D D H
452 D D H H D H D D D H
453 D D H H H D D D D H
454 D D H H D D D D D H
455 D D H H D H H H H D
456 D D H H H D H H H D
457 D D H H H H D H H D
458 D D H H H H H D H D
459 D D H H D D H H H D
460 D D H H D H D H H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
461 D D H H D H H D H D
462 D D H H H D D H H D
463 D D H H H D H D H D
464 D D H H H H D D H D
465 D D H H D D D H H D
466 D D H H D D H D H D
467 D D H H D H D D H D
468 D D H H H D D D H D
469 D D H H D D D D H D
470 D D H H D H H H D D
471 D D H H H D H H D D
472 D D H H H H D H D D
473 D D H H H H H D D D
474 D D H H D D H H D D
475 D D H H D H D H D D
476 D D H H D H H D D D
477 D D H H H D D H D D
478 D D H H H D H D D D
479 D D H H H H D D D D
480 D D H H D D D H D D
481 D D H H D D H D D D
482 D D H H D H D D D D
483 D D H H H D D D D D
484 D D H H D D D D D D
485 H H D H D H H H D H
486 H H D H H D H H D H
487 H H D H H H D H D H
488 H H D H H H H D D H
489 H H D H D D H H D H
490 H H D H D H D H D H
491 H H D H D H H D D H
492 H H D H H D D H D H
493 H H D H H D H D D H
494 H H D H H H D D D H
495 H H D H D D D H D H
496 H H D H D D H D D H
497 H H D H D H D D D H
498 H H D H H D D D D H
499 H H D H D D D D D H
500 H H D H D H H H H D
501 H H D H H D H H H D
502 H H D H H H D H H D
503 H H D H H H H D H D
504 H H D H D D H H H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
505 H H D H D H D H H D
506 H H D H D H H D H D
507 H H D H H D D H H D
508 H H D H H D H D H D
509 H H D H H H D D H D
510 H H D H D D D H H D
511 H H D H D D H D H D
512 H H D H D H D D H D
513 H H D H H D D D H D
514 H H D H D D D D H D
515 H H D H D H H H D D
516 H H D H H D H H D D
517 H H D H H H D H D D
518 H H D H H H H D D D
519 H H D H D D H H D D
520 H H D H D H D H D D
521 H H D H D H H D D D
522 H H D H H D D H D D
523 H H D H H D H D D D
524 H H D H H H D D D D
525 H H D H D D D H D D
526 H H D H D D H D D D
527 H H D H D H D D D D
528 H H D H H D D D D D
529 H H D H D D D D D D
530 H H H D D H H H D H
531 H H H D H D H H D H
532 H H H D H H D H D H
533 H H H D H H H D D H
534 H H H D D D H H D H
535 H H H D D H D H D H
536 H H H D D H H D D H
537 H H H D H D D H D H
538 H H H D H D H D D H
539 H H H D H H D D D H
540 H H H D D D D H D H
541 H H H D D D H D D H
542 H H H D D H D D D H
543 H H H D H D D D D H
544 H H H D D D D D D H
545 H H H D D H H H H D
546 H H H D H D H H H D
547 H H H D H H D H H D
548 H H H D H H H D H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
549 H H H D D D H H H D
550 H H H D D H D H H D
551 H H H D D H H D H D
552 H H H D H D D H H D
553 H H H D H D H D H D
554 H H H D H H D D H D
555 H H H D D D D H H D
556 H H H D D D H D H D
557 H H H D D H D D H D
558 H H H D H D D D H D
559 H H H D D D D D H D
560 H H H D D H H H D D
561 H H H D H D H H D D
562 H H H D H H D H D D
563 H H H D H H H D D D
564 H H H D D D H H D D
565 H H H D D H D H D D
566 H H H D D H H D D D
567 H H H D H D D H D D
568 H H H D H D H D D D
569 H H H D H H D D D D
570 H H H D D D D H D D
571 H H H D D D H D D D
572 H H H D D H D D D D
573 H H H D H D D D D D
574 H H H D D D D D D D
575 H H D D D H H H D H
576 H H D D H D H H D H
577 H H D D H H D H D H
578 H H D D H H H D D H
579 H H D D D D H H D H
580 H H D D D H D H D H
581 H H D D D H H D D H
582 H H D D H D D H D H
583 H H D D H D H D D H
584 H H D D H H D D D H
585 H H D D D D D H D H
586 H H D D D D H D D H
587 H H D D D H D D D H
588 H H D D H D D D D H
589 H H D D D D D D D H
590 H H D D D H H H H D
591 H H D D H D H H H D
592 H H D D H H D H H D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
593 H H D D H H H D H D
594 H H D D D D H H H D
595 H H D D D H D H H D
596 H H D D D H H D H D
597 H H D D H D D H H D
598 H H D D H D H D H D
599 H H D D H H D D H D
600 H H D D D D D H H D
601 H H D D D D H D H D
602 H H D D D H D D H D
603 H H D D H D D D H D
604 H H D D D D D D H D
605 H H D D D H H H D D
606 H H D D H D H H D D
607 H H D D H H D H D D
608 H H D D H H H D D D
609 H H D D D D H H D D
610 H H D D D H D H D D
61 1 H H D D D H H D D D
612 H H D D H D D H D D
613 H H D D H D H D D D
614 H H D D H H D D D D
615 H H D D D D D H D D
616 H H D D D D H D D D
617 H H D D D H D D D D
618 H H D D H D D D D D
619 H H D D D D D D D D
620 D H D H D H H H D H
621 D H D H H D H H D H
622 D H D H H H D H D H
623 D H D H H H H D D H
624 D H D H D D H H D H
625 D H D H D H D H D H
626 D H D H D H H D D H
627 D H D H H D D H D H
628 D H D H H D H D D H
629 D H D H H H D D D H
630 D H D H D D D H D H
631 D H D H D D H D D H
632 D H D H D H D D D H
633 D H D H H D D D D H
634 D H D H D D D D D H
635 D H H D D H H H D H
636 D H H D H D H H D H No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
637 D H H D H H D H D H
638 D H H D H H H D D H
639 D H H D D D H H D H
640 D H H D D H D H D H
641 D H H D D H H D D H
642 D H H D H D D H D H
643 D H H D H D H D D H
644 D H H D H H D D D H
645 D H H D D D D H D H
646 D H H D D D H D D H
647 D H H D D H D D D H
648 D H H D H D D D D H
649 D H H D D D D D D H
650 D H D D D H H H D H
651 D H D D H D H H D H
652 D H D D H H D H D H
653 D H D D H H H D D H
654 D H D D D D H H D H
655 D H D D D H D H D H
656 D H D D D H H D D H
657 D H D D H D D H D H
658 D H D D H D H D D H
659 D H D D H H D D D H
660 D H D D D D D H D H
661 D H D D D D H D D H
662 D H D D D H D D D H
663 D H D D H D D D D H
664 D H D D D D D D D H
665 H D D H D H H H D H
666 H D D H H D H H D H
667 H D D H H H D H D H
668 H D D H H H H D D H
669 H D D H D D H H D H
670 H D D H D H D H D H
671 H D D H D H H D D H
672 H D D H H D D H D H
673 H D D H H D H D D H
674 H D D H H H D D D H
675 H D D H D D D H D H
676 H D D H D D H D D H
677 H D D H D H D D D H
678 H D D H H D D D D H
679 H D D H D D D D D H
680 H D H D D H H H D H No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
681 H D H D H D H H D H
682 H D H D H H D H D H
683 H D H D H H H D D H
684 H D H D D D H H D H
685 H D H D D H D H D H
686 H D H D D H H D D H
687 H D H D H D D H D H
688 H D H D H D H D D H
689 H D H D H H D D D H
690 H D H D D D D H D H
691 H D H D D D H D D H
692 H D H D D H D D D H
693 H D H D H D D D D H
694 H D H D D D D D D H
695 H D D D D H H H D H
696 H D D D H D H H D H
697 H D D D H H D H D H
698 H D D D H H H D D H
699 H D D D D D H H D H
700 H D D D D H D H D H
701 H D D D D H H D D H
702 H D D D H D D H D H
703 H D D D H D H D D H
704 H D D D H H D D D H
705 H D D D D D D H D H
706 H D D D D D H D D H
707 H D D D D H D D D H
708 H D D D H D D D D H
709 H D D D D D D D D H
710 D D D H D H H H D H
71 1 D D D H H D H H D H
712 D D D H H H D H D H
713 D D D H H H H D D H
714 D D D H D D H H D H
715 D D D H D H D H D H
716 D D D H D H H D D H
717 D D D H H D D H D H
718 D D D H H D H D D H
719 D D D H H H D D D H
720 D D D H D D D H D H
721 D D D H D D H D D H
722 D D D H D H D D D H
723 D D D H H D D D D H
724 D D D H D D D D D H No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
725 D D H D D H H H D H
726 D D H D H D H H D H
727 D D H D H H D H D H
728 D D H D H H H D D H
729 D D H D D D H H D H
730 D D H D D H D H D H
731 D D H D D H H D D H
732 D D H D H D D H D H
733 D D H D H D H D D H
734 D D H D H H D D D H
735 D D H D D D D H D H
736 D D H D D D H D D H
737 D D H D D H D D D H
738 D D H D H D D D D H
739 D D H D D D D D D H
740 D D D D D H H H D H
741 D D D D H D H H D H
742 D D D D H H D H D H
743 D D D D H H H D D H
744 D D D D D D H H D H
745 D D D D D H D H D H
746 D D D D D H H D D H
747 D D D D H D D H D H
748 D D D D H D H D D H
749 D D D D H H D D D H
750 D D D D D D D H D H
751 D D D D D D H D D H
752 D D D D D H D D D H
753 D D D D H D D D D H
754 D D D D D D D D D H
755 D H D H D H H H H D
756 D H D H H D H H H D
757 D H D H H H D H H D
758 D H D H H H H D H D
759 D H D H D D H H H D
760 D H D H D H D H H D
761 D H D H D H H D H D
762 D H D H H D D H H D
763 D H D H H D H D H D
764 D H D H H H D D H D
765 D H D H D D D H H D
766 D H D H D D H D H D
767 D H D H D H D D H D
768 D H D H H D D D H D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
769 D H D H D D D D H D
770 D H H D D H H H H D
771 D H H D H D H H H D
772 D H H D H H D H H D
773 D H H D H H H D H D
774 D H H D D D H H H D
775 D H H D D H D H H D
776 D H H D D H H D H D
111 D H H D H D D H H D
11% D H H D H D H D H D
119 D H H D H H D D H D
780 D H H D D D D H H D
781 D H H D D D H D H D
782 D H H D D H D D H D
783 D H H D H D D D H D
784 D H H D D D D D H D
785 D H D D D H H H H D
786 D H D D H D H H H D
787 D H D D H H D H H D
788 D H D D H H H D H D
789 D H D D D D H H H D
790 D H D D D H D H H D
791 D H D D D H H D H D
792 D H D D H D D H H D
793 D H D D H D H D H D
794 D H D D H H D D H D
795 D H D D D D D H H D
796 D H D D D D H D H D
797 D H D D D H D D H D
798 D H D D H D D D H D
799 D H D D D D D D H D
800 H D D H D H H H H D
801 H D D H H D H H H D
802 H D D H H H D H H D
803 H D D H H H H D H D
804 H D D H D D H H H D
805 H D D H D H D H H D
806 H D D H D H H D H D
807 H D D H H D D H H D
808 H D D H H D H D H D
809 H D D H H H D D H D
810 H D D H D D D H H D
81 1 H D D H D D H D H D
812 H D D H D H D D H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
813 H D D H H D D D H D
814 H D D H D D D D H D
815 H D H D D H H H H D
816 H D H D H D H H H D
817 H D H D H H D H H D
818 H D H D H H H D H D
819 H D H D D D H H H D
820 H D H D D H D H H D
821 H D H D D H H D H D
822 H D H D H D D H H D
823 H D H D H D H D H D
824 H D H D H H D D H D
825 H D H D D D D H H D
826 H D H D D D H D H D
827 H D H D D H D D H D
828 H D H D H D D D H D
829 H D H D D D D D H D
830 H D D D D H H H H D
831 H D D D H D H H H D
832 H D D D H H D H H D
833 H D D D H H H D H D
834 H D D D D D H H H D
835 H D D D D H D H H D
836 H D D D D H H D H D
837 H D D D H D D H H D
838 H D D D H D H D H D
839 H D D D H H D D H D
840 H D D D D D D H H D
841 H D D D D D H D H D
842 H D D D D H D D H D
843 H D D D H D D D H D
844 H D D D D D D D H D
845 D D D H D H H H H D
846 D D D H H D H H H D
847 D D D H H H D H H D
848 D D D H H H H D H D
849 D D D H D D H H H D
850 D D D H D H D H H D
851 D D D H D H H D H D
852 D D D H H D D H H D
853 D D D H H D H D H D
854 D D D H H H D D H D
855 D D D H D D D H H D
856 D D D H D D H D H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
857 D D D H D H D D H D
858 D D D H H D D D H D
859 D D D H D D D D H D
860 D D H D D H H H H D
861 D D H D H D H H H D
862 D D H D H H D H H D
863 D D H D H H H D H D
864 D D H D D D H H H D
865 D D H D D H D H H D
866 D D H D D H H D H D
867 D D H D H D D H H D
868 D D H D H D H D H D
869 D D H D H H D D H D
870 D D H D D D D H H D
871 D D H D D D H D H D
872 D D H D D H D D H D
873 D D H D H D D D H D
874 D D H D D D D D H D
875 D D D D D H H H H D
876 D D D D H D H H H D
877 D D D D H H D H H D
878 D D D D H H H D H D
879 D D D D D D H H H D
880 D D D D D H D H H D
881 D D D D D H H D H D
882 D D D D H D D H H D
883 D D D D H D H D H D
884 D D D D H H D D H D
885 D D D D D D D H H D
886 D D D D D D H D H D
887 D D D D D H D D H D
888 D D D D H D D D H D
889 D D D D D D D D H D
890 D H D H D H H H D D
891 D H D H H D H H D D
892 D H D H H H D H D D
893 D H D H H H H D D D
894 D H D H D D H H D D
895 D H D H D H D H D D
896 D H D H D H H D D D
897 D H D H H D D H D D
898 D H D H H D H D D D
899 D H D H H H D D D D
900 D H D H D D D H D D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
901 D H D H D D H D D D
902 D H D H D H D D D D
903 D H D H H D D D D D
904 D H D H D D D D D D
905 D H H D D H H H D D
906 D H H D H D H H D D
907 D H H D H H D H D D
908 D H H D H H H D D D
909 D H H D D D H H D D
910 D H H D D H D H D D
91 1 D H H D D H H D D D
912 D H H D H D D H D D
913 D H H D H D H D D D
914 D H H D H H D D D D
915 D H H D D D D H D D
916 D H H D D D H D D D
917 D H H D D H D D D D
918 D H H D H D D D D D
919 D H H D D D D D D D
920 D H D D D H H H D D
921 D H D D H D H H D D
922 D H D D H H D H D D
923 D H D D H H H D D D
924 D H D D D D H H D D
925 D H D D D H D H D D
926 D H D D D H H D D D
927 D H D D H D D H D D
928 D H D D H D H D D D
929 D H D D H H D D D D
930 D H D D D D D H D D
931 D H D D D D H D D D
932 D H D D D H D D D D
933 D H D D H D D D D D
934 D H D D D D D D D D
935 H D D H D H H H D D
936 H D D H H D H H D D
937 H D D H H H D H D D
938 H D D H H H H D D D
939 H D D H D D H H D D
940 H D D H D H D H D D
941 H D D H D H H D D D
942 H D D H H D D H D D
943 H D D H H D H D D D
944 H D D H H H D D D D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
945 H D D H D D D H D D
946 H D D H D D H D D D
947 H D D H D H D D D D
948 H D D H H D D D D D
949 H D D H D D D D D D
950 H D H D D H H H D D
951 H D H D H D H H D D
952 H D H D H H D H D D
953 H D H D H H H D D D
954 H D H D D D H H D D
955 H D H D D H D H D D
956 H D H D D H H D D D
957 H D H D H D D H D D
958 H D H D H D H D D D
959 H D H D H H D D D D
960 H D H D D D D H D D
961 H D H D D D H D D D
962 H D H D D H D D D D
963 H D H D H D D D D D
964 H D H D D D D D D D
965 H D D D D H H H D D
966 H D D D H D H H D D
967 H D D D H H D H D D
968 H D D D H H H D D D
969 H D D D D D H H D D
970 H D D D D H D H D D
971 H D D D D H H D D D
972 H D D D H D D H D D
973 H D D D H D H D D D
974 H D D D H H D D D D
975 H D D D D D D H D D
976 H D D D D D H D D D
977 H D D D D H D D D D
978 H D D D H D D D D D
979 H D D D D D D D D D
980 D D D H D H H H D D
981 D D D H H D H H D D
982 D D D H H H D H D D
983 D D D H H H H D D D
984 D D D H D D H H D D
985 D D D H D H D H D D
986 D D D H D H H D D D
987 D D D H H D D H D D
988 D D D H H D H D D D
Figure imgf000132_0001
Table 6. Compounds of Formulae Ill-a, Ill-b, III-c, and ΙΠ-d wherein each of R6 and R6 is hydrogen and each of 7 7'
R and R is deuterium.
Figure imgf000132_0002
Figure imgf000133_0001
Figure imgf000134_0001
Figure imgf000135_0001
Figure imgf000136_0001
Figure imgf000137_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
1247 D H D D D H D H H H
1248 D H D D D H H D H H
1249 D H D D H D D H H H
1250 D H D D H D H D H H
1251 D H D D H H D D H H
1252 D H D D D D D H H H
1253 D H D D D D H D H H
1254 D H D D D H D D H H
1255 D H D D H D D D H H
1256 D H D D D D D D H H
1257 H D D H D H H H H H
1258 H D D H H D H H H H
1259 H D D H H H D H H H
1260 H D D H H H H D H H
1261 H D D H D D H H H H
1262 H D D H D H D H H H
1263 H D D H D H H D H H
1264 H D D H H D D H H H
1265 H D D H H D H D H H
1266 H D D H H H D D H H
1267 H D D H D D D H H H
1268 H D D H D D H D H H
1269 H D D H D H D D H H
1270 H D D H H D D D H H
1271 H D D H D D D D H H
1272 H D H D D H H H H H
1273 H D H D H D H H H H
1274 H D H D H H D H H H
1275 H D H D H H H D H H
1276 H D H D D D H H H H
1277 H D H D D H D H H H
1278 H D H D D H H D H H
1279 H D H D H D D H H H
1280 H D H D H D H D H H
1281 H D H D H H D D H H
1282 H D H D D D D H H H
1283 H D H D D D H D H H
1284 H D H D D H D D H H
1285 H D H D H D D D H H
1286 H D H D D D D D H H
1287 H D D D D H H H H H
1288 H D D D H D H H H H
1289 H D D D H H D H H H
1290 H D D D H H H D H H
Figure imgf000139_0001
Figure imgf000140_0001
Figure imgf000141_0001
Figure imgf000142_0001
Figure imgf000143_0001
Figure imgf000144_0001
Figure imgf000145_0001
Figure imgf000146_0001
Figure imgf000147_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
1687 D H D D H D D D D H
1688 D H D D D D D D D H
1689 H D D H D H H H D H
1690 H D D H H D H H D H
1691 H D D H H H D H D H
1692 H D D H H H H D D H
1693 H D D H D D H H D H
1694 H D D H D H D H D H
1695 H D D H D H H D D H
1696 H D D H H D D H D H
1697 H D D H H D H D D H
1698 H D D H H H D D D H
1699 H D D H D D D H D H
1700 H D D H D D H D D H
1701 H D D H D H D D D H
1702 H D D H H D D D D H
1703 H D D H D D D D D H
1704 H D H D D H H H D H
1705 H D H D H D H H D H
1706 H D H D H H D H D H
1707 H D H D H H H D D H
1708 H D H D D D H H D H
1709 H D H D D H D H D H
1710 H D H D D H H D D H
1711 H D H D H D D H D H
1712 H D H D H D H D D H
1713 H D H D H H D D D H
1714 H D H D D D D H D H
1715 H D H D D D H D D H
1716 H D H D D H D D D H
1717 H D H D H D D D D H
1718 H D H D D D D D D H
1719 H D D D D H H H D H
1720 H D D D H D H H D H
1721 H D D D H H D H D H
1722 H D D D H H H D D H
1723 H D D D D D H H D H
1724 H D D D D H D H D H
1725 H D D D D H H D D H
1726 H D D D H D D H D H
1727 H D D D H D H D D H
1728 H D D D H H D D D H
1729 H D D D D D D H D H
1730 H D D D D D H D D H
Figure imgf000149_0001
Figure imgf000150_0001
Figure imgf000151_0001
Figure imgf000152_0001
Figure imgf000153_0001
Figure imgf000154_0001
Figure imgf000155_0001
Figure imgf000156_0001
Table 7. Compounds of Formulae Ill-a, Ill-b, III-c, and ΙΠ-d wherein each of R6 and R6 is deuterium and each of 7 7'
R and R is hydrogen.
Figure imgf000156_0002
No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2077 H D D H H H H H H H
2078 H D H D H H H H H H
2079 H D D D H H H H H H
2080 D D D H H H H H H H
2081 D D H D H H H H H H
2082 D D D D H H H H H H
2083 D H H H D H H H H H
2084 D H H H H D H H H H
2085 D H H H H H D H H H
2086 D H H H H H H D H H
2087 D H H H D D H H H H
2088 D H H H D H D H H H
2089 D H H H D H H D H H
2090 D H H H H D D H H H
2091 D H H H H D H D H H
2092 D H H H H H D D H H
2093 D H H H D D D H H H
2094 D H H H D D H D H H
2095 D H H H D H D D H H
2096 D H H H H D D D H H
2097 D H H H D D D D H H
2098 H D H H D H H H H H
2099 H D H H H D H H H H
2100 H D H H H H D H H H
2101 H D H H H H H D H H
2102 H D H H D D H H H H
2103 H D H H D H D H H H
2104 H D H H D H H D H H
2105 H D H H H D D H H H
2106 H D H H H D H D H H
2107 H D H H H H D D H H
2108 H D H H D D D H H H
2109 H D H H D D H D H H
2110 H D H H D H D D H H
2111 H D H H H D D D H H
2112 H D H H D D D D H H
2113 D D H H D H H H H H
2114 D D H H H D H H H H
2115 D D H H H H D H H H
2116 D D H H H H H D H H
2117 D D H H D D H H H H
2118 D D H H D H D H H H
2119 D D H H D H H D H H
2120 D D H H H D D H H H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2121 D D H H H D H D H H
2122 D D H H H H D D H H
2123 D D H H D D D H H H
2124 D D H H D D H D H H
2125 D D H H D H D D H H
2126 D D H H H D D D H H
2127 D D H H D D D D H H
2128 D H H H H H H H D H
2129 D H H H H H H H H D
2130 D H H H H H H H D D
2131 H D H H H H H H D H
2132 H D H H H H H H H D
2133 H D H H H H H H D D
2134 D D H H H H H H D H
2135 D D H H H H H H H D
2136 D D H H H H H H D D
2137 H H D H D H H H H H
2138 H H D H H D H H H H
2139 H H D H H H D H H H
2140 H H D H H H H D H H
2141 H H D H D D H H H H
2142 H H D H D H D H H H
2143 H H D H D H H D H H
2144 H H D H H D D H H H
2145 H H D H H D H D H H
2146 H H D H H H D D H H
2147 H H D H D D D H H H
2148 H H D H D D H D H H
2149 H H D H D H D D H H
2150 H H D H H D D D H H
2151 H H D H D D D D H H
2152 H H H D D H H H H H
2153 H H H D H D H H H H
2154 H H H D H H D H H H
2155 H H H D H H H D H H
2156 H H H D D D H H H H
2157 H H H D D H D H H H
2158 H H H D D H H D H H
2159 H H H D H D D H H H
2160 H H H D H D H D H H
2161 H H H D H H D D H H
2162 H H H D D D D H H H
2163 H H H D D D H D H H
2164 H H H D D H D D H H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2165 H H H D H D D D H H
2166 H H H D D D D D H H
2167 H H D D D H H H H H
2168 H H D D H D H H H H
2169 H H D D H H D H H H
2170 H H D D H H H D H H
2171 H H D D D D H H H H
2172 H H D D D H D H H H
2173 H H D D D H H D H H
2174 H H D D H D D H H H
2175 H H D D H D H D H H
2176 H H D D H H D D H H
2177 H H D D D D D H H H
2178 H H D D D D H D H H
2179 H H D D D H D D H H
2180 H H D D H D D D H H
2181 H H D D D D D D H H
2182 H H D H H H H H D H
2183 H H D H H H H H H D
2184 H H D H H H H H D D
2185 H H H D H H H H D H
2186 H H H D H H H H H D
2187 H H H D H H H H D D
2188 H H D D H H H H D H
2189 H H D D H H H H H D
2190 H H D D H H H H D D
2191 H H H H D H H H D H
2192 H H H H H D H H D H
2193 H H H H H H D H D H
2194 H H H H H H H D D H
2195 H H H H D D H H D H
2196 H H H H D H D H D H
2197 H H H H D H H D D H
2198 H H H H H D D H D H
2199 H H H H H D H D D H
2200 H H H H H H D D D H
2201 H H H H D D D H D H
2202 H H H H D D H D D H
2203 H H H H D H D D D H
2204 H H H H H D D D D H
2205 H H H H D D D D D H
2206 H H H H D H H H H D
2207 H H H H H D H H H D
2208 H H H H H H D H H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2209 H H H H H H H D H D
2210 H H H H D D H H H D
2211 H H H H D H D H H D
2212 H H H H D H H D H D
2213 H H H H H D D H H D
2214 H H H H H D H D H D
2215 H H H H H H D D H D
2216 H H H H D D D H H D
2217 H H H H D D H D H D
2218 H H H H D H D D H D
2219 H H H H H D D D H D
2220 H H H H D D D D H D
2221 H H H H D H H H D D
2222 H H H H H D H H D D
2223 H H H H H H D H D D
2224 H H H H H H H D D D
2225 H H H H D D H H D D
2226 H H H H D H D H D D
2227 H H H H D H H D D D
2228 H H H H H D D H D D
2229 H H H H H D H D D D
2230 H H H H H H D D D D
2231 H H H H D D D H D D
2232 H H H H D D H D D D
2233 H H H H D H D D D D
2234 H H H H H D D D D D
2235 H H H H D D D D D D
2236 D H D H D H H H H H
2237 D H D H H D H H H H
2238 D H D H H H D H H H
2239 D H D H H H H D H H
2240 D H D H D D H H H H
2241 D H D H D H D H H H
2242 D H D H D H H D H H
2243 D H D H H D D H H H
2244 D H D H H D H D H H
2245 D H D H H H D D H H
2246 D H D H D D D H H H
2247 D H D H D D H D H H
2248 D H D H D H D D H H
2249 D H D H H D D D H H
2250 D H D H D D D D H H
2251 D H H D D H H H H H
2252 D H H D H D H H H H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2253 D H H D H H D H H H
2254 D H H D H H H D H H
2255 D H H D D D H H H H
2256 D H H D D H D H H H
2257 D H H D D H H D H H
2258 D H H D H D D H H H
2259 D H H D H D H D H H
2260 D H H D H H D D H H
2261 D H H D D D D H H H
2262 D H H D D D H D H H
2263 D H H D D H D D H H
2264 D H H D H D D D H H
2265 D H H D D D D D H H
2266 D H D D D H H H H H
2267 D H D D H D H H H H
2268 D H D D H H D H H H
2269 D H D D H H H D H H
2270 D H D D D D H H H H
2271 D H D D D H D H H H
2272 D H D D D H H D H H
2273 D H D D H D D H H H
2274 D H D D H D H D H H
2275 D H D D H H D D H H
2276 D H D D D D D H H H
2277 D H D D D D H D H H
2278 D H D D D H D D H H
2279 D H D D H D D D H H
2280 D H D D D D D D H H
2281 H D D H D H H H H H
2282 H D D H H D H H H H
2283 H D D H H H D H H H
2284 H D D H H H H D H H
2285 H D D H D D H H H H
2286 H D D H D H D H H H
2287 H D D H D H H D H H
2288 H D D H H D D H H H
2289 H D D H H D H D H H
2290 H D D H H H D D H H
2291 H D D H D D D H H H
2292 H D D H D D H D H H
2293 H D D H D H D D H H
2294 H D D H H D D D H H
2295 H D D H D D D D H H
2296 H D H D D H H H H H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2297 H D H D H D H H H H
2298 H D H D H H D H H H
2299 H D H D H H H D H H
2300 H D H D D D H H H H
2301 H D H D D H D H H H
2302 H D H D D H H D H H
2303 H D H D H D D H H H
2304 H D H D H D H D H H
2305 H D H D H H D D H H
2306 H D H D D D D H H H
2307 H D H D D D H D H H
2308 H D H D D H D D H H
2309 H D H D H D D D H H
2310 H D H D D D D D H H
2311 H D D D D H H H H H
2312 H D D D H D H H H H
2313 H D D D H H D H H H
2314 H D D D H H H D H H
2315 H D D D D D H H H H
2316 H D D D D H D H H H
2317 H D D D D H H D H H
2318 H D D D H D D H H H
2319 H D D D H D H D H H
2320 H D D D H H D D H H
2321 H D D D D D D H H H
2322 H D D D D D H D H H
2323 H D D D D H D D H H
2324 H D D D H D D D H H
2325 H D D D D D D D H H
2326 D D D H D H H H H H
2327 D D D H H D H H H H
2328 D D D H H H D H H H
2329 D D D H H H H D H H
2330 D D D H D D H H H H
2331 D D D H D H D H H H
2332 D D D H D H H D H H
2333 D D D H H D D H H H
2334 D D D H H D H D H H
2335 D D D H H H D D H H
2336 D D D H D D D H H H
2337 D D D H D D H D H H
2338 D D D H D H D D H H
2339 D D D H H D D D H H
2340 D D D H D D D D H H No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2341 D D H D D H H H H H
2342 D D H D H D H H H H
2343 D D H D H H D H H H
2344 D D H D H H H D H H
2345 D D H D D D H H H H
2346 D D H D D H D H H H
2347 D D H D D H H D H H
2348 D D H D H D D H H H
2349 D D H D H D H D H H
2350 D D H D H H D D H H
2351 D D H D D D D H H H
2352 D D H D D D H D H H
2353 D D H D D H D D H H
2354 D D H D H D D D H H
2355 D D H D D D D D H H
2356 D D D D D H H H H H
2357 D D D D H D H H H H
2358 D D D D H H D H H H
2359 D D D D H H H D H H
2360 D D D D D D H H H H
2361 D D D D D H D H H H
2362 D D D D D H H D H H
2363 D D D D H D D H H H
2364 D D D D H D H D H H
2365 D D D D H H D D H H
2366 D D D D D D D H H H
2367 D D D D D D H D H H
2368 D D D D D H D D H H
2369 D D D D H D D D H H
2370 D D D D D D D D H H
2371 D H D H H H H H D H
2372 D H H D H H H H D H
2373 D H D D H H H H D H
2374 H D D H H H H H D H
2375 H D H D H H H H D H
2376 H D D D H H H H D H
2377 D D D H H H H H D H
2378 D D H D H H H H D H
2379 D D D D H H H H D H
2380 D H D H H H H H H D
2381 D H H D H H H H H D
2382 D H D D H H H H H D
2383 H D D H H H H H H D
2384 H D H D H H H H H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2385 H D D D H H H H H D
2386 D D D H H H H H H D
2387 D D H D H H H H H D
2388 D D D D H H H H H D
2389 D H D H H H H H D D
2390 D H H D H H H H D D
2391 D H D D H H H H D D
2392 H D D H H H H H D D
2393 H D H D H H H H D D
2394 H D D D H H H H D D
2395 D D D H H H H H D D
2396 D D H D H H H H D D
2397 D D D D H H H H D D
2398 D H H H D H H H D H
2399 D H H H H D H H D H
2400 D H H H H H D H D H
2401 D H H H H H H D D H
2402 D H H H D D H H D H
2403 D H H H D H D H D H
2404 D H H H D H H D D H
2405 D H H H H D D H D H
2406 D H H H H D H D D H
2407 D H H H H H D D D H
2408 D H H H D D D H D H
2409 D H H H D D H D D H
2410 D H H H D H D D D H
2411 D H H H H D D D D H
2412 D H H H D D D D D H
2413 D H H H D H H H H D
2414 D H H H H D H H H D
2415 D H H H H H D H H D
2416 D H H H H H H D H D
2417 D H H H D D H H H D
2418 D H H H D H D H H D
2419 D H H H D H H D H D
2420 D H H H H D D H H D
2421 D H H H H D H D H D
2422 D H H H H H D D H D
2423 D H H H D D D H H D
2424 D H H H D D H D H D
2425 D H H H D H D D H D
2426 D H H H H D D D H D
2427 D H H H D D D D H D
2428 D H H H D H H H D D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2429 D H H H H D H H D D
2430 D H H H H H D H D D
2431 D H H H H H H D D D
2432 D H H H D D H H D D
2433 D H H H D H D H D D
2434 D H H H D H H D D D
2435 D H H H H D D H D D
2436 D H H H H D H D D D
2437 D H H H H H D D D D
2438 D H H H D D D H D D
2439 D H H H D D H D D D
2440 D H H H D H D D D D
2441 D H H H H D D D D D
2442 D H H H D D D D D D
2443 H D H H D H H H D H
2444 H D H H H D H H D H
2445 H D H H H H D H D H
2446 H D H H H H H D D H
2447 H D H H D D H H D H
2448 H D H H D H D H D H
2449 H D H H D H H D D H
2450 H D H H H D D H D H
2451 H D H H H D H D D H
2452 H D H H H H D D D H
2453 H D H H D D D H D H
2454 H D H H D D H D D H
2455 H D H H D H D D D H
2456 H D H H H D D D D H
2457 H D H H D D D D D H
2458 H D H H D H H H H D
2459 H D H H H D H H H D
2460 H D H H H H D H H D
2461 H D H H H H H D H D
2462 H D H H D D H H H D
2463 H D H H D H D H H D
2464 H D H H D H H D H D
2465 H D H H H D D H H D
2466 H D H H H D H D H D
2467 H D H H H H D D H D
2468 H D H H D D D H H D
2469 H D H H D D H D H D
2470 H D H H D H D D H D
2471 H D H H H D D D H D
2472 H D H H D D D D H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2473 H D H H D H H H D D
2474 H D H H H D H H D D
2475 H D H H H H D H D D
2476 H D H H H H H D D D
2477 H D H H D D H H D D
2478 H D H H D H D H D D
2479 H D H H D H H D D D
2480 H D H H H D D H D D
2481 H D H H H D H D D D
2482 H D H H H H D D D D
2483 H D H H D D D H D D
2484 H D H H D D H D D D
2485 H D H H D H D D D D
2486 H D H H H D D D D D
2487 H D H H D D D D D D
2488 D D H H D H H H D H
2489 D D H H H D H H D H
2490 D D H H H H D H D H
2491 D D H H H H H D D H
2492 D D H H D D H H D H
2493 D D H H D H D H D H
2494 D D H H D H H D D H
2495 D D H H H D D H D H
2496 D D H H H D H D D H
2497 D D H H H H D D D H
2498 D D H H D D D H D H
2499 D D H H D D H D D H
2500 D D H H D H D D D H
2501 D D H H H D D D D H
2502 D D H H D D D D D H
2503 D D H H D H H H H D
2504 D D H H H D H H H D
2505 D D H H H H D H H D
2506 D D H H H H H D H D
2507 D D H H D D H H H D
2508 D D H H D H D H H D
2509 D D H H D H H D H D
2510 D D H H H D D H H D
2511 D D H H H D H D H D
2512 D D H H H H D D H D
2513 D D H H D D D H H D
2514 D D H H D D H D H D
2515 D D H H D H D D H D
2516 D D H H H D D D H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2517 D D H H D D D D H D
2518 D D H H D H H H D D
2519 D D H H H D H H D D
2520 D D H H H H D H D D
2521 D D H H H H H D D D
2522 D D H H D D H H D D
2523 D D H H D H D H D D
2524 D D H H D H H D D D
2525 D D H H H D D H D D
2526 D D H H H D H D D D
2527 D D H H H H D D D D
2528 D D H H D D D H D D
2529 D D H H D D H D D D
2530 D D H H D H D D D D
2531 D D H H H D D D D D
2532 D D H H D D D D D D
2533 H H D H D H H H D H
2534 H H D H H D H H D H
2535 H H D H H H D H D H
2536 H H D H H H H D D H
2537 H H D H D D H H D H
2538 H H D H D H D H D H
2539 H H D H D H H D D H
2540 H H D H H D D H D H
2541 H H D H H D H D D H
2542 H H D H H H D D D H
2543 H H D H D D D H D H
2544 H H D H D D H D D H
2545 H H D H D H D D D H
2546 H H D H H D D D D H
2547 H H D H D D D D D H
2548 H H D H D H H H H D
2549 H H D H H D H H H D
2550 H H D H H H D H H D
2551 H H D H H H H D H D
2552 H H D H D D H H H D
2553 H H D H D H D H H D
2554 H H D H D H H D H D
2555 H H D H H D D H H D
2556 H H D H H D H D H D
2557 H H D H H H D D H D
2558 H H D H D D D H H D
2559 H H D H D D H D H D
2560 H H D H D H D D H D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2561 H H D H H D D D H D
2562 H H D H D D D D H D
2563 H H D H D H H H D D
2564 H H D H H D H H D D
2565 H H D H H H D H D D
2566 H H D H H H H D D D
2567 H H D H D D H H D D
2568 H H D H D H D H D D
2569 H H D H D H H D D D
2570 H H D H H D D H D D
2571 H H D H H D H D D D
2572 H H D H H H D D D D
2573 H H D H D D D H D D
2574 H H D H D D H D D D
2575 H H D H D H D D D D
2576 H H D H H D D D D D
2577 H H D H D D D D D D
2578 H H H D D H H H D H
2579 H H H D H D H H D H
2580 H H H D H H D H D H
2581 H H H D H H H D D H
2582 H H H D D D H H D H
2583 H H H D D H D H D H
2584 H H H D D H H D D H
2585 H H H D H D D H D H
2586 H H H D H D H D D H
2587 H H H D H H D D D H
2588 H H H D D D D H D H
2589 H H H D D D H D D H
2590 H H H D D H D D D H
2591 H H H D H D D D D H
2592 H H H D D D D D D H
2593 H H H D D H H H H D
2594 H H H D H D H H H D
2595 H H H D H H D H H D
2596 H H H D H H H D H D
2597 H H H D D D H H H D
2598 H H H D D H D H H D
2599 H H H D D H H D H D
2600 H H H D H D D H H D
2601 H H H D H D H D H D
2602 H H H D H H D D H D
2603 H H H D D D D H H D
2604 H H H D D D H D H D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2605 H H H D D H D D H D
2606 H H H D H D D D H D
2607 H H H D D D D D H D
2608 H H H D D H H H D D
2609 H H H D H D H H D D
2610 H H H D H H D H D D
261 1 H H H D H H H D D D
2612 H H H D D D H H D D
2613 H H H D D H D H D D
2614 H H H D D H H D D D
2615 H H H D H D D H D D
2616 H H H D H D H D D D
2617 H H H D H H D D D D
2618 H H H D D D D H D D
2619 H H H D D D H D D D
2620 H H H D D H D D D D
2621 H H H D H D D D D D
2622 H H H D D D D D D D
2623 H H D D D H H H D H
2624 H H D D H D H H D H
2625 H H D D H H D H D H
2626 H H D D H H H D D H
2627 H H D D D D H H D H
2628 H H D D D H D H D H
2629 H H D D D H H D D H
2630 H H D D H D D H D H
2631 H H D D H D H D D H
2632 H H D D H H D D D H
2633 H H D D D D D H D H
2634 H H D D D D H D D H
2635 H H D D D H D D D H
2636 H H D D H D D D D H
2637 H H D D D D D D D H
2638 H H D D D H H H H D
2639 H H D D H D H H H D
2640 H H D D H H D H H D
2641 H H D D H H H D H D
2642 H H D D D D H H H D
2643 H H D D D H D H H D
2644 H H D D D H H D H D
2645 H H D D H D D H H D
2646 H H D D H D H D H D
2647 H H D D H H D D H D
2648 H H D D D D D H H D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2649 H H D D D D H D H D
2650 H H D D D H D D H D
2651 H H D D H D D D H D
2652 H H D D D D D D H D
2653 H H D D D H H H D D
2654 H H D D H D H H D D
2655 H H D D H H D H D D
2656 H H D D H H H D D D
2657 H H D D D D H H D D
2658 H H D D D H D H D D
2659 H H D D D H H D D D
2660 H H D D H D D H D D
2661 H H D D H D H D D D
2662 H H D D H H D D D D
2663 H H D D D D D H D D
2664 H H D D D D H D D D
2665 H H D D D H D D D D
2666 H H D D H D D D D D
2667 H H D D D D D D D D
2668 D H D H D H H H D H
2669 D H D H H D H H D H
2670 D H D H H H D H D H
2671 D H D H H H H D D H
2672 D H D H D D H H D H
2673 D H D H D H D H D H
2674 D H D H D H H D D H
2675 D H D H H D D H D H
2676 D H D H H D H D D H
2677 D H D H H H D D D H
2678 D H D H D D D H D H
2679 D H D H D D H D D H
2680 D H D H D H D D D H
2681 D H D H H D D D D H
2682 D H D H D D D D D H
2683 D H H D D H H H D H
2684 D H H D H D H H D H
2685 D H H D H H D H D H
2686 D H H D H H H D D H
2687 D H H D D D H H D H
2688 D H H D D H D H D H
2689 D H H D D H H D D H
2690 D H H D H D D H D H
2691 D H H D H D H D D H
2692 D H H D H H D D D H No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2693 D H H D D D D H D H
2694 D H H D D D H D D H
2695 D H H D D H D D D H
2696 D H H D H D D D D H
2697 D H H D D D D D D H
2698 D H D D D H H H D H
2699 D H D D H D H H D H
2700 D H D D H H D H D H
2701 D H D D H H H D D H
2702 D H D D D D H H D H
2703 D H D D D H D H D H
2704 D H D D D H H D D H
2705 D H D D H D D H D H
2706 D H D D H D H D D H
2707 D H D D H H D D D H
2708 D H D D D D D H D H
2709 D H D D D D H D D H
2710 D H D D D H D D D H
2711 D H D D H D D D D H
2712 D H D D D D D D D H
2713 H D D H D H H H D H
2714 H D D H H D H H D H
2715 H D D H H H D H D H
2716 H D D H H H H D D H
2717 H D D H D D H H D H
2718 H D D H D H D H D H
2719 H D D H D H H D D H
2720 H D D H H D D H D H
2721 H D D H H D H D D H
2722 H D D H H H D D D H
2723 H D D H D D D H D H
2724 H D D H D D H D D H
2725 H D D H D H D D D H
2726 H D D H H D D D D H
2727 H D D H D D D D D H
2728 H D H D D H H H D H
2729 H D H D H D H H D H
2730 H D H D H H D H D H
2731 H D H D H H H D D H
2732 H D H D D D H H D H
2733 H D H D D H D H D H
2734 H D H D D H H D D H
2735 H D H D H D D H D H
2736 H D H D H D H D D H No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2737 H D H D H H D D D H
2738 H D H D D D D H D H
2739 H D H D D D H D D H
2740 H D H D D H D D D H
2741 H D H D H D D D D H
2742 H D H D D D D D D H
2743 H D D D D H H H D H
2744 H D D D H D H H D H
2745 H D D D H H D H D H
2746 H D D D H H H D D H
2747 H D D D D D H H D H
2748 H D D D D H D H D H
2749 H D D D D H H D D H
2750 H D D D H D D H D H
2751 H D D D H D H D D H
2752 H D D D H H D D D H
2753 H D D D D D D H D H
2754 H D D D D D H D D H
2755 H D D D D H D D D H
2756 H D D D H D D D D H
2757 H D D D D D D D D H
2758 D D D H D H H H D H
2759 D D D H H D H H D H
2760 D D D H H H D H D H
2761 D D D H H H H D D H
2762 D D D H D D H H D H
2763 D D D H D H D H D H
2764 D D D H D H H D D H
2765 D D D H H D D H D H
2766 D D D H H D H D D H
2767 D D D H H H D D D H
2768 D D D H D D D H D H
2769 D D D H D D H D D H
2770 D D D H D H D D D H
2771 D D D H H D D D D H
2772 D D D H D D D D D H
2773 D D H D D H H H D H
2774 D D H D H D H H D H
2775 D D H D H H D H D H
2776 D D H D H H H D D H
2777 D D H D D D H H D H
2778 D D H D D H D H D H
2779 D D H D D H H D D H
2780 D D H D H D D H D H No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2781 D D H D H D H D D H
2782 D D H D H H D D D H
2783 D D H D D D D H D H
2784 D D H D D D H D D H
2785 D D H D D H D D D H
2786 D D H D H D D D D H
2787 D D H D D D D D D H
2788 D D D D D H H H D H
2789 D D D D H D H H D H
2790 D D D D H H D H D H
2791 D D D D H H H D D H
2792 D D D D D D H H D H
2793 D D D D D H D H D H
2794 D D D D D H H D D H
2795 D D D D H D D H D H
2796 D D D D H D H D D H
2797 D D D D H H D D D H
2798 D D D D D D D H D H
2799 D D D D D D H D D H
2800 D D D D D H D D D H
2801 D D D D H D D D D H
2802 D D D D D D D D D H
2803 D H D H D H H H H D
2804 D H D H H D H H H D
2805 D H D H H H D H H D
2806 D H D H H H H D H D
2807 D H D H D D H H H D
2808 D H D H D H D H H D
2809 D H D H D H H D H D
2810 D H D H H D D H H D
2811 D H D H H D H D H D
2812 D H D H H H D D H D
2813 D H D H D D D H H D
2814 D H D H D D H D H D
2815 D H D H D H D D H D
2816 D H D H H D D D H D
2817 D H D H D D D D H D
2818 D H H D D H H H H D
2819 D H H D H D H H H D
2820 D H H D H H D H H D
2821 D H H D H H H D H D
2822 D H H D D D H H H D
2823 D H H D D H D H H D
2824 D H H D D H H D H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2825 D H H D H D D H H D
2826 D H H D H D H D H D
2827 D H H D H H D D H D
2828 D H H D D D D H H D
2829 D H H D D D H D H D
2830 D H H D D H D D H D
2831 D H H D H D D D H D
2832 D H H D D D D D H D
2833 D H D D D H H H H D
2834 D H D D H D H H H D
2835 D H D D H H D H H D
2836 D H D D H H H D H D
2837 D H D D D D H H H D
2838 D H D D D H D H H D
2839 D H D D D H H D H D
2840 D H D D H D D H H D
2841 D H D D H D H D H D
2842 D H D D H H D D H D
2843 D H D D D D D H H D
2844 D H D D D D H D H D
2845 D H D D D H D D H D
2846 D H D D H D D D H D
2847 D H D D D D D D H D
2848 H D D H D H H H H D
2849 H D D H H D H H H D
2850 H D D H H H D H H D
2851 H D D H H H H D H D
2852 H D D H D D H H H D
2853 H D D H D H D H H D
2854 H D D H D H H D H D
2855 H D D H H D D H H D
2856 H D D H H D H D H D
2857 H D D H H H D D H D
2858 H D D H D D D H H D
2859 H D D H D D H D H D
2860 H D D H D H D D H D
2861 H D D H H D D D H D
2862 H D D H D D D D H D
2863 H D H D D H H H H D
2864 H D H D H D H H H D
2865 H D H D H H D H H D
2866 H D H D H H H D H D
2867 H D H D D D H H H D
2868 H D H D D H D H H D No. R*7R*a Rm/Rm' Rya/Rya' R Rxa Rxb Rxb< Rxc
9l7R9b' Ry7Rya Ryl,/R5"''
2869 H D H D D H H D H D
2870 H D H D H D D H H D
2871 H D H D H D H D H D
2872 H D H D H H D D H D
2873 H D H D D D D H H D
2874 H D H D D D H D H D
2875 H D H D D H D D H D
2876 H D H D H D D D H D
2877 H D H D D D D D H D
2878 H D D D D H H H H D
2879 H D D D H D H H H D
2880 H D D D H H D H H D
2881 H D D D H H H D H D
2882 H D D D D D H H H D
2883 H D D D D H D H H D
2884 H D D D D H H D H D
2885 H D D D H D D H H D
2886 H D D D H D H D H D
2887 H D D D H H D D H D
2888 H D D D D D D H H D
2889 H D D D D D H D H D
2890 H D D D D H D D H D
2891 H D D D H D D D H D
2892 H D D D D D D D H D
2893 D D D H D H H H H D
2894 D D D H H D H H H D
2895 D D D H H H D H H D
2896 D D D H H H H D H D
2897 D D D H D D H H H D
2898 D D D H D H D H H D
2899 D D D H D H H D H D
2900 D D D H H D D H H D
2901 D D D H H D H D H D
2902 D D D H H H D D H D
2903 D D D H D D D H H D
2904 D D D H D D H D H D
2905 D D D H D H D D H D
2906 D D D H H D D D H D
2907 D D D H D D D D H D
2908 D D H D D H H H H D
2909 D D H D H D H H H D
2910 D D H D H H D H H D
2911 D D H D H H H D H D
2912 D D H D D D H H H D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2913 D D H D D H D H H D
2914 D D H D D H H D H D
2915 D D H D H D D H H D
2916 D D H D H D H D H D
2917 D D H D H H D D H D
2918 D D H D D D D H H D
2919 D D H D D D H D H D
2920 D D H D D H D D H D
2921 D D H D H D D D H D
2922 D D H D D D D D H D
2923 D D D D D H H H H D
2924 D D D D H D H H H D
2925 D D D D H H D H H D
2926 D D D D H H H D H D
2927 D D D D D D H H H D
2928 D D D D D H D H H D
2929 D D D D D H H D H D
2930 D D D D H D D H H D
2931 D D D D H D H D H D
2932 D D D D H H D D H D
2933 D D D D D D D H H D
2934 D D D D D D H D H D
2935 D D D D D H D D H D
2936 D D D D H D D D H D
2937 D D D D D D D D H D
2938 D H D H D H H H D D
2939 D H D H H D H H D D
2940 D H D H H H D H D D
2941 D H D H H H H D D D
2942 D H D H D D H H D D
2943 D H D H D H D H D D
2944 D H D H D H H D D D
2945 D H D H H D D H D D
2946 D H D H H D H D D D
2947 D H D H H H D D D D
2948 D H D H D D D H D D
2949 D H D H D D H D D D
2950 D H D H D H D D D D
2951 D H D H H D D D D D
2952 D H D H D D D D D D
2953 D H H D D H H H D D
2954 D H H D H D H H D D
2955 D H H D H H D H D D
2956 D H H D H H H D D D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
2957 D H H D D D H H D D
2958 D H H D D H D H D D
2959 D H H D D H H D D D
2960 D H H D H D D H D D
2961 D H H D H D H D D D
2962 D H H D H H D D D D
2963 D H H D D D D H D D
2964 D H H D D D H D D D
2965 D H H D D H D D D D
2966 D H H D H D D D D D
2967 D H H D D D D D D D
2968 D H D D D H H H D D
2969 D H D D H D H H D D
2970 D H D D H H D H D D
2971 D H D D H H H D D D
2972 D H D D D D H H D D
2973 D H D D D H D H D D
2974 D H D D D H H D D D
2975 D H D D H D D H D D
2976 D H D D H D H D D D
2977 D H D D H H D D D D
2978 D H D D D D D H D D
2979 D H D D D D H D D D
2980 D H D D D H D D D D
2981 D H D D H D D D D D
2982 D H D D D D D D D D
2983 H D D H D H H H D D
2984 H D D H H D H H D D
2985 H D D H H H D H D D
2986 H D D H H H H D D D
2987 H D D H D D H H D D
2988 H D D H D H D H D D
2989 H D D H D H H D D D
2990 H D D H H D D H D D
2991 H D D H H D H D D D
2992 H D D H H H D D D D
2993 H D D H D D D H D D
2994 H D D H D D H D D D
2995 H D D H D H D D D D
2996 H D D H H D D D D D
2997 H D D H D D D D D D
2998 H D H D D H H H D D
2999 H D H D H D H H D D
3000 H D H D H H D H D D No. R*7R*a Rm/Rm' Rya/Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Ry7Rya Ryl,/R5"''
3001 H D H D H H H D D D
3002 H D H D D D H H D D
3003 H D H D D H D H D D
3004 H D H D D H H D D D
3005 H D H D H D D H D D
3006 H D H D H D H D D D
3007 H D H D H H D D D D
3008 H D H D D D D H D D
3009 H D H D D D H D D D
3010 H D H D D H D D D D
3011 H D H D H D D D D D
3012 H D H D D D D D D D
3013 H D D D D H H H D D
3014 H D D D H D H H D D
3015 H D D D H H D H D D
3016 H D D D H H H D D D
3017 H D D D D D H H D D
3018 H D D D D H D H D D
3019 H D D D D H H D D D
3020 H D D D H D D H D D
3021 H D D D H D H D D D
3022 H D D D H H D D D D
3023 H D D D D D D H D D
3024 H D D D D D H D D D
3025 H D D D D H D D D D
3026 H D D D H D D D D D
3027 H D D D D D D D D D
3028 D D D H D H H H D D
3029 D D D H H D H H D D
3030 D D D H H H D H D D
3031 D D D H H H H D D D
3032 D D D H D D H H D D
3033 D D D H D H D H D D
3034 D D D H D H H D D D
3035 D D D H H D D H D D
3036 D D D H H D H D D D
3037 D D D H H H D D D D
3038 D D D H D D D H D D
3039 D D D H D D H D D D
3040 D D D H D H D D D D
3041 D D D H H D D D D D
3042 D D D H D D D D D D
3043 D D H D D H H H D D
3044 D D H D H D H H D D No. R8a/R8a Rm/Rm' R9a/R9a' R9b/R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl,/Ryb'
3045 D D H D H H D H D D
3046 D D H D H H H D D D
3047 D D H D D D H H D D
3048 D D H D D H D H D D
3049 D D H D D H H D D D
3050 D D H D H D D H D D
3051 D D H D H D H D D D
3052 D D H D H H D D D D
3053 D D H D D D D H D D
3054 D D H D D D H D D D
3055 D D H D D H D D D D
3056 D D H D H D D D D D
3057 D D H D D D D D D D
3058 D D D D D H H H D D
3059 D D D D H D H H D D
3060 D D D D H H D H D D
3061 D D D D H H H D D D
3062 D D D D D D H H D D
3063 D D D D D H D H D D
3064 D D D D D H H D D D
3065 D D D D H D D H D D
3066 D D D D H D H D D D
3067 D D D D H H D D D D
3068 D D D D D D D H D D
3069 D D D D D D H D D D
3070 D D D D D H D D D D
3071 D D D D H D D D D D
3072 D D D D D D D D D D
Table 8. Compounds of Formulae Ill-a, Ill-b, III-c, and Ill-d wherein each of R6, R6 , R7 and R7 is deuterium.
Figure imgf000179_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3083 H H H H H H H D H H
3084 H H H H D D H H H H
3085 H H H H D H D H H H
3086 H H H H D H H D H H
3087 H H H H H D D H H H
3088 H H H H H D H D H H
3089 H H H H H H D D H H
3090 H H H H D D D H H H
3091 H H H H D D H D H H
3092 H H H H D H D D H H
3093 H H H H H D D D H H
3094 H H H H D D D D H H
3095 H H H H H H H H D H
3096 H H H H H H H H H D
3097 H H H H H H H H D D
3098 D H D H H H H H H H
3099 D H H D H H H H H H
3100 D H D D H H H H H H
3101 H D D H H H H H H H
3102 H D H D H H H H H H
3103 H D D D H H H H H H
3104 D D D H H H H H H H
3105 D D H D H H H H H H
3106 D D D D H H H H H H
3107 D H H H D H H H H H
3108 D H H H H D H H H H
3109 D H H H H H D H H H
3110 D H H H H H H D H H
3111 D H H H D D H H H H
3112 D H H H D H D H H H
3113 D H H H D H H D H H
3114 D H H H H D D H H H
3115 D H H H H D H D H H
3116 D H H H H H D D H H
3117 D H H H D D D H H H
3118 D H H H D D H D H H
3119 D H H H D H D D H H
3120 D H H H H D D D H H
3121 D H H H D D D D H H
3122 H D H H D H H H H H
3123 H D H H H D H H H H
3124 H D H H H H D H H H
3125 H D H H H H H D H H
3126 H D H H D D H H H H
Figure imgf000181_0001
Figure imgf000182_0001
Figure imgf000183_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3259 H H H H D D D D D D
3260 D H D H D H H H H H
3261 D H D H H D H H H H
3262 D H D H H H D H H H
3263 D H D H H H H D H H
3264 D H D H D D H H H H
3265 D H D H D H D H H H
3266 D H D H D H H D H H
3267 D H D H H D D H H H
3268 D H D H H D H D H H
3269 D H D H H H D D H H
3270 D H D H D D D H H H
3271 D H D H D D H D H H
3272 D H D H D H D D H H
3273 D H D H H D D D H H
3274 D H D H D D D D H H
3275 D H H D D H H H H H
3276 D H H D H D H H H H
3277 D H H D H H D H H H
3278 D H H D H H H D H H
3279 D H H D D D H H H H
3280 D H H D D H D H H H
3281 D H H D D H H D H H
3282 D H H D H D D H H H
3283 D H H D H D H D H H
3284 D H H D H H D D H H
3285 D H H D D D D H H H
3286 D H H D D D H D H H
3287 D H H D D H D D H H
3288 D H H D H D D D H H
3289 D H H D D D D D H H
3290 D H D D D H H H H H
3291 D H D D H D H H H H
3292 D H D D H H D H H H
3293 D H D D H H H D H H
3294 D H D D D D H H H H
3295 D H D D D H D H H H
3296 D H D D D H H D H H
3297 D H D D H D D H H H
3298 D H D D H D H D H H
3299 D H D D H H D D H H
3300 D H D D D D D H H H
3301 D H D D D D H D H H
3302 D H D D D H D D H H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3303 D H D D H D D D H H
3304 D H D D D D D D H H
3305 H D D H D H H H H H
3306 H D D H H D H H H H
3307 H D D H H H D H H H
3308 H D D H H H H D H H
3309 H D D H D D H H H H
3310 H D D H D H D H H H
331 1 H D D H D H H D H H
3312 H D D H H D D H H H
3313 H D D H H D H D H H
3314 H D D H H H D D H H
3315 H D D H D D D H H H
3316 H D D H D D H D H H
3317 H D D H D H D D H H
3318 H D D H H D D D H H
3319 H D D H D D D D H H
3320 H D H D D H H H H H
3321 H D H D H D H H H H
3322 H D H D H H D H H H
3323 H D H D H H H D H H
3324 H D H D D D H H H H
3325 H D H D D H D H H H
3326 H D H D D H H D H H
3327 H D H D H D D H H H
3328 H D H D H D H D H H
3329 H D H D H H D D H H
3330 H D H D D D D H H H
3331 H D H D D D H D H H
3332 H D H D D H D D H H
3333 H D H D H D D D H H
3334 H D H D D D D D H H
3335 H D D D D H H H H H
3336 H D D D H D H H H H
3337 H D D D H H D H H H
3338 H D D D H H H D H H
3339 H D D D D D H H H H
3340 H D D D D H D H H H
3341 H D D D D H H D H H
3342 H D D D H D D H H H
3343 H D D D H D H D H H
3344 H D D D H H D D H H
3345 H D D D D D D H H H
3346 H D D D D D H D H H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3347 H D D D D H D D H H
3348 H D D D H D D D H H
3349 H D D D D D D D H H
3350 D D D H D H H H H H
3351 D D D H H D H H H H
3352 D D D H H H D H H H
3353 D D D H H H H D H H
3354 D D D H D D H H H H
3355 D D D H D H D H H H
3356 D D D H D H H D H H
3357 D D D H H D D H H H
3358 D D D H H D H D H H
3359 D D D H H H D D H H
3360 D D D H D D D H H H
3361 D D D H D D H D H H
3362 D D D H D H D D H H
3363 D D D H H D D D H H
3364 D D D H D D D D H H
3365 D D H D D H H H H H
3366 D D H D H D H H H H
3367 D D H D H H D H H H
3368 D D H D H H H D H H
3369 D D H D D D H H H H
3370 D D H D D H D H H H
3371 D D H D D H H D H H
3372 D D H D H D D H H H
3373 D D H D H D H D H H
3374 D D H D H H D D H H
3375 D D H D D D D H H H
3376 D D H D D D H D H H
3377 D D H D D H D D H H
3378 D D H D H D D D H H
3379 D D H D D D D D H H
3380 D D D D D H H H H H
3381 D D D D H D H H H H
3382 D D D D H H D H H H
3383 D D D D H H H D H H
3384 D D D D D D H H H H
3385 D D D D D H D H H H
3386 D D D D D H H D H H
3387 D D D D H D D H H H
3388 D D D D H D H D H H
3389 D D D D H H D D H H
3390 D D D D D D D H H H
Figure imgf000187_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3435 D H H H H D D D D H
3436 D H H H D D D D D H
3437 D H H H D H H H H D
3438 D H H H H D H H H D
3439 D H H H H H D H H D
3434 D H H H H H H D H D
3441 D H H H D D H H H D
3442 D H H H D H D H H D
3443 D H H H D H H D H D
3444 D H H H H D D H H D
3445 D H H H H D H D H D
3446 D H H H H H D D H D
3447 D H H H D D D H H D
3448 D H H H D D H D H D
3449 D H H H D H D D H D
3450 D H H H H D D D H D
3451 D H H H D D D D H D
3452 D H H H D H H H D D
3453 D H H H H D H H D D
3454 D H H H H H D H D D
3455 D H H H H H H D D D
3456 D H H H D D H H D D
3457 D H H H D H D H D D
3458 D H H H D H H D D D
3459 D H H H H D D H D D
3460 D H H H H D H D D D
3461 D H H H H H D D D D
3462 D H H H D D D H D D
3463 D H H H D D H D D D
3464 D H H H D H D D D D
3465 D H H H H D D D D D
3466 D H H H D D D D D D
3467 H D H H D H H H D H
3468 H D H H H D H H D H
3469 H D H H H H D H D H
3470 H D H H H H H D D H
3471 H D H H D D H H D H
3472 H D H H D H D H D H
3473 H D H H D H H D D H
3474 H D H H H D D H D H
3475 H D H H H D H D D H
3476 H D H H H H D D D H
3477 H D H H D D D H D H
3478 H D H H D D H D D H
Figure imgf000189_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3523 D D H H D D H D D H
3524 D D H H D H D D D H
3525 D D H H H D D D D H
3526 D D H H D D D D D H
3527 D D H H D H H H H D
3528 D D H H H D H H H D
3529 D D H H H H D H H D
3530 D D H H H H H D H D
3531 D D H H D D H H H D
3532 D D H H D H D H H D
3533 D D H H D H H D H D
3534 D D H H H D D H H D
3535 D D H H H D H D H D
3536 D D H H H H D D H D
3537 D D H H D D D H H D
3538 D D H H D D H D H D
3539 D D H H D H D D H D
3540 D D H H H D D D H D
3541 D D H H D D D D H D
3542 D D H H D H H H D D
3543 D D H H H D H H D D
3544 D D H H H H D H D D
3545 D D H H H H H D D D
3546 D D H H D D H H D D
3547 D D H H D H D H D D
3548 D D H H D H H D D D
3549 D D H H H D D H D D
3550 D D H H H D H D D D
3551 D D H H H H D D D D
3552 D D H H D D D H D D
3553 D D H H D D H D D D
3554 D D H H D H D D D D
3555 D D H H H D D D D D
3556 D D H H D D D D D D
3557 H H D H D H H H D H
3558 H H D H H D H H D H
3559 H H D H H H D H D H
3560 H H D H H H H D D H
3561 H H D H D D H H D H
3562 H H D H D H D H D H
3563 H H D H D H H D D H
3564 H H D H H D D H D H
3565 H H D H H D H D D H
3566 H H D H H H D D D H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3567 H H D H D D D H D H
3568 H H D H D D H D D H
3569 H H D H D H D D D H
3570 H H D H H D D D D H
3571 H H D H D D D D D H
3572 H H D H D H H H H D
3573 H H D H H D H H H D
3574 H H D H H H D H H D
3575 H H D H H H H D H D
3576 H H D H D D H H H D
3577 H H D H D H D H H D
3578 H H D H D H H D H D
3579 H H D H H D D H H D
3580 H H D H H D H D H D
3581 H H D H H H D D H D
3582 H H D H D D D H H D
3583 H H D H D D H D H D
3584 H H D H D H D D H D
3585 H H D H H D D D H D
3586 H H D H D D D D H D
3587 H H D H D H H H D D
3588 H H D H H D H H D D
3589 H H D H H H D H D D
3590 H H D H H H H D D D
3591 H H D H D D H H D D
3592 H H D H D H D H D D
3593 H H D H D H H D D D
3594 H H D H H D D H D D
3595 H H D H H D H D D D
3596 H H D H H H D D D D
3597 H H D H D D D H D D
3598 H H D H D D H D D D
3599 H H D H D H D D D D
3600 H H D H H D D D D D
3601 H H D H D D D D D D
3602 H H H D D H H H D H
3603 H H H D H D H H D H
3604 H H H D H H D H D H
3605 H H H D H H H D D H
3606 H H H D D D H H D H
3607 H H H D D H D H D H
3608 H H H D D H H D D H
3609 H H H D H D D H D H
3610 H H H D H D H D D H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
361 1 H H H D H H D D D H
3612 H H H D D D D H D H
3613 H H H D D D H D D H
3614 H H H D D H D D D H
3615 H H H D H D D D D H
3616 H H H D D D D D D H
3617 H H H D D H H H H D
3618 H H H D H D H H H D
3619 H H H D H H D H H D
3620 H H H D H H H D H D
3621 H H H D D D H H H D
3622 H H H D D H D H H D
3623 H H H D D H H D H D
3624 H H H D H D D H H D
3625 H H H D H D H D H D
3626 H H H D H H D D H D
3627 H H H D D D D H H D
3628 H H H D D D H D H D
3629 H H H D D H D D H D
3630 H H H D H D D D H D
3631 H H H D D D D D H D
3632 H H H D D H H H D D
3633 H H H D H D H H D D
3634 H H H D H H D H D D
3635 H H H D H H H D D D
3636 H H H D D D H H D D
3637 H H H D D H D H D D
3638 H H H D D H H D D D
3639 H H H D H D D H D D
3640 H H H D H D H D D D
3641 H H H D H H D D D D
3642 H H H D D D D H D D
3643 H H H D D D H D D D
3644 H H H D D H D D D D
3645 H H H D H D D D D D
3646 H H H D D D D D D D
3647 H H D D D H H H D H
3648 H H D D H D H H D H
3649 H H D D H H D H D H
3650 H H D D H H H D D H
3651 H H D D D D H H D H
3652 H H D D D H D H D H
3653 H H D D D H H D D H
3654 H H D D H D D H D H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3655 H H D D H D H D D H
3656 H H D D H H D D D H
3657 H H D D D D D H D H
3658 H H D D D D H D D H
3659 H H D D D H D D D H
3660 H H D D H D D D D H
3661 H H D D D D D D D H
3662 H H D D D H H H H D
3663 H H D D H D H H H D
3664 H H D D H H D H H D
3665 H H D D H H H D H D
3666 H H D D D D H H H D
3667 H H D D D H D H H D
3668 H H D D D H H D H D
3669 H H D D H D D H H D
3670 H H D D H D H D H D
3671 H H D D H H D D H D
3672 H H D D D D D H H D
3673 H H D D D D H D H D
3674 H H D D D H D D H D
3675 H H D D H D D D H D
3676 H H D D D D D D H D
3677 H H D D D H H H D D
3678 H H D D H D H H D D
3679 H H D D H H D H D D
3680 H H D D H H H D D D
3681 H H D D D D H H D D
3682 H H D D D H D H D D
3683 H H D D D H H D D D
3684 H H D D H D D H D D
3685 H H D D H D H D D D
3686 H H D D H H D D D D
3687 H H D D D D D H D D
3688 H H D D D D H D D D
3689 H H D D D H D D D D
3690 H H D D H D D D D D
3691 H H D D D D D D D D
3692 D H D H D H H H D H
3693 D H D H H D H H D H
3694 D H D H H H D H D H
3695 D H D H H H H D D H
3696 D H D H D D H H D H
3697 D H D H D H D H D H
3698 D H D H D H H D D H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3699 D H D H H D D H D H
3700 D H D H H D H D D H
3701 D H D H H H D D D H
3702 D H D H D D D H D H
3703 D H D H D D H D D H
3704 D H D H D H D D D H
3705 D H D H H D D D D H
3706 D H D H D D D D D H
3707 D H H D D H H H D H
3708 D H H D H D H H D H
3709 D H H D H H D H D H
3710 D H H D H H H D D H
371 1 D H H D D D H H D H
3712 D H H D D H D H D H
3713 D H H D D H H D D H
3714 D H H D H D D H D H
3715 D H H D H D H D D H
3716 D H H D H H D D D H
3717 D H H D D D D H D H
3718 D H H D D D H D D H
3719 D H H D D H D D D H
3720 D H H D H D D D D H
3721 D H H D D D D D D H
3722 D H D D D H H H D H
3723 D H D D H D H H D H
3724 D H D D H H D H D H
3725 D H D D H H H D D H
3726 D H D D D D H H D H
3727 D H D D D H D H D H
3728 D H D D D H H D D H
3729 D H D D H D D H D H
3730 D H D D H D H D D H
3731 D H D D H H D D D H
3732 D H D D D D D H D H
3733 D H D D D D H D D H
3734 D H D D D H D D D H
3735 D H D D H D D D D H
3736 D H D D D D D D D H
3737 H D D H D H H H D H
3738 H D D H H D H H D H
3739 H D D H H H D H D H
3740 H D D H H H H D D H
3741 H D D H D D H H D H
3742 H D D H D H D H D H No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3743 H D D H D H H D D H
3744 H D D H H D D H D H
3745 H D D H H D H D D H
3746 H D D H H H D D D H
3747 H D D H D D D H D H
3748 H D D H D D H D D H
3749 H D D H D H D D D H
3750 H D D H H D D D D H
3751 H D D H D D D D D H
3752 H D H D D H H H D H
3753 H D H D H D H H D H
3754 H D H D H H D H D H
3755 H D H D H H H D D H
3756 H D H D D D H H D H
3757 H D H D D H D H D H
3758 H D H D D H H D D H
3759 H D H D H D D H D H
3760 H D H D H D H D D H
3761 H D H D H H D D D H
3762 H D H D D D D H D H
3763 H D H D D D H D D H
3764 H D H D D H D D D H
3765 H D H D H D D D D H
3766 H D H D D D D D D H
3767 H D D D D H H H D H
3768 H D D D H D H H D H
3769 H D D D H H D H D H
3770 H D D D H H H D D H
3771 H D D D D D H H D H
3772 H D D D D H D H D H
3773 H D D D D H H D D H
3774 H D D D H D D H D H
3775 H D D D H D H D D H
3776 H D D D H H D D D H
3777 H D D D D D D H D H
3778 H D D D D D H D D H
3779 H D D D D H D D D H
3780 H D D D H D D D D H
3781 H D D D D D D D D H
3782 D D D H D H H H D H
3783 D D D H H D H H D H
3784 D D D H H H D H D H
3785 D D D H H H H D D H
3786 D D D H D D H H D H
Figure imgf000196_0001
Figure imgf000197_0001
Figure imgf000198_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3919 D D D H H H D H H D
3920 D D D H H H H D H D
3921 D D D H D D H H H D
3922 D D D H D H D H H D
3923 D D D H D H H D H D
3924 D D D H H D D H H D
3925 D D D H H D H D H D
3926 D D D H H H D D H D
3927 D D D H D D D H H D
3928 D D D H D D H D H D
3929 D D D H D H D D H D
3930 D D D H H D D D H D
3931 D D D H D D D D H D
3932 D D H D D H H H H D
3933 D D H D H D H H H D
3934 D D H D H H D H H D
3935 D D H D H H H D H D
3936 D D H D D D H H H D
3937 D D H D D H D H H D
3938 D D H D D H H D H D
3939 D D H D H D D H H D
3940 D D H D H D H D H D
3941 D D H D H H D D H D
3942 D D H D D D D H H D
3943 D D H D D D H D H D
3944 D D H D D H D D H D
3945 D D H D H D D D H D
3946 D D H D D D D D H D
3947 D D D D D H H H H D
3948 D D D D H D H H H D
3949 D D D D H H D H H D
3950 D D D D H H H D H D
3951 D D D D D D H H H D
3952 D D D D D H D H H D
3953 D D D D D H H D H D
3954 D D D D H D D H H D
3955 D D D D H D H D H D
3956 D D D D H H D D H D
3957 D D D D D D D H H D
3958 D D D D D D H D H D
3959 D D D D D H D D H D
3960 D D D D H D D D H D
3961 D D D D D D D D H D
3962 D H D H D H H H D D No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7R5"''
3963 D H D H H D H H D D
3964 D H D H H H D H D D
3965 D H D H H H H D D D
3966 D H D H D D H H D D
3967 D H D H D H D H D D
3968 D H D H D H H D D D
3969 D H D H H D D H D D
3970 D H D H H D H D D D
3971 D H D H H H D D D D
3972 D H D H D D D H D D
3973 D H D H D D H D D D
3974 D H D H D H D D D D
3975 D H D H H D D D D D
3976 D H D H D D D D D D
3977 D H H D D H H H D D
3978 D H H D H D H H D D
3979 D H H D H H D H D D
3980 D H H D H H H D D D
3981 D H H D D D H H D D
3982 D H H D D H D H D D
3983 D H H D D H H D D D
3984 D H H D H D D H D D
3985 D H H D H D H D D D
3986 D H H D H H D D D D
3987 D H H D D D D H D D
3988 D H H D D D H D D D
3989 D H H D D H D D D D
3990 D H H D H D D D D D
3991 D H H D D D D D D D
3992 D H D D D H H H D D
3993 D H D D H D H H D D
3994 D H D D H H D H D D
3995 D H D D H H H D D D
3996 D H D D D D H H D D
3997 D H D D D H D H D D
3998 D H D D D H H D D D
3999 D H D D H D D H D D
4000 D H D D H D H D D D
4001 D H D D H H D D D D
4002 D H D D D D D H D D
4003 D H D D D D H D D D
4004 D H D D D H D D D D
4005 D H D D H D D D D D
4006 D H D D D D D D D D
Figure imgf000201_0001
Figure imgf000202_0001
No. R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b' Rxa Rxb Rxb< Rxc Rya/Rya Ryl7Ryb'
4095 D D D D H D D D D D
4096 D D D D D D D D D D
[0042] In some embodiments of Formula I, each of Rxa, Rx , Rx ', Rxc, Rya, Rya', Ry and Ry ' is hydrogen. Accordingly, in some embodiments, the present invention provides a compound of Formula IV:
Figure imgf000203_0001
IV
harmaceutically acceptable salt thereof, wherein: -R1 b
R 1 c
R2a
2b
R2 is R:
R3a
^R: 3b
R is RJC ; and
each of Rla, Rl , Rlc, R2a, R2 , R2c, R3a, R3 , R3c, R4, R4', R4", R5, R6, R6', R7, R7', R8a, R8a', R8 , R8 ', R9a, R9a', and R9 is as defined herein, provided that at least one of Rla, Rl , Rlc, R2a,
R2b R2c R3a R3b R3c R4 R4' r4" r5 r6 r6' r7 r7 R8a R8a' R8b R8b' R9a R9a' R9b is deuterium. [0043] In some embodiments of Formula IV, the compound is selected from those in Table 9 and Table 10.
Table 9. Compounds of Formula IV, wherein R5 is H.
Figure imgf000204_0001
No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-39 CD3 CH3 CD3 H H D H H H H
IV-40 CD3 CH3 CD3 D D H H H H H
IV-41 CD3 CH3 CD3 D H D H H H H
IV-42 CD3 CH3 CD3 H D D H H H H
IV-43 CD3 CH3 CD3 D D D H H H H
IV-44 CH3 CD3 CD3 D H H H H H H
IV-45 CH3 CD3 CD3 H D H H H H H
IV-46 CH3 CD3 CD3 H H D H H H H
IV-47 CH3 CD3 CD3 D D H H H H H
IV-48 CH3 CD3 CD3 D H D H H H H
IV-49 CH3 CD3 CD3 H D D H H H H
IV-50 CH3 CD3 CD3 D D D H H H H
IV-51 CD3 CD3 CD3 D H H H H H H
IV-52 CD3 CH3 CH3 H H H D H H H
IV-53 CD3 CH3 CH3 H H H H D H H
IV-54 CD3 CH3 CH3 H H H H H D H
IV-55 CD3 CH3 CH3 H H H H H H D
IV-56 CD3 CH3 CH3 H H H D D H H
IV-57 CD3 CH3 CH3 H H H D H D H
IV-58 CD3 CH3 CH3 H H H D H H D
IV-59 CD3 CH3 CH3 H H H H D D H
IV-60 CD3 CH3 CH3 H H H H D H D
IV-61 CD3 CH3 CH3 H H H H H D D
IV-62 CD3 CH3 CH3 H H H D D D H
IV-63 CD3 CH3 CH3 H H H D D H D
IV-64 CD3 CH3 CH3 H H H D H D D
IV-65 CD3 CH3 CH3 H H H H D D D
IV-66 CD3 CH3 CH3 H H H D D D D
IV-67 CH3 CD3 CH3 H H H D H H H
IV-68 CH3 CD3 CH3 H H H H D H H
IV-69 CH3 CD3 CH3 H H H H H D H
IV-70 CH3 CD3 CH3 H H H H H H D
IV-71 CH3 CD3 CH3 H H H D D H H
IV-72 CH3 CD3 CH3 H H H D H D H
IV-73 CH3 CD3 CH3 H H H D H H D
IV-74 CH3 CD3 CH3 H H H H D D H
IV-75 CH3 CD3 CH3 H H H H D H D
IV-76 CH3 CD3 CH3 H H H H H D D
IV-77 CH3 CD3 CH3 H H H D D D H
IV-78 CH3 CD3 CH3 H H H D D H D
IV-79 CH3 CD3 CH3 H H H D H D D
IV-80 CH3 CD3 CH3 H H H H D D D
IV-81 CH3 CD3 CH3 H H H D D D D
IV-82 CH3 CH3 CD3 H H H D H H H No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-83 CH3 CH3 CD3 H H H H D H H
IV-84 CH3 CH3 CD3 H H H H H D H
IV-85 CH3 CH3 CD3 H H H H H H D
IV-86 CH3 CH3 CD3 H H H D D H H
IV-87 CH3 CH3 CD3 H H H D H D H
IV-88 CH3 CH3 CD3 H H H D H H D
IV-89 CH3 CH3 CD3 H H H H D D H
IV-90 CH3 CH3 CD3 H H H H D H D
IV-91 CH3 CH3 CD3 H H H H H D D
IV-92 CH3 CH3 CD3 H H H D D D H
IV-93 CH3 CH3 CD3 H H H D D H D
IV-94 CH3 CH3 CD3 H H H D H D D
IV-95 CH3 CH3 CD3 H H H H D D D
IV-96 CH3 CH3 CD3 H H H D D D D
IV-97 CD3 CD3 CH3 H H H D H H H
IV-98 CD3 CD3 CH3 H H H H D H H
IV-99 CD3 CD3 CH3 H H H H H D H
IV- 100 CD3 CD3 CH3 H H H H H H D
IV-101 CD3 CD3 CH3 H H H D D H H
IV- 102 CD3 CD3 CH3 H H H D H D H
IV- 103 CD3 CD3 CH3 H H H D H H D
IV- 104 CD3 CD3 CH3 H H H H D D H
IV- 105 CD3 CD3 CH3 H H H H D H D
IV- 106 CD3 CD3 CH3 H H H H H D D
IV- 107 CD3 CD3 CH3 H H H D D D H
IV- 108 CD3 CD3 CH3 H H H D D H D
IV- 109 CD3 CD3 CH3 H H H D H D D
IV-110 CD3 CD3 CH3 H H H H D D D
IV-111 CD3 CD3 CH3 H H H D D D D
IV-112 CD3 CH3 CD3 H H H D H H H
IV-113 CD3 CH3 CD3 H H H H D H H
IV-114 CD3 CH3 CD3 H H H H H D H
IV-115 CD3 CH3 CD3 H H H H H H D
IV-116 CD3 CH3 CD3 H H H D D H H
IV-117 CD3 CH3 CD3 H H H D H D H
IV-118 CD3 CH3 CD3 H H H D H H D
IV-119 CD3 CH3 CD3 H H H H D D H
IV- 120 CD3 CH3 CD3 H H H H D H D
IV-121 CD3 CH3 CD3 H H H H H D D
IV- 122 CD3 CH3 CD3 H H H D D D H
IV- 123 CD3 CH3 CD3 H H H D D H D
IV- 124 CD3 CH3 CD3 H H H D H D D
IV- 125 CD3 CH3 CD3 H H H H D D D
IV- 126 CD3 CH3 CD3 H H H D D D D No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV- 127 CH3 CD3 CD3 H H H D H H H
IV- 128 CH3 CD3 CD3 H H H H D H H
IV- 129 CH3 CD3 CD3 H H H H H D H
IV-130 CH3 CD3 CD3 H H H H H H D
IV-131 CH3 CD3 CD3 H H H D D H H
IV- 132 CH3 CD3 CD3 H H H D H D H
IV-133 CH3 CD3 CD3 H H H D H H D
IV- 134 CH3 CD3 CD3 H H H H D D H
IV-135 CH3 CD3 CD3 H H H H D H D
IV-136 CH3 CD3 CD3 H H H H H D D
IV-137 CH3 CD3 CD3 H H H D D D H
IV-138 CH3 CD3 CD3 H H H D D H D
IV-139 CH3 CD3 CD3 H H H D H D D
IV- 140 CH3 CD3 CD3 H H H H D D D
IV-141 CH3 CD3 CD3 H H H D D D D
IV- 142 CD3 CH3 CH3 D H H D H H H
IV- 143 CD3 CH3 CH3 D H H H D H H
IV- 144 CD3 CH3 CH3 D H H H H D H
IV- 145 CD3 CH3 CH3 D H H H H H D
IV- 146 CD3 CH3 CH3 D H H D D H H
IV- 147 CD3 CH3 CH3 D H H D H D H
IV- 148 CD3 CH3 CH3 D H H D H H D
IV- 149 CD3 CH3 CH3 D H H H D D H
IV- 150 CD3 CH3 CH3 D H H H D H D
IV-151 CD3 CH3 CH3 D H H H H D D
IV- 152 CD3 CH3 CH3 D H H D D D H
IV- 153 CD3 CH3 CH3 D H H D D H D
IV- 154 CD3 CH3 CH3 D H H D H D D
IV-155 CD3 CH3 CH3 D H H H D D D
IV- 156 CD3 CH3 CH3 D H H D D D D
IV- 157 CD3 CH3 CH3 H D H D H H H
IV-158 CD3 CH3 CH3 H D H H D H H
IV- 159 CD3 CH3 CH3 H D H H H D H
IV- 160 CD3 CH3 CH3 H D H H H H D
IV-161 CD3 CH3 CH3 H D H D D H H
IV- 162 CD3 CH3 CH3 H D H D H D H
IV- 163 CD3 CH3 CH3 H D H D H H D
IV- 164 CD3 CH3 CH3 H D H H D D H
IV- 165 CD3 CH3 CH3 H D H H D H D
IV- 166 CD3 CH3 CH3 H D H H H D D
IV- 167 CD3 CH3 CH3 H D H D D D H
IV- 168 CD3 CH3 CH3 H D H D D H D
IV- 169 CD3 CH3 CH3 H D H D H D D
IV- 170 CD3 CH3 CH3 H D H H D D D No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-171 CD3 CH3 CH3 H D H D D D D
IV- 172 CD3 CH3 CH3 H H D D H H H
IV- 173 CD3 CH3 CH3 H H D H D H H
IV- 174 CD3 CH3 CH3 H H D H H D H
IV- 175 CD3 CH3 CH3 H H D H H H D
IV- 176 CD3 CH3 CH3 H H D D D H H
IV- 177 CD3 CH3 CH3 H H D D H D H
IV- 178 CD3 CH3 CH3 H H D D H H D
IV- 179 CD3 CH3 CH3 H H D H D D H
IV- 180 CD3 CH3 CH3 H H D H D H D
IV-181 CD3 CH3 CH3 H H D H H D D
IV- 182 CD3 CH3 CH3 H H D D D D H
IV- 183 CD3 CH3 CH3 H H D D D H D
IV- 184 CD3 CH3 CH3 H H D D H D D
IV- 185 CD3 CH3 CH3 H H D H D D D
IV- 186 CD3 CH3 CH3 H H D D D D D
IV- 187 CD3 CH3 CH3 D D H D H H H
IV- 188 CD3 CH3 CH3 D D H H D H H
IV- 189 CD3 CH3 CH3 D D H H H D H
IV- 190 CD3 CH3 CH3 D D H H H H D
IV-191 CD3 CH3 CH3 D D H D D H H
IV- 192 CD3 CH3 CH3 D D H D H D H
IV- 193 CD3 CH3 CH3 D D H D H H D
IV- 194 CD3 CH3 CH3 D D H H D D H
IV- 195 CD3 CH3 CH3 D D H H D H D
IV- 196 CD3 CH3 CH3 D D H H H D D
IV- 197 CD3 CH3 CH3 D D H D D D H
IV- 198 CD3 CH3 CH3 D D H D D H D
IV- 199 CD3 CH3 CH3 D D H D H D D
IV-200 CD3 CH3 CH3 D D H H D D D
IV-201 CD3 CH3 CH3 D D H D D D D
IV-202 CD3 CH3 CH3 D H D D H H H
IV-203 CD3 CH3 CH3 D H D H D H H
IV-204 CD3 CH3 CH3 D H D H H D H
IV-205 CD3 CH3 CH3 D H D H H H D
IV-206 CD3 CH3 CH3 D H D D D H H
IV-207 CD3 CH3 CH3 D H D D H D H
IV-208 CD3 CH3 CH3 D H D D H H D
IV-209 CD3 CH3 CH3 D H D H D D H
IV-210 CD3 CH3 CH3 D H D H D H D
IV-211 CD3 CH3 CH3 D H D H H D D
IV-212 CD3 CH3 CH3 D H D D D D H
IV-213 CD3 CH3 CH3 D H D D D H D
IV-214 CD3 CH3 CH3 D H D D H D D No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-215 CD3 CH3 CH3 D H D H D D D
IV-216 CD3 CH3 CH3 D H D D D D D
IV-217 CD3 CH3 CH3 H D D D H H H
IV-218 CD3 CH3 CH3 H D D H D H H
IV-219 CD3 CH3 CH3 H D D H H D H
IV-220 CD3 CH3 CH3 H D D H H H D
IV-221 CD3 CH3 CH3 H D D D D H H
IV-222 CD3 CH3 CH3 H D D D H D H
IV-223 CD3 CH3 CH3 H D D D H H D
IV-224 CD3 CH3 CH3 H D D H D D H
IV-225 CD3 CH3 CH3 H D D H D H D
IV-226 CD3 CH3 CH3 H D D H H D D
IV-227 CD3 CH3 CH3 H D D D D D H
IV-228 CD3 CH3 CH3 H D D D D H D
IV-229 CD3 CH3 CH3 H D D D H D D
IV-230 CD3 CH3 CH3 H D D H D D D
IV-231 CD3 CH3 CH3 H D D D D D D
IV-232 CD3 CH3 CH3 D D D D H H H
IV-233 CD3 CH3 CH3 D D D H D H H
IV-234 CD3 CH3 CH3 D D D H H D H
IV-235 CD3 CH3 CH3 D D D H H H D
IV-236 CD3 CH3 CH3 D D D D D H H
IV-237 CD3 CH3 CH3 D D D D H D H
IV-238 CD3 CH3 CH3 D D D D H H D
IV-239 CD3 CH3 CH3 D D D H D D H
IV-240 CD3 CH3 CH3 D D D H D H D
IV-241 CD3 CH3 CH3 D D D H H D D
IV-242 CD3 CH3 CH3 D D D D D D H
IV-243 CD3 CH3 CH3 D D D D D H D
IV-244 CD3 CH3 CH3 D D D D H D D
IV-245 CD3 CH3 CH3 D D D H D D D
IV-246 CD3 CH3 CH3 D D D D D D D
IV-247 CH3 CD3 CH3 D H H D H H H
IV-248 CH3 CD3 CH3 D H H H D H H
IV-249 CH3 CD3 CH3 D H H H H D H
IV-250 CH3 CD3 CH3 D H H H H H D
IV-251 CH3 CD3 CH3 D H H D D H H
IV-252 CH3 CD3 CH3 D H H D H D H
IV-253 CH3 CD3 CH3 D H H D H H D
IV-254 CH3 CD3 CH3 D H H H D D H
IV-255 CH3 CD3 CH3 D H H H D H D
IV-256 CH3 CD3 CH3 D H H H H D D
IV-257 CH3 CD3 CH3 D H H D D D H
IV-258 CH3 CD3 CH3 D H H D D H D No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-259 CH3 CD3 CH3 D H H D H D D
IV-260 CH3 CD3 CH3 D H H H D D D
IV-261 CH3 CD3 CH3 D H H D D D D
IV-262 CH3 CD3 CH3 H D H D H H H
IV-263 CH3 CD3 CH3 H D H H D H H
IV-264 CH3 CD3 CH3 H D H H H D H
IV-265 CH3 CD3 CH3 H D H H H H D
IV-266 CH3 CD3 CH3 H D H D D H H
IV-267 CH3 CD3 CH3 H D H D H D H
IV-268 CH3 CD3 CH3 H D H D H H D
IV-269 CH3 CD3 CH3 H D H H D D H
IV-270 CH3 CD3 CH3 H D H H D H D
IV-271 CH3 CD3 CH3 H D H H H D D
IV-272 CH3 CD3 CH3 H D H D D D H
IV-273 CH3 CD3 CH3 H D H D D H D
IV-274 CH3 CD3 CH3 H D H D H D D
IV-275 CH3 CD3 CH3 H D H H D D D
IV-276 CH3 CD3 CH3 H D H D D D D
IV-277 CH3 CD3 CH3 H H D D H H H
IV-278 CH3 CD3 CH3 H H D H D H H
IV-279 CH3 CD3 CH3 H H D H H D H
IV-280 CH3 CD3 CH3 H H D H H H D
IV-281 CH3 CD3 CH3 H H D D D H H
IV-282 CH3 CD3 CH3 H H D D H D H
IV-283 CH3 CD3 CH3 H H D D H H D
IV-284 CH3 CD3 CH3 H H D H D D H
IV-285 CH3 CD3 CH3 H H D H D H D
IV-286 CH3 CD3 CH3 H H D H H D D
IV-287 CH3 CD3 CH3 H H D D D D H
IV-288 CH3 CD3 CH3 H H D D D H D
IV-289 CH3 CD3 CH3 H H D D H D D
IV-290 CH3 CD3 CH3 H H D H D D D
IV-291 CH3 CD3 CH3 H H D D D D D
IV-292 CH3 CD3 CH3 D D H D H H H
IV-293 CH3 CD3 CH3 D D H H D H H
IV-294 CH3 CD3 CH3 D D H H H D H
IV-295 CH3 CD3 CH3 D D H H H H D
IV-296 CH3 CD3 CH3 D D H D D H H
IV-297 CH3 CD3 CH3 D D H D H D H
IV-298 CH3 CD3 CH3 D D H D H H D
IV-299 CH3 CD3 CH3 D D H H D D H
IV-300 CH3 CD3 CH3 D D H H D H D
IV-301 CH3 CD3 CH3 D D H H H D D
IV-302 CH3 CD3 CH3 D D H D D D H No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-303 CH3 CD3 CH3 D D H D D H D
IV-304 CH3 CD3 CH3 D D H D H D D
IV-305 CH3 CD3 CH3 D D H H D D D
IV-306 CH3 CD3 CH3 D D H D D D D
IV-307 CH3 CD3 CH3 D H D D H H H
IV-308 CH3 CD3 CH3 D H D H D H H
IV-309 CH3 CD3 CH3 D H D H H D H
IV-310 CH3 CD3 CH3 D H D H H H D
IV-311 CH3 CD3 CH3 D H D D D H H
IV-312 CH3 CD3 CH3 D H D D H D H
IV-313 CH3 CD3 CH3 D H D D H H D
IV-314 CH3 CD3 CH3 D H D H D D H
IV-315 CH3 CD3 CH3 D H D H D H D
IV-316 CH3 CD3 CH3 D H D H H D D
IV-317 CH3 CD3 CH3 D H D D D D H
IV-318 CH3 CD3 CH3 D H D D D H D
IV-319 CH3 CD3 CH3 D H D D H D D
IV-320 CH3 CD3 CH3 D H D H D D D
IV-321 CH3 CD3 CH3 D H D D D D D
IV-322 CH3 CD3 CH3 H D D D H H H
IV-323 CH3 CD3 CH3 H D D H D H H
IV-324 CH3 CD3 CH3 H D D H H D H
IV-325 CH3 CD3 CH3 H D D H H H D
IV-326 CH3 CD3 CH3 H D D D D H H
IV-327 CH3 CD3 CH3 H D D D H D H
IV-328 CH3 CD3 CH3 H D D D H H D
IV-329 CH3 CD3 CH3 H D D H D D H
IV-330 CH3 CD3 CH3 H D D H D H D
IV-331 CH3 CD3 CH3 H D D H H D D
IV-332 CH3 CD3 CH3 H D D D D D H
IV-333 CH3 CD3 CH3 H D D D D H D
IV-334 CH3 CD3 CH3 H D D D H D D
IV-335 CH3 CD3 CH3 H D D H D D D
IV-336 CH3 CD3 CH3 H D D D D D D
IV-337 CH3 CD3 CH3 D D D D H H H
IV-338 CH3 CD3 CH3 D D D H D H H
IV-339 CH3 CD3 CH3 D D D H H D H
IV-340 CH3 CD3 CH3 D D D H H H D
IV-341 CH3 CD3 CH3 D D D D D H H
IV-342 CH3 CD3 CH3 D D D D H D H
IV-343 CH3 CD3 CH3 D D D D H H D
IV-344 CH3 CD3 CH3 D D D H D D H
IV-345 CH3 CD3 CH3 D D D H D H D
IV-346 CH3 CD3 CH3 D D D H H D D No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-347 CH3 CD3 CH3 D D D D D D H
IV-348 CH3 CD3 CH3 D D D D D H D
IV-349 CH3 CD3 CH3 D D D D H D D
IV-350 CH3 CD3 CH3 D D D H D D D
IV-351 CH3 CD3 CH3 D D D D D D D
IV-352 CH3 CH3 CD3 D H H D H H H
IV-353 CH3 CH3 CD3 D H H H D H H
IV-354 CH3 CH3 CD3 D H H H H D H
IV-355 CH3 CH3 CD3 D H H H H H D
IV-356 CH3 CH3 CD3 D H H D D H H
IV-357 CH3 CH3 CD3 D H H D H D H
IV-358 CH3 CH3 CD3 D H H D H H D
IV-359 CH3 CH3 CD3 D H H H D D H
IV-360 CH3 CH3 CD3 D H H H D H D
IV-361 CH3 CH3 CD3 D H H H H D D
IV-362 CH3 CH3 CD3 D H H D D D H
IV-363 CH3 CH3 CD3 D H H D D H D
IV-364 CH3 CH3 CD3 D H H D H D D
IV-365 CH3 CH3 CD3 D H H H D D D
IV-366 CH3 CH3 CD3 D H H D D D D
IV-367 CH3 CH3 CD3 H D H D H H H
IV-368 CH3 CH3 CD3 H D H H D H H
IV-369 CH3 CH3 CD3 H D H H H D H
IV-370 CH3 CH3 CD3 H D H H H H D
IV-371 CH3 CH3 CD3 H D H D D H H
IV-372 CH3 CH3 CD3 H D H D H D H
IV-373 CH3 CH3 CD3 H D H D H H D
IV-374 CH3 CH3 CD3 H D H H D D H
IV-375 CH3 CH3 CD3 H D H H D H D
IV-376 CH3 CH3 CD3 H D H H H D D
IV-377 CH3 CH3 CD3 H D H D D D H
IV-378 CH3 CH3 CD3 H D H D D H D
IV-379 CH3 CH3 CD3 H D H D H D D
IV-380 CH3 CH3 CD3 H D H H D D D
IV-381 CH3 CH3 CD3 H D H D D D D
IV-382 CH3 CH3 CD3 H H D D H H H
IV-383 CH3 CH3 CD3 H H D H D H H
IV-384 CH3 CH3 CD3 H H D H H D H
IV-385 CH3 CH3 CD3 H H D H H H D
IV-386 CH3 CH3 CD3 H H D D D H H
IV-387 CH3 CH3 CD3 H H D D H D H
IV-388 CH3 CH3 CD3 H H D D H H D
IV-389 CH3 CH3 CD3 H H D H D D H
IV-390 CH3 CH3 CD3 H H D H D H D No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-391 CH3 CH3 CD3 H H D H H D D
IV-392 CH3 CH3 CD3 H H D D D D H
IV-393 CH3 CH3 CD3 H H D D D H D
IV-394 CH3 CH3 CD3 H H D D H D D
IV-395 CH3 CH3 CD3 H H D H D D D
IV-396 CH3 CH3 CD3 H H D D D D D
IV-397 CH3 CH3 CD3 D D H D H H H
IV-398 CH3 CH3 CD3 D D H H D H H
IV-399 CH3 CH3 CD3 D D H H H D H
IV-400 CH3 CH3 CD3 D D H H H H D
IV-401 CH3 CH3 CD3 D D H D D H H
IV-402 CH3 CH3 CD3 D D H D H D H
IV-403 CH3 CH3 CD3 D D H D H H D
IV-404 CH3 CH3 CD3 D D H H D D H
IV-405 CH3 CH3 CD3 D D H H D H D
IV-406 CH3 CH3 CD3 D D H H H D D
IV-407 CH3 CH3 CD3 D D H D D D H
IV-408 CH3 CH3 CD3 D D H D D H D
IV-409 CH3 CH3 CD3 D D H D H D D
IV-410 CH3 CH3 CD3 D D H H D D D
IV-411 CH3 CH3 CD3 D D H D D D D
IV-412 CH3 CH3 CD3 D H D D H H H
IV-413 CH3 CH3 CD3 D H D H D H H
IV-414 CH3 CH3 CD3 D H D H H D H
IV-415 CH3 CH3 CD3 D H D H H H D
IV-416 CH3 CH3 CD3 D H D D D H H
IV-417 CH3 CH3 CD3 D H D D H D H
IV-418 CH3 CH3 CD3 D H D D H H D
IV-419 CH3 CH3 CD3 D H D H D D H
IV-420 CH3 CH3 CD3 D H D H D H D
IV-421 CH3 CH3 CD3 D H D H H D D
IV-422 CH3 CH3 CD3 D H D D D D H
IV-423 CH3 CH3 CD3 D H D D D H D
IV-424 CH3 CH3 CD3 D H D D H D D
IV-425 CH3 CH3 CD3 D H D H D D D
IV-426 CH3 CH3 CD3 D H D D D D D
IV-427 CH3 CH3 CD3 H D D D H H H
IV-428 CH3 CH3 CD3 H D D H D H H
IV-429 CH3 CH3 CD3 H D D H H D H
IV-430 CH3 CH3 CD3 H D D H H H D
IV-431 CH3 CH3 CD3 H D D D D H H
IV-432 CH3 CH3 CD3 H D D D H D H
IV-433 CH3 CH3 CD3 H D D D H H D
IV-434 CH3 CH3 CD3 H D D H D D H No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-435 CH3 CH3 CD3 H D D H D H D
IV-436 CH3 CH3 CD3 H D D H H D D
IV-437 CH3 CH3 CD3 H D D D D D H
IV-438 CH3 CH3 CD3 H D D D D H D
IV-439 CH3 CH3 CD3 H D D D H D D
IV-440 CH3 CH3 CD3 H D D H D D D
IV-441 CH3 CH3 CD3 H D D D D D D
IV-442 CH3 CH3 CD3 D D D D H H H
IV-443 CH3 CH3 CD3 D D D H D H H
IV-444 CH3 CH3 CD3 D D D H H D H
IV-445 CH3 CH3 CD3 D D D H H H D
IV-446 CH3 CH3 CD3 D D D D D H H
IV-447 CH3 CH3 CD3 D D D D H D H
IV-448 CH3 CH3 CD3 D D D D H H D
IV-449 CH3 CH3 CD3 D D D H D D H
IV-450 CH3 CH3 CD3 D D D H D H D
IV-451 CH3 CH3 CD3 D D D H H D D
IV-452 CH3 CH3 CD3 D D D D D D H
IV-453 CH3 CH3 CD3 D D D D D H D
IV-454 CH3 CH3 CD3 D D D D H D D
IV-455 CH3 CH3 CD3 D D D H D D D
IV-456 CH3 CH3 CD3 D D D D D D D
IV-457 CD3 CD3 CH3 D H H D H H H
IV-458 CD3 CD3 CH3 D H H H D H H
IV-459 CD3 CD3 CH3 D H H H H D H
IV-460 CD3 CD3 CH3 D H H H H H D
IV-461 CD3 CD3 CH3 D H H D D H H
IV-462 CD3 CD3 CH3 D H H D H D H
IV-463 CD3 CD3 CH3 D H H D H H D
IV-464 CD3 CD3 CH3 D H H H D D H
IV-465 CD3 CD3 CH3 D H H H D H D
IV-466 CD3 CD3 CH3 D H H H H D D
IV-467 CD3 CD3 CH3 D H H D D D H
IV-468 CD3 CD3 CH3 D H H D D H D
IV-469 CD3 CD3 CH3 D H H D H D D
IV-470 CD3 CD3 CH3 D H H H D D D
IV-471 CD3 CD3 CH3 D H H D D D D
IV-472 CD3 CD3 CH3 H D H D H H H
IV-473 CD3 CD3 CH3 H D H H D H H
IV-474 CD3 CD3 CH3 H D H H H D H
IV-475 CD3 CD3 CH3 H D H H H H D
IV-476 CD3 CD3 CH3 H D H D D H H
IV-477 CD3 CD3 CH3 H D H D H D H
IV-478 CD3 CD3 CH3 H D H D H H D No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-479 CD3 CD3 CH3 H D H H D D H
IV-480 CD3 CD3 CH3 H D H H D H D
IV-481 CD3 CD3 CH3 H D H H H D D
IV-482 CD3 CD3 CH3 H D H D D D H
IV-483 CD3 CD3 CH3 H D H D D H D
IV-484 CD3 CD3 CH3 H D H D H D D
IV-485 CD3 CD3 CH3 H D H H D D D
IV-486 CD3 CD3 CH3 H D H D D D D
IV-487 CD3 CD3 CH3 H H D D H H H
IV-488 CD3 CD3 CH3 H H D H D H H
IV-489 CD3 CD3 CH3 H H D H H D H
IV-490 CD3 CD3 CH3 H H D H H H D
IV-491 CD3 CD3 CH3 H H D D D H H
IV-492 CD3 CD3 CH3 H H D D H D H
IV-493 CD3 CD3 CH3 H H D D H H D
IV-494 CD3 CD3 CH3 H H D H D D H
IV-495 CD3 CD3 CH3 H H D H D H D
IV-496 CD3 CD3 CH3 H H D H H D D
IV-497 CD3 CD3 CH3 H H D D D D H
IV-498 CD3 CD3 CH3 H H D D D H D
IV-499 CD3 CD3 CH3 H H D D H D D
IV-500 CD3 CD3 CH3 H H D H D D D
IV-501 CD3 CD3 CH3 H H D D D D D
IV-502 CD3 CD3 CH3 D D H D H H H
IV-503 CD3 CD3 CH3 D D H H D H H
IV-504 CD3 CD3 CH3 D D H H H D H
IV-505 CD3 CD3 CH3 D D H H H H D
IV-506 CD3 CD3 CH3 D D H D D H H
IV-507 CD3 CD3 CH3 D D H D H D H
IV-508 CD3 CD3 CH3 D D H D H H D
IV-509 CD3 CD3 CH3 D D H H D D H
IV-510 CD3 CD3 CH3 D D H H D H D
IV-511 CD3 CD3 CH3 D D H H H D D
IV-512 CD3 CD3 CH3 D D H D D D H
IV-513 CD3 CD3 CH3 D D H D D H D
IV-514 CD3 CD3 CH3 D D H D H D D
IV-515 CD3 CD3 CH3 D D H H D D D
IV-516 CD3 CD3 CH3 D D H D D D D
IV-517 CD3 CD3 CH3 D H D D H H H
IV-518 CD3 CD3 CH3 D H D H D H H
IV-519 CD3 CD3 CH3 D H D H H D H
IV-520 CD3 CD3 CH3 D H D H H H D
IV-521 CD3 CD3 CH3 D H D D D H H
IV-522 CD3 CD3 CH3 D H D D H D H No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-523 CD3 CD3 CH3 D H D D H H D
IV-524 CD3 CD3 CH3 D H D H D D H
IV-525 CD3 CD3 CH3 D H D H D H D
IV-526 CD3 CD3 CH3 D H D H H D D
IV-527 CD3 CD3 CH3 D H D D D D H
IV-528 CD3 CD3 CH3 D H D D D H D
IV-529 CD3 CD3 CH3 D H D D H D D
IV-530 CD3 CD3 CH3 D H D H D D D
IV-531 CD3 CD3 CH3 D H D D D D D
IV-532 CD3 CD3 CH3 H D D D H H H
IV-533 CD3 CD3 CH3 H D D H D H H
IV-534 CD3 CD3 CH3 H D D H H D H
IV-535 CD3 CD3 CH3 H D D H H H D
IV-536 CD3 CD3 CH3 H D D D D H H
IV-537 CD3 CD3 CH3 H D D D H D H
IV-538 CD3 CD3 CH3 H D D D H H D
IV-539 CD3 CD3 CH3 H D D H D D H
IV-540 CD3 CD3 CH3 H D D H D H D
IV-541 CD3 CD3 CH3 H D D H H D D
IV-542 CD3 CD3 CH3 H D D D D D H
IV-543 CD3 CD3 CH3 H D D D D H D
IV-544 CD3 CD3 CH3 H D D D H D D
IV-545 CD3 CD3 CH3 H D D H D D D
IV-546 CD3 CD3 CH3 H D D D D D D
IV-547 CD3 CD3 CH3 D D D D H H H
IV-548 CD3 CD3 CH3 D D D H D H H
IV-549 CD3 CD3 CH3 D D D H H D H
IV-550 CD3 CD3 CH3 D D D H H H D
IV-551 CD3 CD3 CH3 D D D D D H H
IV-552 CD3 CD3 CH3 D D D D H D H
IV-553 CD3 CD3 CH3 D D D D H H D
IV-554 CD3 CD3 CH3 D D D H D D H
IV-555 CD3 CD3 CH3 D D D H D H D
IV-556 CD3 CD3 CH3 D D D H H D D
IV-557 CD3 CD3 CH3 D D D D D D H
IV-558 CD3 CD3 CH3 D D D D D H D
IV-559 CD3 CD3 CH3 D D D D H D D
IV-560 CD3 CD3 CH3 D D D H D D D
IV-561 CD3 CD3 CH3 D D D D D D D
IV-562 CD3 CH3 CD3 D H H D H H H
IV-563 CD3 CH3 CD3 D H H H D H H
IV-564 CD3 CH3 CD3 D H H H H D H
IV-565 CD3 CH3 CD3 D H H H H H D
IV-566 CD3 CH3 CD3 D H H D D H H No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-567 CD3 CH3 CD3 D H H D H D H
IV-568 CD3 CH3 CD3 D H H D H H D
IV-569 CD3 CH3 CD3 D H H H D D H
IV-570 CD3 CH3 CD3 D H H H D H D
IV-571 CD3 CH3 CD3 D H H H H D D
IV-572 CD3 CH3 CD3 D H H D D D H
IV-573 CD3 CH3 CD3 D H H D D H D
IV-574 CD3 CH3 CD3 D H H D H D D
IV-575 CD3 CH3 CD3 D H H H D D D
IV-576 CD3 CH3 CD3 D H H D D D D
IV-577 CD3 CH3 CD3 H D H D H H H
IV-578 CD3 CH3 CD3 H D H H D H H
IV-579 CD3 CH3 CD3 H D H H H D H
IV-580 CD3 CH3 CD3 H D H H H H D
IV-581 CD3 CH3 CD3 H D H D D H H
IV-582 CD3 CH3 CD3 H D H D H D H
IV-583 CD3 CH3 CD3 H D H D H H D
IV-584 CD3 CH3 CD3 H D H H D D H
IV-585 CD3 CH3 CD3 H D H H D H D
IV-586 CD3 CH3 CD3 H D H H H D D
IV-587 CD3 CH3 CD3 H D H D D D H
IV-588 CD3 CH3 CD3 H D H D D H D
IV-589 CD3 CH3 CD3 H D H D H D D
IV-590 CD3 CH3 CD3 H D H H D D D
IV-591 CD3 CH3 CD3 H D H D D D D
IV-592 CD3 CH3 CD3 H H D D H H H
IV-593 CD3 CH3 CD3 H H D H D H H
IV-594 CD3 CH3 CD3 H H D H H D H
IV-595 CD3 CH3 CD3 H H D H H H D
IV-596 CD3 CH3 CD3 H H D D D H H
IV-597 CD3 CH3 CD3 H H D D H D H
IV-598 CD3 CH3 CD3 H H D D H H D
IV-599 CD3 CH3 CD3 H H D H D D H
IV-600 CD3 CH3 CD3 H H D H D H D
IV-601 CD3 CH3 CD3 H H D H H D D
IV-602 CD3 CH3 CD3 H H D D D D H
IV-603 CD3 CH3 CD3 H H D D D H D
IV-604 CD3 CH3 CD3 H H D D H D D
IV-605 CD3 CH3 CD3 H H D H D D D
IV-606 CD3 CH3 CD3 H H D D D D D
IV-607 CD3 CH3 CD3 D D H D H H H
IV-608 CD3 CH3 CD3 D D H H D H H
IV-609 CD3 CH3 CD3 D D H H H D H
IV-610 CD3 CH3 CD3 D D H H H H D No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-611 CD3 CH3 CD3 D D H D D H H
IV-612 CD3 CH3 CD3 D D H D H D H
IV-613 CD3 CH3 CD3 D D H D H H D
IV-614 CD3 CH3 CD3 D D H H D D H
IV-615 CD3 CH3 CD3 D D H H D H D
IV-616 CD3 CH3 CD3 D D H H H D D
IV-617 CD3 CH3 CD3 D D H D D D H
IV-618 CD3 CH3 CD3 D D H D D H D
IV-619 CD3 CH3 CD3 D D H D H D D
IV-620 CD3 CH3 CD3 D D H H D D D
IV-621 CD3 CH3 CD3 D D H D D D D
IV-622 CD3 CH3 CD3 D H D D H H H
IV-623 CD3 CH3 CD3 D H D H D H H
IV-624 CD3 CH3 CD3 D H D H H D H
IV-625 CD3 CH3 CD3 D H D H H H D
IV-626 CD3 CH3 CD3 D H D D D H H
IV-627 CD3 CH3 CD3 D H D D H D H
IV-628 CD3 CH3 CD3 D H D D H H D
IV-629 CD3 CH3 CD3 D H D H D D H
IV-630 CD3 CH3 CD3 D H D H D H D
IV-631 CD3 CH3 CD3 D H D H H D D
IV-632 CD3 CH3 CD3 D H D D D D H
IV-633 CD3 CH3 CD3 D H D D D H D
IV-634 CD3 CH3 CD3 D H D D H D D
IV-635 CD3 CH3 CD3 D H D H D D D
IV-636 CD3 CH3 CD3 D H D D D D D
IV-637 CD3 CH3 CD3 H D D D H H H
IV-638 CD3 CH3 CD3 H D D H D H H
IV-639 CD3 CH3 CD3 H D D H H D H
IV-640 CD3 CH3 CD3 H D D H H H D
IV-641 CD3 CH3 CD3 H D D D D H H
IV-642 CD3 CH3 CD3 H D D D H D H
IV-643 CD3 CH3 CD3 H D D D H H D
IV-644 CD3 CH3 CD3 H D D H D D H
IV-645 CD3 CH3 CD3 H D D H D H D
IV-646 CD3 CH3 CD3 H D D H H D D
IV-647 CD3 CH3 CD3 H D D D D D H
IV-648 CD3 CH3 CD3 H D D D D H D
IV-649 CD3 CH3 CD3 H D D D H D D
IV-650 CD3 CH3 CD3 H D D H D D D
IV-651 CD3 CH3 CD3 H D D D D D D
IV-652 CD3 CH3 CD3 D D D D H H H
IV-653 CD3 CH3 CD3 D D D H D H H
IV-654 CD3 CH3 CD3 D D D H H D H No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-655 CD3 CH3 CD3 D D D H H H D
IV-656 CD3 CH3 CD3 D D D D D H H
IV-657 CD3 CH3 CD3 D D D D H D H
IV-658 CD3 CH3 CD3 D D D D H H D
IV-659 CD3 CH3 CD3 D D D H D D H
IV-660 CD3 CH3 CD3 D D D H D H D
IV-661 CD3 CH3 CD3 D D D H H D D
IV-662 CD3 CH3 CD3 D D D D D D H
IV-663 CD3 CH3 CD3 D D D D D H D
IV-664 CD3 CH3 CD3 D D D D H D D
IV-665 CD3 CH3 CD3 D D D H D D D
IV-666 CD3 CH3 CD3 D D D D D D D
IV-667 CH3 CD3 CD3 D H H D H H H
IV-668 CH3 CD3 CD3 D H H H D H H
IV-669 CH3 CD3 CD3 D H H H H D H
IV-670 CH3 CD3 CD3 D H H H H H D
IV-671 CH3 CD3 CD3 D H H D D H H
IV-672 CH3 CD3 CD3 D H H D H D H
IV-673 CH3 CD3 CD3 D H H D H H D
IV-674 CH3 CD3 CD3 D H H H D D H
IV-675 CH3 CD3 CD3 D H H H D H D
IV-676 CH3 CD3 CD3 D H H H H D D
IV-677 CH3 CD3 CD3 D H H D D D H
IV-678 CH3 CD3 CD3 D H H D D H D
IV-679 CH3 CD3 CD3 D H H D H D D
IV-680 CH3 CD3 CD3 D H H H D D D
IV-681 CH3 CD3 CD3 D H H D D D D
IV-682 CH3 CD3 CD3 H D H D H H H
IV-683 CH3 CD3 CD3 H D H H D H H
IV-684 CH3 CD3 CD3 H D H H H D H
IV-685 CH3 CD3 CD3 H D H H H H D
IV-686 CH3 CD3 CD3 H D H D D H H
IV-687 CH3 CD3 CD3 H D H D H D H
IV-688 CH3 CD3 CD3 H D H D H H D
IV-689 CH3 CD3 CD3 H D H H D D H
IV-690 CH3 CD3 CD3 H D H H D H D
IV-691 CH3 CD3 CD3 H D H H H D D
IV-692 CH3 CD3 CD3 H D H D D D H
IV-693 CH3 CD3 CD3 H D H D D H D
IV-694 CH3 CD3 CD3 H D H D H D D
IV-695 CH3 CD3 CD3 H D H H D D D
IV-696 CH3 CD3 CD3 H D H D D D D
IV-697 CH3 CD3 CD3 H H D D H H H
IV-698 CH3 CD3 CD3 H H D H D H H No. R R RJ R /R /R R6/R6 R7/R7 R*a/R*a Rm/Rm' Ry7Rya' R9l7R9b'
IV-699 CH3 CD3 CD3 H H D H H D H
IV-700 CH3 CD3 CD3 H H D H H H D
IV-701 CH3 CD3 CD3 H H D D D H H
IV-702 CH3 CD3 CD3 H H D D H D H
IV-703 CH3 CD3 CD3 H H D D H H D
IV-704 CH3 CD3 CD3 H H D H D D H
IV-705 CH3 CD3 CD3 H H D H D H D
IV-706 CH3 CD3 CD3 H H D H H D D
IV-707 CH3 CD3 CD3 H H D D D D H
IV-708 CH3 CD3 CD3 H H D D D H D
IV-709 CH3 CD3 CD3 H H D D H D D
IV-710 CH3 CD3 CD3 H H D H D D D
IV-711 CH3 CD3 CD3 H H D D D D D
IV-712 CH3 CD3 CD3 D D H D H H H
IV-713 CH3 CD3 CD3 D D H H D H H
IV-714 CH3 CD3 CD3 D D H H H D H
IV-715 CH3 CD3 CD3 D D H H H H D
IV-716 CH3 CD3 CD3 D D H D D H H
IV-717 CH3 CD3 CD3 D D H D H D H
IV-718 CH3 CD3 CD3 D D H D H H D
IV-719 CH3 CD3 CD3 D D H H D D H
IV-720 CH3 CD3 CD3 D D H H D H D
IV-721 CH3 CD3 CD3 D D H H H D D
IV-722 CH3 CD3 CD3 D D H D D D H
IV-723 CH3 CD3 CD3 D D H D D H D
IV-724 CH3 CD3 CD3 D D H D H D D
IV-725 CH3 CD3 CD3 D D H H D D D
IV-726 CH3 CD3 CD3 D D H D D D D
IV-727 CH3 CD3 CD3 D H D D H H H
IV-728 CH3 CD3 CD3 D H D H D H H
IV-729 CH3 CD3 CD3 D H D H H D H
IV-730 CH3 CD3 CD3 D H D H H H D
IV-731 CH3 CD3 CD3 D H D D D H H
IV-732 CH3 CD3 CD3 D H D D H D H
IV-733 CH3 CD3 CD3 D H D D H H D
IV-734 CH3 CD3 CD3 D H D H D D H
IV-735 CH3 CD3 CD3 D H D H D H D
IV-736 CH3 CD3 CD3 D H D H H D D
IV-737 CH3 CD3 CD3 D H D D D D H
IV-738 CH3 CD3 CD3 D H D D D H D
IV-739 CH3 CD3 CD3 D H D D H D D
IV-740 CH3 CD3 CD3 D H D H D D D
IV-741 CH3 CD3 CD3 D H D D D D D
IV-742 CH3 CD3 CD3 H D D D H H H No. R R RJ R /R /R R6/R6 R7/R7 R*A/R*A Rm/Rm' RY7RYA' RY|>/RY|>'
IV-743 CH3 CD3 CD3 H D D H D H H
IV-744 CH3 CD3 CD3 H D D H H D H
IV-745 CH3 CD3 CD3 H D D H H H D
IV-746 CH3 CD3 CD3 H D D D D H H
IV-747 CH3 CD3 CD3 H D D D H D H
IV-748 CH3 CD3 CD3 H D D D H H D
IV-749 CH3 CD3 CD3 H D D H D D H
IV-750 CH3 CD3 CD3 H D D H D H D
IV-751 CH3 CD3 CD3 H D D H H D D
IV-752 CH3 CD3 CD3 H D D D D D H
IV-753 CH3 CD3 CD3 H D D D D H D
IV-754 CH3 CD3 CD3 H D D D H D D
IV-755 CH3 CD3 CD3 H D D H D D D
IV-756 CH3 CD3 CD3 H D D D D D D
IV-757 CH3 CD3 CD3 D D D D H H H
IV-758 CH3 CD3 CD3 D D D H D H H
IV-759 CH3 CD3 CD3 D D D H H D H
IV-760 CH3 CD3 CD3 D D D H H H D
IV-761 CH3 CD3 CD3 D D D D D H H
IV-762 CH3 CD3 CD3 D D D D H D H
IV-763 CH3 CD3 CD3 D D D D H H D
IV-764 CH3 CD3 CD3 D D D H D D H
IV-765 CH3 CD3 CD3 D D D H D H D
IV-766 CH3 CD3 CD3 D D D H H D D
IV-767 CH3 CD3 CD3 D D D D D D H
IV-768 CH3 CD3 CD3 D D D D D H D
IV-769 CH3 CD3 CD3 D D D D H D D
IV-770 CH3 CD3 CD3 D D D H D D D
IV-771 CH3 CD3 CD3 D D D D D D D
Table 10. Compounds of Formula IV, wherein R5 is D.
Figure imgf000221_0001
No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV-782 CD3 CH3 CH3 H D H H H H H
IV-783 CD3 CH3 CH3 H H D H H H H
IV-784 CD3 CH3 CH3 D D H H H H H
IV-785 CD3 CH3 CH3 D H D H H H H
IV-786 CD3 CH3 CH3 H D D H H H H
IV-787 CD3 CH3 CH3 D D D H H H H
IV-788 CH3 CD3 CH3 D H H H H H H
IV-789 CH3 CD3 CH3 H D H H H H H
IV-790 CH3 CD3 CH3 H H D H H H H
IV-791 CH3 CD3 CH3 D D H H H H H
IV-792 CH3 CD3 CH3 D H D H H H H
IV-793 CH3 CD3 CH3 H D D H H H H
IV-794 CH3 CD3 CH3 D D D H H H H
IV-795 CH3 CH3 CD3 D H H H H H H
IV-796 CH3 CH3 CD3 H D H H H H H
IV-797 CH3 CH3 CD3 H H D H H H H
IV-798 CH3 CH3 CD3 D D H H H H H
IV-799 CH3 CH3 CD3 D H D H H H H
IV-800 CH3 CH3 CD3 H D D H H H H
IV-801 CH3 CH3 CD3 D D D H H H H
IV-802 CD3 CD3 CH3 D H H H H H H
IV-803 CD3 CD3 CH3 H D H H H H H
IV-804 CD3 CD3 CH3 H H D H H H H
IV-805 CD3 CD3 CH3 D D H H H H H
IV-806 CD3 CD3 CH3 D H D H H H H
IV-807 CD3 CD3 CH3 H D D H H H H
IV-808 CD3 CD3 CH3 D D D H H H H
IV-809 CD3 CH3 CD3 D H H H H H H
IV-810 CD3 CH3 CD3 H D H H H H H
IV-811 CD3 CH3 CD3 H H D H H H H
IV-812 CD3 CH3 CD3 D D H H H H H
IV-813 CD3 CH3 CD3 D H D H H H H
IV-814 CD3 CH3 CD3 H D D H H H H
IV-815 CD3 CH3 CD3 D D D H H H H
IV-816 CH3 CD3 CD3 D H H H H H H
IV-817 CH3 CD3 CD3 H D H H H H H
IV-818 CH3 CD3 CD3 H H D H H H H
IV-819 CH3 CD3 CD3 D D H H H H H
IV-820 CH3 CD3 CD3 D H D H H H H
IV-821 CH3 CD3 CD3 H D D H H H H
IV-822 CH3 CD3 CD3 D D D H H H H
IV-823 CD3 CD3 CD3 D H H H H H H
IV-824 CD3 CH3 CH3 H H H D H H H
IV-825 CD3 CH3 CH3 H H H H D H H No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV-826 CD3 CH3 CH3 H H H H H D H
IV-827 CD3 CH3 CH3 H H H H H H D
IV-828 CD3 CH3 CH3 H H H D D H H
IV-829 CD3 CH3 CH3 H H H D H D H
IV-830 CD3 CH3 CH3 H H H D H H D
IV-831 CD3 CH3 CH3 H H H H D D H
IV-832 CD3 CH3 CH3 H H H H D H D
IV-833 CD3 CH3 CH3 H H H H H D D
IV-834 CD3 CH3 CH3 H H H D D D H
IV-835 CD3 CH3 CH3 H H H D D H D
IV-836 CD3 CH3 CH3 H H H D H D D
IV-837 CD3 CH3 CH3 H H H H D D D
IV-838 CD3 CH3 CH3 H H H D D D D
IV-839 CH3 CD3 CH3 H H H D H H H
IV-840 CH3 CD3 CH3 H H H H D H H
IV-841 CH3 CD3 CH3 H H H H H D H
IV-842 CH3 CD3 CH3 H H H H H H D
IV-843 CH3 CD3 CH3 H H H D D H H
IV-844 CH3 CD3 CH3 H H H D H D H
IV-845 CH3 CD3 CH3 H H H D H H D
IV-846 CH3 CD3 CH3 H H H H D D H
IV-847 CH3 CD3 CH3 H H H H D H D
IV-848 CH3 CD3 CH3 H H H H H D D
IV-849 CH3 CD3 CH3 H H H D D D H
IV-850 CH3 CD3 CH3 H H H D D H D
IV-851 CH3 CD3 CH3 H H H D H D D
IV-852 CH3 CD3 CH3 H H H H D D D
IV-853 CH3 CD3 CH3 H H H D D D D
IV-854 CH3 CH3 CD3 H H H D H H H
IV-855 CH3 CH3 CD3 H H H H D H H
IV-856 CH3 CH3 CD3 H H H H H D H
IV-857 CH3 CH3 CD3 H H H H H H D
IV-858 CH3 CH3 CD3 H H H D D H H
IV-859 CH3 CH3 CD3 H H H D H D H
IV-860 CH3 CH3 CD3 H H H D H H D
IV-861 CH3 CH3 CD3 H H H H D D H
IV-862 CH3 CH3 CD3 H H H H D H D
IV-863 CH3 CH3 CD3 H H H H H D D
IV-864 CH3 CH3 CD3 H H H D D D H
IV-865 CH3 CH3 CD3 H H H D D H D
IV-866 CH3 CH3 CD3 H H H D H D D
IV-867 CH3 CH3 CD3 H H H H D D D
IV-868 CH3 CH3 CD3 H H H D D D D
IV-869 CD3 CD3 CH3 H H H D H H H No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV-870 CD3 CD3 CH3 H H H H D H H
IV-871 CD3 CD3 CH3 H H H H H D H
IV-872 CD3 CD3 CH3 H H H H H H D
IV-873 CD3 CD3 CH3 H H H D D H H
IV-874 CD3 CD3 CH3 H H H D H D H
IV-875 CD3 CD3 CH3 H H H D H H D
IV-876 CD3 CD3 CH3 H H H H D D H
IV-877 CD3 CD3 CH3 H H H H D H D
IV-878 CD3 CD3 CH3 H H H H H D D
IV-879 CD3 CD3 CH3 H H H D D D H
IV-880 CD3 CD3 CH3 H H H D D H D
IV-881 CD3 CD3 CH3 H H H D H D D
IV-882 CD3 CD3 CH3 H H H H D D D
IV-883 CD3 CD3 CH3 H H H D D D D
IV-884 CD3 CH3 CD3 H H H D H H H
IV-885 CD3 CH3 CD3 H H H H D H H
IV-886 CD3 CH3 CD3 H H H H H D H
IV-887 CD3 CH3 CD3 H H H H H H D
IV-888 CD3 CH3 CD3 H H H D D H H
IV-889 CD3 CH3 CD3 H H H D H D H
IV-890 CD3 CH3 CD3 H H H D H H D
IV-891 CD3 CH3 CD3 H H H H D D H
IV-892 CD3 CH3 CD3 H H H H D H D
IV-893 CD3 CH3 CD3 H H H H H D D
IV-894 CD3 CH3 CD3 H H H D D D H
IV-895 CD3 CH3 CD3 H H H D D H D
IV-896 CD3 CH3 CD3 H H H D H D D
IV-897 CD3 CH3 CD3 H H H H D D D
IV-898 CD3 CH3 CD3 H H H D D D D
IV-899 CH3 CD3 CD3 H H H D H H H
IV-900 CH3 CD3 CD3 H H H H D H H
IV-901 CH3 CD3 CD3 H H H H H D H
IV-902 CH3 CD3 CD3 H H H H H H D
IV-903 CH3 CD3 CD3 H H H D D H H
IV-904 CH3 CD3 CD3 H H H D H D H
IV-905 CH3 CD3 CD3 H H H D H H D
IV-906 CH3 CD3 CD3 H H H H D D H
IV-907 CH3 CD3 CD3 H H H H D H D
IV-908 CH3 CD3 CD3 H H H H H D D
IV-909 CH3 CD3 CD3 H H H D D D H
IV-910 CH3 CD3 CD3 H H H D D H D
IV-911 CH3 CD3 CD3 H H H D H D D
IV-912 CH3 CD3 CD3 H H H H D D D
IV-913 CH3 CD3 CD3 H H H D D D D No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV-914 CD3 CH3 CH3 D H H D H H H
IV-915 CD3 CH3 CH3 D H H H D H H
IV-916 CD3 CH3 CH3 D H H H H D H
IV-917 CD3 CH3 CH3 D H H H H H D
IV-918 CD3 CH3 CH3 D H H D D H H
IV-919 CD3 CH3 CH3 D H H D H D H
IV-920 CD3 CH3 CH3 D H H D H H D
IV-921 CD3 CH3 CH3 D H H H D D H
IV-922 CD3 CH3 CH3 D H H H D H D
IV-923 CD3 CH3 CH3 D H H H H D D
IV-924 CD3 CH3 CH3 D H H D D D H
IV-925 CD3 CH3 CH3 D H H D D H D
IV-926 CD3 CH3 CH3 D H H D H D D
IV-927 CD3 CH3 CH3 D H H H D D D
IV-928 CD3 CH3 CH3 D H H D D D D
IV-929 CD3 CH3 CH3 H D H D H H H
IV-930 CD3 CH3 CH3 H D H H D H H
IV-931 CD3 CH3 CH3 H D H H H D H
IV-932 CD3 CH3 CH3 H D H H H H D
IV-933 CD3 CH3 CH3 H D H D D H H
IV-934 CD3 CH3 CH3 H D H D H D H
IV-935 CD3 CH3 CH3 H D H D H H D
IV-936 CD3 CH3 CH3 H D H H D D H
IV-937 CD3 CH3 CH3 H D H H D H D
IV-938 CD3 CH3 CH3 H D H H H D D
IV-939 CD3 CH3 CH3 H D H D D D H
IV-940 CD3 CH3 CH3 H D H D D H D
IV-941 CD3 CH3 CH3 H D H D H D D
IV-942 CD3 CH3 CH3 H D H H D D D
IV-943 CD3 CH3 CH3 H D H D D D D
IV-944 CD3 CH3 CH3 H H D D H H H
IV-945 CD3 CH3 CH3 H H D H D H H
IV-946 CD3 CH3 CH3 H H D H H D H
IV-947 CD3 CH3 CH3 H H D H H H D
IV-948 CD3 CH3 CH3 H H D D D H H
IV-949 CD3 CH3 CH3 H H D D H D H
IV-950 CD3 CH3 CH3 H H D D H H D
IV-951 CD3 CH3 CH3 H H D H D D H
IV-952 CD3 CH3 CH3 H H D H D H D
IV-953 CD3 CH3 CH3 H H D H H D D
IV-954 CD3 CH3 CH3 H H D D D D H
IV-955 CD3 CH3 CH3 H H D D D H D
IV-956 CD3 CH3 CH3 H H D D H D D
IV-957 CD3 CH3 CH3 H H D H D D D No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV-958 CD3 CH3 CH3 H H D D D D D
IV-959 CD3 CH3 CH3 D D H D H H H
IV-960 CD3 CH3 CH3 D D H H D H H
IV-961 CD3 CH3 CH3 D D H H H D H
IV-962 CD3 CH3 CH3 D D H H H H D
IV-963 CD3 CH3 CH3 D D H D D H H
IV-964 CD3 CH3 CH3 D D H D H D H
IV-965 CD3 CH3 CH3 D D H D H H D
IV-966 CD3 CH3 CH3 D D H H D D H
IV-967 CD3 CH3 CH3 D D H H D H D
IV-968 CD3 CH3 CH3 D D H H H D D
IV-969 CD3 CH3 CH3 D D H D D D H
IV-970 CD3 CH3 CH3 D D H D D H D
IV-971 CD3 CH3 CH3 D D H D H D D
IV-972 CD3 CH3 CH3 D D H H D D D
IV-973 CD3 CH3 CH3 D D H D D D D
IV-974 CD3 CH3 CH3 D H D D H H H
IV-975 CD3 CH3 CH3 D H D H D H H
IV-976 CD3 CH3 CH3 D H D H H D H
IV-977 CD3 CH3 CH3 D H D H H H D
IV-978 CD3 CH3 CH3 D H D D D H H
IV-979 CD3 CH3 CH3 D H D D H D H
IV-980 CD3 CH3 CH3 D H D D H H D
IV-981 CD3 CH3 CH3 D H D H D D H
IV-982 CD3 CH3 CH3 D H D H D H D
IV-983 CD3 CH3 CH3 D H D H H D D
IV-984 CD3 CH3 CH3 D H D D D D H
IV-985 CD3 CH3 CH3 D H D D D H D
IV-986 CD3 CH3 CH3 D H D D H D D
IV-987 CD3 CH3 CH3 D H D H D D D
IV-988 CD3 CH3 CH3 D H D D D D D
IV-989 CD3 CH3 CH3 H D D D H H H
IV-990 CD3 CH3 CH3 H D D H D H H
IV-991 CD3 CH3 CH3 H D D H H D H
IV-992 CD3 CH3 CH3 H D D H H H D
IV-993 CD3 CH3 CH3 H D D D D H H
IV-994 CD3 CH3 CH3 H D D D H D H
IV-995 CD3 CH3 CH3 H D D D H H D
IV-996 CD3 CH3 CH3 H D D H D D H
IV-997 CD3 CH3 CH3 H D D H D H D
IV-998 CD3 CH3 CH3 H D D H H D D
IV-999 CD3 CH3 CH3 H D D D D D H
IV- 1000 CD3 CH3 CH3 H D D D D H D
IV- 1001 CD3 CH3 CH3 H D D D H D D No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV- 1002 CD3 CH3 CH3 H D D H D D D
IV- 1003 CD3 CH3 CH3 H D D D D D D
IV- 1004 CD3 CH3 CH3 D D D D H H H
IV- 1005 CD3 CH3 CH3 D D D H D H H
IV- 1006 CD3 CH3 CH3 D D D H H D H
IV- 1007 CD3 CH3 CH3 D D D H H H D
IV- 1008 CD3 CH3 CH3 D D D D D H H
IV- 1009 CD3 CH3 CH3 D D D D H D H
IV- 1010 CD3 CH3 CH3 D D D D H H D
IV- 1011 CD3 CH3 CH3 D D D H D D H
IV-1012 CD3 CH3 CH3 D D D H D H D
IV- 1013 CD3 CH3 CH3 D D D H H D D
IV-1014 CD3 CH3 CH3 D D D D D D H
IV- 1015 CD3 CH3 CH3 D D D D D H D
IV- 1016 CD3 CH3 CH3 D D D D H D D
IV- 1017 CD3 CH3 CH3 D D D H D D D
IV- 1018 CD3 CH3 CH3 D D D D D D D
IV- 1019 CH3 CD3 CH3 D H H D H H H
IV- 1020 CH3 CD3 CH3 D H H H D H H
IV- 1021 CH3 CD3 CH3 D H H H H D H
IV- 1022 CH3 CD3 CH3 D H H H H H D
IV- 1023 CH3 CD3 CH3 D H H D D H H
IV- 1024 CH3 CD3 CH3 D H H D H D H
IV- 1025 CH3 CD3 CH3 D H H D H H D
IV- 1026 CH3 CD3 CH3 D H H H D D H
IV- 1027 CH3 CD3 CH3 D H H H D H D
IV- 1028 CH3 CD3 CH3 D H H H H D D
IV- 1029 CH3 CD3 CH3 D H H D D D H
IV- 1030 CH3 CD3 CH3 D H H D D H D
IV- 1031 CH3 CD3 CH3 D H H D H D D
IV- 1032 CH3 CD3 CH3 D H H H D D D
IV- 1033 CH3 CD3 CH3 D H H D D D D
IV- 1034 CH3 CD3 CH3 H D H D H H H
IV- 1035 CH3 CD3 CH3 H D H H D H H
IV- 1036 CH3 CD3 CH3 H D H H H D H
IV- 1037 CH3 CD3 CH3 H D H H H H D
IV- 1038 CH3 CD3 CH3 H D H D D H H
IV- 1039 CH3 CD3 CH3 H D H D H D H
IV- 1040 CH3 CD3 CH3 H D H D H H D
IV- 1041 CH3 CD3 CH3 H D H H D D H
IV- 1042 CH3 CD3 CH3 H D H H D H D
IV- 1043 CH3 CD3 CH3 H D H H H D D
IV- 1044 CH3 CD3 CH3 H D H D D D H
IV- 1045 CH3 CD3 CH3 H D H D D H D No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9l7R9b'
IV- 1046 CH3 CD3 CH3 H D H D H D D
IV- 1047 CH3 CD3 CH3 H D H H D D D
IV- 1048 c¾ CD3 CH3 H D H D D D D
IV- 1049 c¾ CD3 CH3 H H D D H H H
IV- 1050 c¾ CD3 CH3 H H D H D H H
IV- 1051 c¾ CD3 CH3 H H D H H D H
IV- 1052 c¾ CD3 CH3 H H D H H H D
IV- 1053 c¾ CD3 CH3 H H D D D H H
IV- 1054 c¾ CD3 CH3 H H D D H D H
IV- 1055 c¾ CD3 CH3 H H D D H H D
IV- 1056 CH3 CD3 CH3 H H D H D D H
IV- 1057 CH3 CD3 CH3 H H D H D H D
IV- 1058 CH3 CD3 CH3 H H D H H D D
IV- 1059 CH3 CD3 CH3 H H D D D D H
IV- 1060 CH3 CD3 CH3 H H D D D H D
IV- 1061 CH3 CD3 CH3 H H D D H D D
IV- 1062 CH3 CD3 CH3 H H D H D D D
IV- 1063 CH3 CD3 CH3 H H D D D D D
IV- 1064 CH3 CD3 CH3 D D H D H H H
IV- 1065 CH3 CD3 CH3 D D H H D H H
IV- 1066 CH3 CD3 CH3 D D H H H D H
IV- 1067 CH3 CD3 CH3 D D H H H H D
IV- 1068 CH3 CD3 CH3 D D H D D H H
IV- 1069 CH3 CD3 CH3 D D H D H D H
IV- 1070 CH3 CD3 CH3 D D H D H H D
IV- 1071 CH3 CD3 CH3 D D H H D D H
IV- 1072 CH3 CD3 CH3 D D H H D H D
IV- 1073 CH3 CD3 CH3 D D H H H D D
IV- 1074 CH3 CD3 CH3 D D H D D D H
IV- 1075 CH3 CD3 CH3 D D H D D H D
IV- 1076 CH3 CD3 CH3 D D H D H D D
IV- 1077 CH3 CD3 CH3 D D H H D D D
IV- 1078 CH3 CD3 CH3 D D H D D D D
IV- 1079 CH3 CD3 CH3 D H D D H H H
IV- 1080 CH3 CD3 CH3 D H D H D H H
IV- 1081 CH3 CD3 CH3 D H D H H D H
IV- 1082 CH3 CD3 CH3 D H D H H H D
IV- 1083 CH3 CD3 CH3 D H D D D H H
IV- 1084 CH3 CD3 CH3 D H D D H D H
IV- 1085 CH3 CD3 CH3 D H D D H H D
IV- 1086 CH3 CD3 CH3 D H D H D D H
IV- 1087 CH3 CD3 CH3 D H D H D H D
IV- 1088 CH3 CD3 CH3 D H D H H D D
IV- 1089 CH3 CD3 CH3 D H D D D D H No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV- 1090 CH3 CD3 CH3 D H D D D H D
IV- 1091 CH3 CD3 CH3 D H D D H D D
IV- 1092 CH3 CD3 CH3 D H D H D D D
IV- 1093 CH3 CD3 CH3 D H D D D D D
IV- 1094 CH3 CD3 CH3 H D D D H H H
IV- 1095 CH3 CD3 CH3 H D D H D H H
IV- 1096 CH3 CD3 CH3 H D D H H D H
IV- 1097 CH3 CD3 CH3 H D D H H H D
IV- 1098 CH3 CD3 CH3 H D D D D H H
IV- 1099 CH3 CD3 CH3 H D D D H D H
IV- 1100 CH3 CD3 CH3 H D D D H H D
IV- 1101 CH3 CD3 CH3 H D D H D D H
IV- 1102 CH3 CD3 CH3 H D D H D H D
IV- 1103 CH3 CD3 CH3 H D D H H D D
IV- 1104 CH3 CD3 CH3 H D D D D D H
IV- 1105 CH3 CD3 CH3 H D D D D H D
IV- 1106 CH3 CD3 CH3 H D D D H D D
IV- 1107 CH3 CD3 CH3 H D D H D D D
IV- 1108 CH3 CD3 CH3 H D D D D D D
IV- 1109 CH3 CD3 CH3 D D D D H H H
IV-1110 CH3 CD3 CH3 D D D H D H H
IV-1111 CH3 CD3 CH3 D D D H H D H
IV-1112 CH3 CD3 CH3 D D D H H H D
IV-1113 CH3 CD3 CH3 D D D D D H H
IV-1114 CH3 CD3 CH3 D D D D H D H
IV-1115 CH3 CD3 CH3 D D D D H H D
IV-1116 CH3 CD3 CH3 D D D H D D H
IV-1117 CH3 CD3 CH3 D D D H D H D
IV-1118 CH3 CD3 CH3 D D D H H D D
IV-1119 CH3 CD3 CH3 D D D D D D H
IV- 1120 CH3 CD3 CH3 D D D D D H D
IV-1121 CH3 CD3 CH3 D D D D H D D
IV- 1122 CH3 CD3 CH3 D D D H D D D
IV- 1123 CH3 CD3 CH3 D D D D D D D
IV- 1124 CH3 CH3 CD3 D H H D H H H
IV- 1125 CH3 CH3 CD3 D H H H D H H
IV- 1126 CH3 CH3 CD3 D H H H H D H
IV- 1127 CH3 CH3 CD3 D H H H H H D
IV- 1128 CH3 CH3 CD3 D H H D D H H
IV- 1129 CH3 CH3 CD3 D H H D H D H
IV- 1130 CH3 CH3 CD3 D H H D H H D
IV-1131 CH3 CH3 CD3 D H H H D D H
IV- 1132 CH3 CH3 CD3 D H H H D H D
IV- 1133 CH3 CH3 CD3 D H H H H D D No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV- 1134 CH3 CH3 CD3 D H H D D D H
IV-1135 CH3 CH3 CD3 D H H D D H D
IV- 1136 c¾ CH3 CD3 D H H D H D D
IV- 1137 c¾ CH3 CD3 D H H H D D D
IV-1138 c¾ CH3 CD3 D H H D D D D
IV- 1139 CH3 CH3 CD3 H D H D H H H
IV- 1140 CH3 CH3 CD3 H D H H D H H
IV-1141 CH3 CH3 CD3 H D H H H D H
IV- 1142 CH3 CH3 CD3 H D H H H H D
IV- 1143 CH3 CH3 CD3 H D H D D H H
IV- 1144 CH3 CH3 CD3 H D H D H D H
IV- 1145 CH3 CH3 CD3 H D H D H H D
IV- 1146 CH3 CH3 CD3 H D H H D D H
IV- 1147 CH3 CH3 CD3 H D H H D H D
IV- 1148 CH3 CH3 CD3 H D H H H D D
IV- 1149 CH3 CH3 CD3 H D H D D D H
IV- 1150 CH3 CH3 CD3 H D H D D H D
IV-1151 CH3 CH3 CD3 H D H D H D D
IV- 1152 CH3 CH3 CD3 H D H H D D D
IV- 1153 CH3 CH3 CD3 H D H D D D D
IV- 1154 CH3 CH3 CD3 H H D D H H H
IV- 1155 CH3 CH3 CD3 H H D H D H H
IV- 1156 CH3 CH3 CD3 H H D H H D H
IV- 1157 CH3 CH3 CD3 H H D H H H D
IV- 1158 CH3 CH3 CD3 H H D D D H H
IV- 1159 CH3 CH3 CD3 H H D D H D H
IV- 1160 CH3 CH3 CD3 H H D D H H D
IV- 1161 CH3 CH3 CD3 H H D H D D H
IV- 1162 CH3 CH3 CD3 H H D H D H D
IV- 1163 CH3 CH3 CD3 H H D H H D D
IV- 1164 CH3 CH3 CD3 H H D D D D H
IV- 1165 CH3 CH3 CD3 H H D D D H D
IV- 1166 CH3 CH3 CD3 H H D D H D D
IV- 1167 CH3 CH3 CD3 H H D H D D D
IV- 1168 CH3 CH3 CD3 H H D D D D D
IV- 1169 CH3 CH3 CD3 D D H D H H H
IV- 1170 CH3 CH3 CD3 D D H H D H H
IV- 1171 CH3 CH3 CD3 D D H H H D H
IV- 1172 CH3 CH3 CD3 D D H H H H D
IV- 1173 CH3 CH3 CD3 D D H D D H H
IV- 1174 CH3 CH3 CD3 D D H D H D H
IV- 1175 CH3 CH3 CD3 D D H D H H D
IV- 1176 CH3 CH3 CD3 D D H H D D H
IV- 1177 CH3 CH3 CD3 D D H H D H D No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV- 1178 CH3 CH3 CD3 D D H H H D D
IV- 1179 CH3 CH3 CD3 D D H D D D H
IV- 1180 CH3 CH3 CD3 D D H D D H D
IV-1181 CH3 CH3 CD3 D D H D H D D
IV- 1182 CH3 CH3 CD3 D D H H D D D
IV- 1183 CH3 CH3 CD3 D D H D D D D
IV- 1184 CH3 CH3 CD3 D H D D H H H
IV- 1185 CH3 CH3 CD3 D H D H D H H
IV- 1186 CH3 CH3 CD3 D H D H H D H
IV- 1187 CH3 CH3 CD3 D H D H H H D
IV- 1188 CH3 CH3 CD3 D H D D D H H
IV- 1189 CH3 CH3 CD3 D H D D H D H
IV- 1190 CH3 CH3 CD3 D H D D H H D
IV- 1191 CH3 CH3 CD3 D H D H D D H
IV- 1192 CH3 CH3 CD3 D H D H D H D
IV- 1193 CH3 CH3 CD3 D H D H H D D
IV- 1194 CH3 CH3 CD3 D H D D D D H
IV- 1195 CH3 CH3 CD3 D H D D D H D
IV- 1196 CH3 CH3 CD3 D H D D H D D
IV- 1197 CH3 CH3 CD3 D H D H D D D
IV- 1198 CH3 CH3 CD3 D H D D D D D
IV- 1199 CH3 CH3 CD3 H D D D H H H
IV- 1200 CH3 CH3 CD3 H D D H D H H
IV- 1201 CH3 CH3 CD3 H D D H H D H
IV- 1202 CH3 CH3 CD3 H D D H H H D
IV- 1203 CH3 CH3 CD3 H D D D D H H
IV- 1204 CH3 CH3 CD3 H D D D H D H
IV- 1205 CH3 CH3 CD3 H D D D H H D
IV- 1206 CH3 CH3 CD3 H D D H D D H
IV- 1207 CH3 CH3 CD3 H D D H D H D
IV- 1208 CH3 CH3 CD3 H D D H H D D
IV- 1209 CH3 CH3 CD3 H D D D D D H
IV-1210 CH3 CH3 CD3 H D D D D H D
IV-1211 CH3 CH3 CD3 H D D D H D D
IV-1212 CH3 CH3 CD3 H D D H D D D
IV-1213 CH3 CH3 CD3 H D D D D D D
IV-1214 CH3 CH3 CD3 D D D D H H H
IV-1215 CH3 CH3 CD3 D D D H D H H
IV-1216 CH3 CH3 CD3 D D D H H D H
IV-1217 CH3 CH3 CD3 D D D H H H D
IV-1218 CH3 CH3 CD3 D D D D D H H
IV-1219 CH3 CH3 CD3 D D D D H D H
IV- 1220 CH3 CH3 CD3 D D D D H H D
IV- 1221 CH3 CH3 CD3 D D D H D D H No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV- 1222 CH3 CH3 CD3 D D D H D H D
IV- 1223 CH3 CH3 CD3 D D D H H D D
IV- 1224 c¾ CH3 CD3 D D D D D D H
IV- 1225 c¾ CH3 CD3 D D D D D H D
IV- 1226 c¾ CH3 CD3 D D D D H D D
IV- 1227 c¾ CH3 CD3 D D D H D D D
IV- 1228 c¾ CH3 CD3 D D D D D D D
IV- 1229 CD3 CD3 CH3 D H H D H H H
IV- 1230 CD3 CD3 CH3 D H H H D H H
IV- 1231 CD3 CD3 CH3 D H H H H D H
IV- 1232 CD3 CD3 CH3 D H H H H H D
IV- 1233 CD3 CD3 CH3 D H H D D H H
IV- 1234 CD3 CD3 CH3 D H H D H D H
IV- 1235 CD3 CD3 CH3 D H H D H H D
IV- 1236 CD3 CD3 CH3 D H H H D D H
IV- 1237 CD3 CD3 CH3 D H H H D H D
IV- 1238 CD3 CD3 CH3 D H H H H D D
IV- 1239 CD3 CD3 CH3 D H H D D D H
IV- 1240 CD3 CD3 CH3 D H H D D H D
IV- 1241 CD3 CD3 CH3 D H H D H D D
IV- 1242 CD3 CD3 CH3 D H H H D D D
IV- 1243 CD3 CD3 CH3 D H H D D D D
IV- 1244 CD3 CD3 CH3 H D H D H H H
IV- 1245 CD3 CD3 CH3 H D H H D H H
IV- 1246 CD3 CD3 CH3 H D H H H D H
IV- 1247 CD3 CD3 CH3 H D H H H H D
IV- 1248 CD3 CD3 CH3 H D H D D H H
IV- 1249 CD3 CD3 CH3 H D H D H D H
IV- 1250 CD3 CD3 CH3 H D H D H H D
IV- 1251 CD3 CD3 CH3 H D H H D D H
IV- 1252 CD3 CD3 CH3 H D H H D H D
IV- 1253 CD3 CD3 CH3 H D H H H D D
IV- 1254 CD3 CD3 CH3 H D H D D D H
IV- 1255 CD3 CD3 CH3 H D H D D H D
IV- 1256 CD3 CD3 CH3 H D H D H D D
IV- 1257 CD3 CD3 CH3 H D H H D D D
IV- 1258 CD3 CD3 CH3 H D H D D D D
IV- 1259 CD3 CD3 CH3 H H D D H H H
IV- 1260 CD3 CD3 CH3 H H D H D H H
IV- 1261 CD3 CD3 CH3 H H D H H D H
IV- 1262 CD3 CD3 CH3 H H D H H H D
IV- 1263 CD3 CD3 CH3 H H D D D H H
IV- 1264 CD3 CD3 CH3 H H D D H D H
IV- 1265 CD3 CD3 CH3 H H D D H H D No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV- 1266 CD3 CD3 CH3 H H D H D D H
IV- 1267 CD3 CD3 CH3 H H D H D H D
IV- 1268 CD3 CD3 CH3 H H D H H D D
IV- 1269 CD3 CD3 CH3 H H D D D D H
IV- 1270 CD3 CD3 CH3 H H D D D H D
IV- 1271 CD3 CD3 CH3 H H D D H D D
IV- 1272 CD3 CD3 CH3 H H D H D D D
IV- 1273 CD3 CD3 CH3 H H D D D D D
IV- 1274 CD3 CD3 CH3 D D H D H H H
IV- 1275 CD3 CD3 CH3 D D H H D H H
IV- 1276 CD3 CD3 CH3 D D H H H D H
IV- 1277 CD3 CD3 CH3 D D H H H H D
IV- 1278 CD3 CD3 CH3 D D H D D H H
IV- 1279 CD3 CD3 CH3 D D H D H D H
IV- 1280 CD3 CD3 CH3 D D H D H H D
IV- 1281 CD3 CD3 CH3 D D H H D D H
IV- 1282 CD3 CD3 CH3 D D H H D H D
IV- 1283 CD3 CD3 CH3 D D H H H D D
IV- 1284 CD3 CD3 CH3 D D H D D D H
IV- 1285 CD3 CD3 CH3 D D H D D H D
IV- 1286 CD3 CD3 CH3 D D H D H D D
IV- 1287 CD3 CD3 CH3 D D H H D D D
IV- 1288 CD3 CD3 CH3 D D H D D D D
IV- 1289 CD3 CD3 CH3 D H D D H H H
IV- 1290 CD3 CD3 CH3 D H D H D H H
IV- 1291 CD3 CD3 CH3 D H D H H D H
IV- 1292 CD3 CD3 CH3 D H D H H H D
IV- 1293 CD3 CD3 CH3 D H D D D H H
IV- 1294 CD3 CD3 CH3 D H D D H D H
IV- 1295 CD3 CD3 CH3 D H D D H H D
IV- 1296 CD3 CD3 CH3 D H D H D D H
IV- 1297 CD3 CD3 CH3 D H D H D H D
IV- 1298 CD3 CD3 CH3 D H D H H D D
IV- 1299 CD3 CD3 CH3 D H D D D D H
IV- 1300 CD3 CD3 CH3 D H D D D H D
IV- 1301 CD3 CD3 CH3 D H D D H D D
IV- 1302 CD3 CD3 CH3 D H D H D D D
IV- 1303 CD3 CD3 CH3 D H D D D D D
IV- 1304 CD3 CD3 CH3 H D D D H H H
IV- 1305 CD3 CD3 CH3 H D D H D H H
IV- 1306 CD3 CD3 CH3 H D D H H D H
IV- 1307 CD3 CD3 CH3 H D D H H H D
IV- 1308 CD3 CD3 CH3 H D D D D H H
IV- 1309 CD3 CD3 CH3 H D D D H D H No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV-1310 CD3 CD3 CH3 H D D D H H D
IV-1311 CD3 CD3 CH3 H D D H D D H
IV-1312 CD3 CD3 CH3 H D D H D H D
IV-1313 CD3 CD3 CH3 H D D H H D D
IV-1314 CD3 CD3 CH3 H D D D D D H
IV-1315 CD3 CD3 CH3 H D D D D H D
IV-1316 CD3 CD3 CH3 H D D D H D D
IV-1317 CD3 CD3 CH3 H D D H D D D
IV-1318 CD3 CD3 CH3 H D D D D D D
IV-1319 CD3 CD3 CH3 D D D D H H H
IV- 1320 CD3 CD3 CH3 D D D H D H H
IV- 1321 CD3 CD3 CH3 D D D H H D H
IV- 1322 CD3 CD3 CH3 D D D H H H D
IV- 1323 CD3 CD3 CH3 D D D D D H H
IV- 1324 CD3 CD3 CH3 D D D D H D H
IV- 1325 CD3 CD3 CH3 D D D D H H D
IV- 1326 CD3 CD3 CH3 D D D H D D H
IV- 1327 CD3 CD3 CH3 D D D H D H D
IV- 1328 CD3 CD3 CH3 D D D H H D D
IV- 1329 CD3 CD3 CH3 D D D D D D H
IV- 1330 CD3 CD3 CH3 D D D D D H D
IV- 1331 CD3 CD3 CH3 D D D D H D D
IV- 1332 CD3 CD3 CH3 D D D H D D D
IV- 1333 CD3 CD3 CH3 D D D D D D D
IV- 1334 CD3 CH3 CD3 D H H D H H H
IV-1335 CD3 CH3 CD3 D H H H D H H
IV- 1336 CD3 CH3 CD3 D H H H H D H
IV- 1337 CD3 CH3 CD3 D H H H H H D
IV-1338 CD3 CH3 CD3 D H H D D H H
IV- 1339 CD3 CH3 CD3 D H H D H D H
IV- 1340 CD3 CH3 CD3 D H H D H H D
IV- 1341 CD3 CH3 CD3 D H H H D D H
IV- 1342 CD3 CH3 CD3 D H H H D H D
IV- 1343 CD3 CH3 CD3 D H H H H D D
IV- 1344 CD3 CH3 CD3 D H H D D D H
IV- 1345 CD3 CH3 CD3 D H H D D H D
IV- 1346 CD3 CH3 CD3 D H H D H D D
IV- 1347 CD3 CH3 CD3 D H H H D D D
IV- 1348 CD3 CH3 CD3 D H H D D D D
IV- 1349 CD3 CH3 CD3 H D H D H H H
IV- 1350 CD3 CH3 CD3 H D H H D H H
IV-1351 CD3 CH3 CD3 H D H H H D H
IV- 1352 CD3 CH3 CD3 H D H H H H D
IV- 1353 CD3 CH3 CD3 H D H D D H H No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV- 1354 CD3 CH3 CD3 H D H D H D H
IV-1355 CD3 CH3 CD3 H D H D H H D
IV- 1356 CD3 CH3 CD3 H D H H D D H
IV- 1357 CD3 CH3 CD3 H D H H D H D
IV-1358 CD3 CH3 CD3 H D H H H D D
IV- 1359 CD3 CH3 CD3 H D H D D D H
IV- 1360 CD3 CH3 CD3 H D H D D H D
IV- 1361 CD3 CH3 CD3 H D H D H D D
IV- 1362 CD3 CH3 CD3 H D H H D D D
IV- 1363 CD3 CH3 CD3 H D H D D D D
IV- 1364 CD3 CH3 CD3 H H D D H H H
IV- 1365 CD3 CH3 CD3 H H D H D H H
IV- 1366 CD3 CH3 CD3 H H D H H D H
IV- 1367 CD3 CH3 CD3 H H D H H H D
IV- 1368 CD3 CH3 CD3 H H D D D H H
IV- 1369 CD3 CH3 CD3 H H D D H D H
IV- 1370 CD3 CH3 CD3 H H D D H H D
IV- 1371 CD3 CH3 CD3 H H D H D D H
IV- 1372 CD3 CH3 CD3 H H D H D H D
IV- 1373 CD3 CH3 CD3 H H D H H D D
IV- 1374 CD3 CH3 CD3 H H D D D D H
IV- 1375 CD3 CH3 CD3 H H D D D H D
IV- 1376 CD3 CH3 CD3 H H D D H D D
IV- 1377 CD3 CH3 CD3 H H D H D D D
IV- 1378 CD3 CH3 CD3 H H D D D D D
IV- 1379 CD3 CH3 CD3 D D H D H H H
IV- 1380 CD3 CH3 CD3 D D H H D H H
IV-1381 CD3 CH3 CD3 D D H H H D H
IV- 1382 CD3 CH3 CD3 D D H H H H D
IV- 1383 CD3 CH3 CD3 D D H D D H H
IV- 1384 CD3 CH3 CD3 D D H D H D H
IV- 1385 CD3 CH3 CD3 D D H D H H D
IV- 1386 CD3 CH3 CD3 D D H H D D H
IV- 1387 CD3 CH3 CD3 D D H H D H D
IV- 1388 CD3 CH3 CD3 D D H H H D D
IV- 1389 CD3 CH3 CD3 D D H D D D H
IV- 1390 CD3 CH3 CD3 D D H D D H D
IV- 1391 CD3 CH3 CD3 D D H D H D D
IV- 1392 CD3 CH3 CD3 D D H H D D D
IV- 1393 CD3 CH3 CD3 D D H D D D D
IV- 1394 CD3 CH3 CD3 D H D D H H H
IV- 1395 CD3 CH3 CD3 D H D H D H H
IV- 1396 CD3 CH3 CD3 D H D H H D H
IV- 1397 CD3 CH3 CD3 D H D H H H D No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV- 1398 CD3 CH3 CD3 D H D D D H H
IV- 1399 CD3 CH3 CD3 D H D D H D H
IV- 1400 CD3 CH3 CD3 D H D D H H D
IV- 1401 CD3 CH3 CD3 D H D H D D H
IV- 1402 CD3 CH3 CD3 D H D H D H D
IV- 1403 CD3 CH3 CD3 D H D H H D D
IV- 1404 CD3 CH3 CD3 D H D D D D H
IV- 1405 CD3 CH3 CD3 D H D D D H D
IV- 1406 CD3 CH3 CD3 D H D D H D D
IV- 1407 CD3 CH3 CD3 D H D H D D D
IV- 1408 CD3 CH3 CD3 D H D D D D D
IV- 1409 CD3 CH3 CD3 H D D D H H H
IV-1410 CD3 CH3 CD3 H D D H D H H
IV-1411 CD3 CH3 CD3 H D D H H D H
IV-1412 CD3 CH3 CD3 H D D H H H D
IV-1413 CD3 CH3 CD3 H D D D D H H
IV-1414 CD3 CH3 CD3 H D D D H D H
IV-1415 CD3 CH3 CD3 H D D D H H D
IV-1416 CD3 CH3 CD3 H D D H D D H
IV-1417 CD3 CH3 CD3 H D D H D H D
IV-1418 CD3 CH3 CD3 H D D H H D D
IV-1419 CD3 CH3 CD3 H D D D D D H
IV- 1420 CD3 CH3 CD3 H D D D D H D
IV- 1421 CD3 CH3 CD3 H D D D H D D
IV- 1422 CD3 CH3 CD3 H D D H D D D
IV- 1423 CD3 CH3 CD3 H D D D D D D
IV- 1424 CD3 CH3 CD3 D D D D H H H
IV- 1425 CD3 CH3 CD3 D D D H D H H
IV- 1426 CD3 CH3 CD3 D D D H H D H
IV- 1427 CD3 CH3 CD3 D D D H H H D
IV- 1428 CD3 CH3 CD3 D D D D D H H
IV- 1429 CD3 CH3 CD3 D D D D H D H
IV- 1430 CD3 CH3 CD3 D D D D H H D
IV- 1431 CD3 CH3 CD3 D D D H D D H
IV- 1432 CD3 CH3 CD3 D D D H D H D
IV- 1433 CD3 CH3 CD3 D D D H H D D
IV- 1434 CD3 CH3 CD3 D D D D D D H
IV- 1435 CD3 CH3 CD3 D D D D D H D
IV- 1436 CD3 CH3 CD3 D D D D H D D
IV- 1437 CD3 CH3 CD3 D D D H D D D
IV- 1438 CD3 CH3 CD3 D D D D D D D
IV- 1439 CH3 CD3 CD3 D H H D H H H
IV- 1440 CH3 CD3 CD3 D H H H D H H
IV- 1441 CH3 CD3 CD3 D H H H H D H No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV- 1442 CH3 CD3 CD3 D H H H H H D
IV- 1443 CH3 CD3 CD3 D H H D D H H
IV- 1444 c¾ CD3 CD3 D H H D H D H
IV- 1445 c¾ CD3 CD3 D H H D H H D
IV- 1446 c¾ CD3 CD3 D H H H D D H
IV- 1447 c¾ CD3 CD3 D H H H D H D
IV- 1448 c¾ CD3 CD3 D H H H H D D
IV- 1449 c¾ CD3 CD3 D H H D D D H
IV- 1450 c¾ CD3 CD3 D H H D D H D
IV- 1451 c¾ CD3 CD3 D H H D H D D
IV- 1452 CH3 CD3 CD3 D H H H D D D
IV- 1453 CH3 CD3 CD3 D H H D D D D
IV- 1454 CH3 CD3 CD3 H D H D H H H
IV- 1455 CH3 CD3 CD3 H D H H D H H
IV- 1456 CH3 CD3 CD3 H D H H H D H
IV- 1457 CH3 CD3 CD3 H D H H H H D
IV- 1458 CH3 CD3 CD3 H D H D D H H
IV- 1459 CH3 CD3 CD3 H D H D H D H
IV- 1460 CH3 CD3 CD3 H D H D H H D
IV- 1461 CH3 CD3 CD3 H D H H D D H
IV- 1462 CH3 CD3 CD3 H D H H D H D
IV- 1463 CH3 CD3 CD3 H D H H H D D
IV- 1464 CH3 CD3 CD3 H D H D D D H
IV- 1465 CH3 CD3 CD3 H D H D D H D
IV- 1466 CH3 CD3 CD3 H D H D H D D
IV- 1467 CH3 CD3 CD3 H D H H D D D
IV- 1468 CH3 CD3 CD3 H D H D D D D
IV- 1469 CH3 CD3 CD3 H H D D H H H
IV- 1470 CH3 CD3 CD3 H H D H D H H
IV- 1471 CH3 CD3 CD3 H H D H H D H
IV- 1472 CH3 CD3 CD3 H H D H H H D
IV- 1473 CH3 CD3 CD3 H H D D D H H
IV- 1474 CH3 CD3 CD3 H H D D H D H
IV- 1475 CH3 CD3 CD3 H H D D H H D
IV- 1476 CH3 CD3 CD3 H H D H D D H
IV- 1477 CH3 CD3 CD3 H H D H D H D
IV- 1478 CH3 CD3 CD3 H H D H H D D
IV- 1479 CH3 CD3 CD3 H H D D D D H
IV- 1480 CH3 CD3 CD3 H H D D D H D
IV- 1481 CH3 CD3 CD3 H H D D H D D
IV- 1482 CH3 CD3 CD3 H H D H D D D
IV- 1483 CH3 CD3 CD3 H H D D D D D
IV- 1484 CH3 CD3 CD3 D D H D H H H
IV- 1485 CH3 CD3 CD3 D D H H D H H No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9l7R9b'
IV- 1486 CH3 CD3 CD3 D D H H H D H
IV- 1487 CH3 CD3 CD3 D D H H H H D
IV- 1488 CH3 CD3 CD3 D D H D D H H
IV- 1489 CH3 CD3 CD3 D D H D H D H
IV- 1490 CH3 CD3 CD3 D D H D H H D
IV- 1491 CH3 CD3 CD3 D D H H D D H
IV- 1492 CH3 CD3 CD3 D D H H D H D
IV- 1493 CH3 CD3 CD3 D D H H H D D
IV- 1494 CH3 CD3 CD3 D D H D D D H
IV- 1495 CH3 CD3 CD3 D D H D D H D
IV- 1496 CH3 CD3 CD3 D D H D H D D
IV- 1497 CH3 CD3 CD3 D D H H D D D
IV- 1498 CH3 CD3 CD3 D D H D D D D
IV- 1499 CH3 CD3 CD3 D H D D H H H
IV- 1500 CH3 CD3 CD3 D H D H D H H
IV- 1501 CH3 CD3 CD3 D H D H H D H
IV- 1502 CH3 CD3 CD3 D H D H H H D
IV- 1503 CH3 CD3 CD3 D H D D D H H
IV- 1504 CH3 CD3 CD3 D H D D H D H
IV- 1505 CH3 CD3 CD3 D H D D H H D
IV- 1506 CH3 CD3 CD3 D H D H D D H
IV- 1507 CH3 CD3 CD3 D H D H D H D
IV- 1508 CH3 CD3 CD3 D H D H H D D
IV- 1509 CH3 CD3 CD3 D H D D D D H
IV-1510 CH3 CD3 CD3 D H D D D H D
IV-1511 CH3 CD3 CD3 D H D D H D D
IV-1512 CH3 CD3 CD3 D H D H D D D
IV-1513 CH3 CD3 CD3 D H D D D D D
IV-1514 CH3 CD3 CD3 H D D D H H H
IV-1515 CH3 CD3 CD3 H D D H D H H
IV-1516 CH3 CD3 CD3 H D D H H D H
IV-1517 CH3 CD3 CD3 H D D H H H D
IV-1518 CH3 CD3 CD3 H D D D D H H
IV-1519 CH3 CD3 CD3 H D D D H D H
IV- 1520 CH3 CD3 CD3 H D D D H H D
IV- 1521 CH3 CD3 CD3 H D D H D D H
IV- 1522 CH3 CD3 CD3 H D D H D H D
IV- 1523 CH3 CD3 CD3 H D D H H D D
IV- 1524 CH3 CD3 CD3 H D D D D D H
IV- 1525 CH3 CD3 CD3 H D D D D H D
IV- 1526 CH3 CD3 CD3 H D D D H D D
IV- 1527 CH3 CD3 CD3 H D D H D D D
IV- 1528 CH3 CD3 CD3 H D D D D D D
IV- 1529 CH3 CD3 CD3 D D D D H H H No. R R RJ R /R /R RVR6 R7/R7 R*7R*a Rm/Rm' RYA/RYA' R9L7R9B'
IV- 1530 CH3 CD3 CD3 D D D H D H H
IV- 1531 CH3 CD3 CD3 D D D H H D H
IV- 1532 c¾ CD3 CD3 D D D H H H D
IV- 1533 CH3 CD3 CD3 D D D D D H H
IV- 1534 CH3 CD3 CD3 D D D D H D H
IV- 1535 CH3 CD3 CD3 D D D D H H D
IV- 1536 CH3 CD3 CD3 D D D H D D H
IV- 1537 CH3 CD3 CD3 D D D H D H D
IV- 1538 CH3 CD3 CD3 D D D H H D D
IV- 1539 CH3 CD3 CD3 D D D D D D H
IV- 1540 CH3 CD3 CD3 D D D D D H D
IV- 1541 CH3 CD3 CD3 D D D D H D D
IV- 1542 CH3 CD3 CD3 D D D H D D D
IV- 1543 CH3 CD3 CD3 D D D D D D D
[0044] In some embodiments of Formula I, each of R5, R9a, R9a', R9 , R9 ', Rxa, Rx , Rx ', Rxc, Rya, Rya', Ry and Ry ' is hydrogen. Accordingly, in some embodiments, the present invention provides a compound of Formula V:
Figure imgf000239_0001
V
or a pharmaceutically acceptable salt thereof, wherein:
R1 a
1 b
R
R 1 c
Figure imgf000240_0001
each of Rla, Rl , Rlc, R2a, R2, R2c, R3a, R3, R3c, R4, R4', R4", R6, R6', R7, R7', R8a, R8a', R8, and R8 ' is as defined herein, provided that at least one of Rla, Rl, Rlc, R2a, R2, R2c, R3a, R3, R3c, R4, R4', R4", R6, R6', R7, R7', R8a, R8a', R8, and R8 ' is deuterium.
[0045] In some embodiments of Formula I, each of R5, R8a, R8a', R8, R8 ', R9a, R9a', R9, R9 ', Rxa, Rx, Rx ', Rxc, Rya, Rya', Ry and Ry ' is hydrogen. Accordingly, in some embodiments, the present invention provides a compound of Formula VI:
Figure imgf000240_0002
VI
or a harmaceutically acceptable salt thereof, wherein:
Figure imgf000240_0003
each of Rla, Rl , Rlc, R2a, R2 , R2c, R3a, R3 , R3c, R4, R4', R4", R6, R6', R7, and R7' is as defined herein, provided that at least one of Rla, Rl , Rlc, R2a, R2 , R2c, R3a, R3 , R3c, R4, R4', R4", R6, R6 , R7, and R7 is deuterium.
Uses of Compounds and Pharmaceutically Acceptable Compositions
[0046] Compounds and compositions described herein are generally useful for the inhibition of protein kinase activity of one or more enzymes.
[0047] The compounds of the invention may be formulated into therapeutic compositions as natural or sail forms. Pharmaceutically accepiabie non-toxic salts include the base addition salts (formed with free carboxyl or other anionic groups) which may be derived from inorganic bases such as, for example, sodium, potassium, ammonium, calcium, or ferric hydroxides, and such organic bases as isopropyiamine, trimethylamine, 2-ethyiamino-ethanoi, histidine, procaine, and the like. Such salts may also be formed as acid addition salts with any free cationic groups and will generally be formed with inorganic acids such as, for example, hydrochloric, sulfuric, or phosphoric acids, or organic acids such as acetic, citric, p-toluenesulfonic, methanesulfonic acid, oxalic, tartaric, mandelie, and the like.
[0048] Salts of the invention can include amine salts formed by the protonation of an amino group with inorganic acids such as hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, phosphoric acid, and the like. Salts of the invention can also include amine salts formed by the protonation of an ammo group with suitable organic acids, such as p- toluenesulfonic acid, acetic acid, methanesulfonic acid and the like. Additional excipients which are contemplated for use in the practice of the present invention are those available to those of ordinary skill in the art, for example, those found in the United States Pharmacopeia Vol. XXII and National Formulary Vol. XVII, U. S. Pharmacopeia Convention, Inc., Rockville, Md. (1989), the relevant contents of which is incorporated herein by reference. In addition, polymorphs of the invention compounds are included in the present invention.
[0049] In some embodiments, a compound of Formula I is in the form of a hydrochloride salt. In some such embodiments, a compound of Formula I is in the form of a di hydrochloride salt. In some embodiments, a compound of Formula I is in the form of a dihydrochloride monohydrate. [0050] Protein kinases are families of enzymes that catalyze the phosphorylation of specific residues in proteins, broadly classified into tyrosine and serine/threonine kinases. Inappropriate kinase activity, arising from mutation, over-expression, or inappropriate regulation, dys- regulation or de-regulation, as well as over- or under-production of growth factors or cytokines has been implicated in many diseases, including but not limited too cancer, cardiovascular diseases, allergies, asthma and other respiratory diseases, autoimmune diseases, inflammatory diseases, bone diseases, metabolic disorders, and neurological and neurodegenerative disorders such as Alzheimer's disease. Inappropriate kinase activity triggers a variety of biological cellular responses relating to cell growth, cell differentiation, survival, apoptosis, mitogenesis, cell cycle control, and cell mobility implicated in the aforementioned and related diseases.
[0051] Protein kinases have emerged as an important class of enzymes as targets for therapeutic intervention. In particular, the JAK family of cellular protein tyrosine kinases (Jakl, Jak2, Jak3, and Tyk2) play a central role in cytokine signaling (Kisseleva et al, Gene, 2002, 285, 1 ; Yamaoka et al. Genome Biology 2004, 5, 253)). Upon binding to their receptors, cytokines activate JAK which then phosphorylate the cytokine receptor, thereby creating docking sites for signaling molecules, notably, members of the signal transducer and activator of transcription (STAT) family that ultimately lead to gene expression. Numerous cytokines are known to activate the JAK family, including IFN family cytokines (IFN-as/p/ro/Limitin, IFN-γ, IL-10, IL- 19, IL-20, IL-22), gpl 30 family cytokines (IL-6, IL-11 , OSM, LIF, CNTF, NNT-l/BSF-3, G- CSF, CT-1 , Leptin, IL-12, IL-23), jC family cytokines (IL-2, IL-7, TSLP, IL-9, IL-15, IL-21, IL-4, IL-13), IL-3 family cytokines (IL-3, IL-5, GM-CSF), single chain family cytokines (EPO, GH, PRL, TPO), receptor tyrosine kinases (EGF, PDGF, CSF-1, HGF), and G-protein coupled receptors (ATI).
[0052] Until recently, the therapeutic potential of JAK inhibitors has focused on diseases affecting various pathologies of the immune system, including, but not limited to, atopy (allergic asthma, atopic dermatitis, allergic rhinitis), cell mediated hypersensitivity (allergic contact dermatitis, hypersensitivity pneumonitis), rheumatic diseases (systemic lupus erythematosus (SLE), rheumatoid arthritis, juvenile arthritis, Sjogren's Syndrome, scleroderma, polymyositis, ankylosing spondylitis, psoriatic arthritis), transplantation (transplant rejection, graft vs host disease), viral diseases (Epstein Barr Virus, Hepatitis B, Hepatitis C, HIV, HTLV1, Vaicella- Zoster Virus, Human Papilloma Virus), cancer (leukemia, lymphoma), cardiovascular disease (cardiac hypertrophy, atherosclerosis and arteriosclerosis), neurodegenerative diseases (motor neuron disease), food allergy, inflammatory bowel disease, Crohn's disease, cutaneous inflammation, and immune suppression induced by solid tumors. Most efforts to date have targeted JAK3 inhibition for immunosuppression, for example organ transplantation and allograft acceptance (for a review, see Borie et al. Current Opinion in Investigational Drugs, 2003, 4(11), 1297).
[0053] Most recently, two significant findings of the role of the EPO-JAK2 signaling pathway in myeloproliferative disorders and proliferative diabetic retinopathy were found. First, a gain-of-function, somatic (acquired) mutation of the JAK2 kinase (V617F) was reported to be a causative factor in a number of "typical" myeloproliferative disorders, including polycythemia vera, essential thrombocythemia and myelofibrosis with myeloid metaplasia, and the mutation has been found in patients with either "atypical" myeloproliferative disorders and myelodysplastic syndrome (for reviews see Tefferi and Gilliland, Cell Cycle 2005, 4(8), e61; Pesu et. al. Molecular Interventions 2005, 5(4), 211). Additionally it was found that (a) the V617F JAK2 mutation was associated with constitutive phosphorylation of JAK2 and its downstream effectors as well as induction of erythropoietin hypersensitivity in cell based experiments, (b) V617F JAK2-induced cell proliferation signals were inhibited by small molecule inhibitors of JAK2, and (c) murine bone marrow transduced with a retrovirus containing V617F JAK2 included erythrocytosis in the transplanted mice.
[0054] Furthermore, it has been found that mutations in EPO-R also keep the JAK pathway constitutively activated leading to myeloproliferative disorders.
[0055] It has also been demonstrated that the JAK pathway may be recruited in cell survival and proliferation. For example, in the case of the cells that are Philadelphia chromosome positive that result in chronic myelogenous leukemia (CML), there is evidence that the Jak pathway is recruited in constitutive activation. Accordingly, using a JAK inhibitor may have use in CML in which the Philadelphia chromosome has been shown to produce the hybrid Bcr-Abl, thus keeping cells constitutively active.
[0001] In cases of resistance mutations that arise on account of specific inhibitors to BCR- ABL, as in the case of the T3151 gatekeeper mutation, or any other mutation, it may be possible to use a JAK inhibitor due to the fact that the BCR-ABL mutant (e.g., BCR-ABL(T315I)) utilizes the Jak pathway. Thus Jak inhibitors may be useful in the treatment of patients with resistance to known therapies where BCR-ABL is directly targeted and drug resistance has now been shown as the dominant (50-90%) of all resistance in patients where existing therapies fail. Without wishing to be bound by any particular theory, it is believed that compounds of the present invention may be effective inhibitors of drug resistant forms of protein kinases.
[0002] As used herein, the term "resistance" refers to changes in the wild-type nucleic acid sequence coding a target protein, and/or the protein sequence of the target, which changes decrease or abolish the inhibitory effect of the inhibitor on the target protein.
[0056] The activity of a compound utilized in this invention as an inhibitor of JAK2, or a mutant thereof, may be assayed in vitro, in vivo or in a cell line. In vitro assays include assays that determine inhibition of either the phosphorylation activity and/or the subsequent functional consequences, or ATPase activity of activated JAK2, or a mutant thereof. Alternate in vitro assays quantitate the ability of the inhibitor to bind to JAK2. Inhibitor binding may be measured by radiolabeling the inhibitor prior to binding, isolating the inhibitor/JAK2 complex and determining the amount of radiolabel bound. Alternatively, inhibitor binding may be determined by running a competition experiment where new inhibitors are incubated with JAK2 bound to known radioligands.
[0057] According to another embodiment, the invention provides a method for treating or lessening the severity of a JAK2-mediated disease or condition in a patient comprising the step of administering to said patient a composition according to the present invention.
[0058] The term "JAK2-mediated disease", as used herein means any disease or other deleterious condition in which a JAK2 kinase is known to play a role. Accordingly, another embodiment of the present invention relates to treating or lessening the severity of one or more diseases in which JAK2 is known to play a role.
[0059] The compounds and methods of the present invention, or pharmaceutically acceptable salts, hydrates, solvates, crystal forms and individual diastereomers thereof, are useful in treating a variety of disorders, including, but not limited to for example, proliferative diabetic retinopathy and other angiogenic-associated disorders, eye disease, inflammation such as psoriasis, and a viral infection. The kinds of cancer that can be treated include, but are not limited to, myeloproliferative disorders, polycythemia vera, essential thrombocythemia, myeloid fibrosis with myeloid metaplasia, other myeloid-linked disorders, an alimentary/gastrointestinal tract cancer, colon cancer, liver cancer, skin cancer, breast cancer, ovarian cancer, prostate cancer, multiple myeloma, lymphoma (including Non-Hodgkin's lymphoma and Hodgkin's lymphoma), leukemia (including acute myelogenous leukemia, chronic myelogenous leukemia which may be drug resistant, chronic myelomonocytic leukemia, chronic lymphocytic leukemia, chronic neutrophilic (CNL), eosinophilic (CEL) and myelomonocytic (CMML) leukemias; juvenile myelomonocytic leukemia (JMML)), hypereosinophilic syndrome, myelodysplastic syndromes, including refractory anemia with ringed sideroblasts, kidney cancer, lung cancer, muscle cancer, bone cancer, bladder cancer or brain cancer.
[0060] Some examples of the diseases and disorders thai can be treated also include ocular neovascularization, infantile haemangiomas: organ hypoxia, vascular hyperplasia, organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type 1 diabetes and complications from diabetes, inflammatory disease, acute pancreatitis, chronic pancreatitis, asthma, allergies, adult respirator ' distress syndrome, cardiovascular disease, liver disease, other blood disorders, asthma, rhinitis, atopic, dermatitis, autoimmune thyroid disorders, ulcerative colitis. Crohn's disease, metastatic melanoma, Kaposi's sarcoma, multiple myeloma, conditions associated with cytokines, and other autoimmune diseases including glomerulonephritis, scleroderma, chronic thyroiditis. Graves' disease, autoimmune gastritis, autoimmune hemolytic anemia, autoimmune neutropenia, thrombocytopenia, atopy (e.g. allergic asthma, atopic dermatitis, or allergic rhinitis), chronic active hepatitis, myasthenia gravis, multiple sclerosis, inflammatory bowel disease, graft vs host disease, neurodegenerative diseases including motor neuron disease. Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, cerebral ischemia, or neurodegenerative disease caused by traumatic injury, strike, glutama e neurotoxicity or hypoxia; i chenuc/reperfusion injury in stroke, myocardial ischemia, renal ischemia, heart attacks, cardiac hypertrophy, atherosclerosis and arteriosclerosis, organ hypoxia, platelet aggregation, and mastocytosis. In some embodiments, the disease being treated is selected from rheumatoid arthritis, juvenile idiopathic arthritis, psoriasis, systemic scleroderma and Crohn's disease. Examples of some additional diseases and disorders that can be treated also include cell mediated hypersensitivity (allergic contact dermatitis, hypersensitivity pneumonitis), rheumatic diseases (e.g., systemic lupus erythematosus (SEE), juvenile arthritis. Sjogren's Syndrome, scleroderma, polymyositis, ankylosing spondylitis, psoriatic arthritis), viral diseases (Epstein Barr Virus, Hepatitis B, Hepatitis C, HIV, HTLV1 , Vaicel la-Zoster Virus. Human Papilloma Virus), food allergy, cutaneous inflammation, and immune suppression induced by solid tumors.
[0061] One embodiment provides a method for treating a disease selected from systemic sclerosis, rheumatoid arthritis, mastocytosis, chronic myelogenous leukemia, and chronic eosinophilic leukemia comprising administering to a subject in need thereof a therapeutically effective amount of a compound of the invention. In another embodiment, the disease is systemic sclerosis. In another embodiment, the disease is rheumatoid arthritis. In another embodiment, the disease is mastocytosis, such as systemic mastocytosis. In another embodiment, the disease is chronic myelogenous leukemia, such as drug resistant chronic myelogenous leukemia. In another embodiment, the disease is chronic eosinophilic leukemia. A further embodiment provides for the use of a therapeutically effective amount of a compound of the invention in the manufacture of a medicament for treating a disease selected from, systemic sclerosis, rheumatoid arthritis, mastocytosis, chronic myelogenous leukemia, and chronic eosinophilic leukemia in a subject in need thereof.
[0062] In some embodiments, the present invention relates to a method of treating or lessening the severity of a myeloproliferative disease or condition. In some embodiments, the myeloproliferative disease or condition is selected from primary myelofibrosis, secondary myelofibrosis, polycythemia vera, essential thrombocythemia, post polycythemia vera, and post essential thrombocythemia. In some embodiments, said method comprises administering to a patient in need thereof a composition according to the present invention.
[0063] Also provided herein are methods of treating myelofibrosis in a subject, comprising administering to the subject an effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof or a hydrate thereof, wherein the subject has previously received another myelofibrosis therapy. In some embodiments, the previous therapy is a treatment with a JAK2 inhibitor which is not N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-l- ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutically acceptable salt thereof or a hydrate thereof. In some embodiments, the previous therapy comprises administration of INCBO 18424 (ruxolitinib). In some embodiments, the subject is unresponsive to the previous therapy. In some embodiments, the previous therapy is a treatment with N-tert-butyl-3-[(5-methyl-2- {[4-(2-pyrrolidin-l -ylethoxy)phenyl]amino}pyrimidin-4- yl)amino]benzenesulfonamide or a pharmaceutically acceptable salt thereof or a hydrate thereof. In some embodiments, the previous therapy has been discontinued upon indication of elevated levels of amylase, lipase, aspartate aminotransferase ("AST"), alanine aminotransferase ("ALT"), and/or creatinine. In some embodiments, the previous therapy has been discontinued upon indication of a hematologic condition selected from the group consisting of anemia, thrombocytopenia, and neutropenia.
[0064] The compounds and compositions, according to the method of the present invention, may be administered using any amount and any route of administration effective for treating or lessening the severity of the condition being treated. The exact amount required will vary from subject to subject, depending on the species, age, and general condition of the subject, the severity of the infection, the particular agent, its mode of administration, and the like. Compounds of the invention are preferably formulated in dosage unit form for ease of administration and uniformity of dosage. The expression "dosage unit form" as used herein refers to a physically discrete unit of agent appropriate for the patient to be treated. It will be understood, however, that the total daily usage of the compounds and compositions of the present invention will be decided by the attending physician within the scope of sound medical judgment. The specific effective dose level for any particular patient or organism will depend upon a variety of factors including the disorder being treated and the severity of the disorder; the activity of the specific compound employed; the specific composition employed; the age, body weight, general health, sex and diet of the patient; the time of administration, route of administration, and rate of excretion of the specific compound employed; the duration of the treatment; drugs used in combination or coincidental with the specific compound employed, and like factors well known in the medical arts. The term "patient", as used herein, means an animal, preferably a mammal, and most preferably a human.
[0065] The pharmaceutical compositions for the administration of the compounds described herein may conveniently be presented in dosage unit form and may be prepared by any of the methods well known m the art of pharmacy. All methods include bringing the active ingredient into association with the carrier which constitutes one or more accessory ingredients. In general, the pharmaceutical compositions are prepared by uniformly and intimately bringing the active ingredient into association with a liquid carrier or a finely divided solid earner or both, and then, if necessary, shaping the product into the desired formulation. In the pharmaceutical composition the active object compound is included in an amount sufficient to produce the desired effect upon the process or condition of diseases. The pharmaceutical compositions containing the active ingredient may be in a form suitable for oral use, for example, as tablets, troches, lozenges, aqueous or oily suspensions, dispersihle powders or granules, emulsions, hard or soft capsules, or syrups or elixirs.
[0066] Compositions intended for oral use may be prepared according to any method known to the art for the manufacture of pharmaceutical compositions and such compositions may contain one or more agents selected from the group consisting of sweetening agents, flavoring agents, coloring agents and preserving agents in order to provide pharmaceutically elegant and palatable preparations. Tablets contain the active ingredient in admixture with non-toxic pharmaceutically acceptable excipients which are suitable for the manufacture of tablets. These excipients may be for example, inert diluents, such as calcium carbonate, sodium carbonate, lactose, calcium phosphate or sodium phosphate; granulating and disintegrating agents, for example, corn starch, or alginic acid; binding agents, for example starch, gelatin or acacia, and lubricating agents, for example magnesium stearate, stearic acid or talc. The tablets may be uncoated or they may be coated by known techniques to delay disintegration and absorption in the gastrointestinal tract and thereby provide a sustained action over a longer period. For example, a time delay material such as glyceryl monostearate or glyceryl distearate may be employed. They may also be coated to form, osmotic therapeutic tablets for control release.
[0067] Formulations for oral use may also be presented as hard gelatin capsules wherein the active ingredient is mixed with an inert solid diluent, for example, calcium carbonate, calcium phosphate or kaolin, or as soft gelatin capsules wherein the active ingredient is mixed with water or an oil medium, for example peanut oil, liquid paraffin, or olive oil.
[0068] Gelatin capsules, in addition to the active ingredient, may comprise rmcrocrystallme cellulose, for example, silicified mierocrystaliine cellulose, and a Iubncant such as, for example, magnesium stearate or sodium stearyl fumarate.
[0069] Aqueous suspensions contain the active materials in admixture with excipients suitable for the manufacture of aqueous suspensions. Such excipients are suspending agents, for example sodium carboxymethylcellulose, methylcellulose, hydroxy-propylmethylcellulose, sodium alginate, polyvinyl-pyrrolidone, gum tragacanth and gum acacia; dispersing or wetting agents may be a naturally-occurring phosphatide, for example lecithin, or condensation products of an alkylene oxide with fatty acids, for example polyoxyethylene stearate, or condensation products of ethylene oxide with long chain aliphatic alcohols, for example heptadecaeth leneoxy cetanol or condensation products of ethylene oxide with partial esters derived from fatty acids and a hexitol such as poiyoxyethylene sorbitol monooleate, or condensation products of ethylene oxide with partial esters derived from fatty acids and hexitoi anhydrides, for example polyethylene sorbitan monooleate. Also useful as a soluhilizer is polyethylene glycol, for example. The aqueous suspensions may also contain one or more preservatives, for example ethyl, or n propy , p-hydroxybenzoate, one or more coloring agents, one or more flavoring agents, and one or more sweetening agents, such as sucrose or saccharin.
[0070] Oily suspensions may be formulated by suspending the active ingredient in a vegetable oil, for example arachis oil, olive oil, sesame oil or coconut oil, or in a mineral oil such as liquid paraffin. The oily suspensions may contain a thickening agent, for example beeswax, hard paraffin or cetyl alcohol. Sweetening agents such as those set forth above, and flavoring agents may be added to provide a palatable oral preparation. These compositions may be preserved by the addition of an antioxidant such as ascorbic acid,
[0071] Dispersible powders and granules suitable for preparation of an aqueous suspension by the addition of water provide the active ingredient in admixture with a dispersing or wetting agent, suspending agent and one or more preservatives. Suitable dispersing or wetting agents and suspending agents are exemplified by those already mentioned above. Additional exeipients, for example sweetening, flavoring and coloring agents, may also be present,
[0072] Syrups and elixirs may be formulated with sweetening agents, for example glycerol, propylene glycol, sorbitol or sucrose. Such formulations may also contain a demulcent, a preservative and flavoring and coloring agents,
[0073] The pharmaceutical compositions may be in the form of a sterile injectable aqueous or oleagenoiis suspension. This suspension may be formulated according to the known art using those suitable dispersing or wetting agents and suspending agents which have been mentioned above. The sterile injectable preparation may also be a sterile injectable solution or suspension in a parenterally-aeceptable diluent or solvent or cosolvent or complexing agent or dispersing agent or excipient or combination thereof, for example 1,3-butanediol, polyethylene glycols, polypropylene glycols, ethanol or other alcohols, povidones, various brands of TWEEN surfactant, sodium dodecyl sulfate, sodium deoxycholate, dimethylacetamide, polysorbates, poloxamers, cyclodextrins, lipids, and exeipients such as inorganic salts (e.g., sodium chloride), buffering agents (e.g., sodium citrate, sodium phosphate), and sugars (e.g., saccharose and dextrose). Among the acceptable vehicles and solvents that may be employed are water, dextrose solutions. Ringer's solutions and isotonic sodium chloride solution. In addition, sterile, fixed oils are conventionally employed as a solvent or suspending medium. For this purpose any bland fixed oil may be employed including synthetic mono- or digiycerides. In addition, fatty acids such as oleic acid find use in the preparation of imectables.
[0074] Depending on the condition being treated, these pharmaceutical compositions may be formulated and administered systemicaily or locally. Techniques for formulation and administration may be found in the latest edition of "'Remington's Pharmaceutical Sciences" (Mack Publishing Co, Easton Pa. ). Suitable routes may, for example, include oral or transmucosal administration; as well as parenteral delivery, including intramuscular, subcutaneous, intramedullary, intrathecal, intraventricular, intravenous, intraperitoneal, or intranasal administration. For injection, the pharmaceutical compositions of the invention may be formulated in aqueous solutions, preferably in physiologically compatible buffers such as Hanks' solution, Ringer's solution, or physiologically buffered saline. For tissue or cellular administration, penetrants appropriate to the particular barrier to be permeated are used in the formulation. Such penetrants are generally known in the art. Pharmaceutical formulations for parenteral administration include aqueous solutions of the active compounds in water-soluble form. Additionally, suspensions of the active compounds may be prepared as appropriate oily injection suspensions. Suitable lipophilic solvents or vehicles include fatty oils such as sesame oil, or synthetic fatty acid esters, such as ethyl oleate or triglycerides, or liposomes. Aqueous injection suspensions may contain substances that increase the viscosity of the suspension, such as sodium carboxyrnethyl cellulose, sorbitol, or dextran. Optionally, the suspension may also contain suitable stabilizers or agents that increase the solubility of the compounds to allow for the preparation of highly concentrated solutions.
[0075] The corn pounds of the present invention may also be administered in the form of suppositories for rectal administration of the drug. These compositions can be prepared by mixing the drug with a suitable non-irritating excipient which is solid at ordinary temperatures but liquid at the rectal temperature and will therefore melt in the rectum to release the drug. Such materials are cocoa butter and polyethylene glycols. [0076] For topical use, creams, ointments, jellies, solutions or suspensions, etc., containing the compounds of the present invention are employed. (For purposes of this application, topical application shall include mouthwashes and gargles).
[0077] According to one embodiment, the invention relates to a method of inhibiting protein kinase activity in a biological sample comprising the step of contacting said biological sample with a compound of this invention, or a composition comprising said compound. In some embodiments, the present invention provides a method of inhibiting JAK2 activity in a biological sample comprising the step of contacting said biological sample with a compound of this invention, or a composition comprising said compound.
[0078] The term "biological sample", as used herein, includes, without limitation, cell cultures or extracts thereof; biopsied material obtained from a mammal or extracts thereof; and blood, saliva, urine, feces, semen, tears, or other body fluids or extracts thereof.
[0079] Another embodiment of the present invention relates to a method of inhibiting protein kinase activity in a patient comprising the step of administering to said patient a compound of the present invention, or a composition comprising said compound. In some embodiments, the present invention provides a method of inhibiting JAK2 activity in a patient comprising the step of administering to said patient a compound of the present invention, or a composition comprising said compound.
[0080] The compounds of this invention, or pharmaceutical compositions thereof, may also be incorporated into compositions for coating an implantable medical device, such as prostheses, artificial valves, vascular grafts, stents and catheters. Vascular stents, for example, have been used to overcome restenosis (re-narrowing of the vessel wall after injury). However, patients using stents or other implantable devices risk clot formation or platelet activation. These unwanted effects may be prevented or mitigated by pre-coating the device with a pharmaceutically acceptable composition comprising a kinase inhibitor. Implantable devices coated with a compound of this invention are another embodiment of the present invention.
EXEMPLIFICATION Example 1. Synthesis of Compounds of Formula I.
[0081] Compounds of the present invention may be prepared using conditions analogous to those in Example 90 of U.S. Patent No. 7,528,143. For example, a compound of formula a
Figure imgf000252_0001
a
is combined with a compound of formula b
Figure imgf000252_0002
b
under suitable conditions to form a compound of Formula I. Such conditions include, for example, Pd2(dba)3, Xantphos and cesium carbonate in dioxane.
Example 2. Determination of Efficacy of Selected Compounds
[0082] It will be appreciated that the activity of compounds of Formula I can be assessed according to the following methods.
[0083] BaF/3, HEL & HDF cells are grown in RPMi 1640 medium (Gibco BRL, Gaithersburg, Md.) supplemented with penicillin, streptomycin, L-giutamine, and 10% fetal bovine serum (FBS). CTLL-2 cells are grown in the same media further supplemented with 20 U/iiiL recombinant IL-2 (Hoffmann-La oche, Nutley, N.J.). Plasmid containing the human JAK2 coding sequence is available from Invitrogen (Madison, Wis.). JAK2V6) 7t cDNA can be generated by using site-directed mutagenesis to introduce the V617F mutation into the human JAK2 coding sequence followed by verification using two-directional sequencing. This cDNA can be subsequently subeloned into a retroviral vector and transduced into BaF/3 cells. Permanently transduced BaF/3 cells expressing JAK2 jl ,F are selected and maintained with 1 nig/ml G418. GFP can be introduced into this cells by Ientiviral transduction using pLenti6-GFP (Invitrogen) followed by selection with blasticidin and confirmation of GFP expression using FACs analysis.
[0084] Cell proliferation assay can be performed using the XTT cell proliferation kit according to the manufacturer's instructions (Roche, Alameda, Calif). In brief, approximately 2.5x 103 cells are plated in triplicate into microtiter-plate wells in 100
Figure imgf000253_0001
RPMI growth media plus various doses of test compound. After 72 hour incubation twenty microliters of XTT is added to the wells and allowed to incubate for 4-6 hours. The colored formazan product that is formed is measured spectrophotometrically using the Vmax spectrophotometer (Molecular Devices, Sunnyvale, Calif.) at 450 nm with correction at 650 nm. IC50 values can be determined using the GraphPad Prism 4.0 software (San Diego, Calif), wherefore OD values were plotted on y-axis (linear scale) and concentration (mM) on the x-axis (log scale). Data can be subjected to a non-linear regression fit analysis and IC50 values can be determined as the concentration which inhibited proliferation 50%.
[0085] BaF/3-JAKV617F cells cultured in growth medium (RPMI, 10% FBS, 1 mg/ml G418 and 10 μg/ml blasticidin) are treated with test compound at 1, 3 and 10 μΜ for 24 h. Following harvesting cells by centrifugation at 890 RCF (relative centrifugation force) for 5 min, genomic DNA can be isolated from cell pellets using a DNA isolation kit (Puregen, Chino, Calif). 5 μg genomic DNA of each sample can be subjected to 1.2% agarose gel electrophoresis to detect genomic DNA fragmentation (DNA laddering assay). As a control, adherent normal human dermal fibroblasts (NHDF) cultured in growth medium (Cambrex, Walkersville, Md.) at 60% confluence can be treated with test compound as described above. Following 2 washes with ice cold PBS, genomic DNA is isolated from the NHDF cells for agarose gel electrophoresis.
[0086] Immunoblotting
[0087] BaF/3-JAKV617F cells treated with test compound or vehicle control are centrifuged, washed 2* with ice-cold PBS and lysed using RIPA buffer. Protein concentration can be determined using the BCA method (Pierce, Rockford, 111.) and 100 μg of total cellular protein of each sample in l Laemmli buffer can be subjected to Western blot analysis. The protein blot can be probed with an anti-phospho-STAT5 (Tyr694/699) (Upstate Biotechnology, Charlottesville, Va.), subsequently can be stripped and re-probed with an anti-STAT5 antibody (Cell Signaling Technology, Danvers, Mass.). The phospho-STAT5 or STAT5 protein can be visualized by the enhanced chemoluminescence method (Pierce). In vivo signaling studies can be performed in a similar fashion. Briefly, on day 11 after cell injection, animals are orally dosed with either vehicle or 100 mg/kg of test compound. Spleens are harvested 7 h after dosing and quickly homogenized in a FastPrep machine (Qbiogen, Irvine, Calif). 100 μg of each spleen homogenate can be subjected to Western blot analysis. The protein blot can be probed with an anti-phospho-STAT5 (Tyr694/699) and subsequently with an anti-STAT5 antibody and can be visualized by the enhanced chemoluminescence method.
[0003] It will be appreciated that, although the general methods depict the synthesis of certain compounds of the present invention, the above general methods, and other methods known to one of ordinary skill in the art, can be applied to all compounds and subclasses and species of each of these compounds, as described herein. While a number of embodiments of this invention are described herein, it is apparent that the basic examples may be altered to provide other embodiments that utilize the compounds and methods of this invention. Therefore, it will be appreciated that the scope of this invention is to be defined by the appended claims rather than by the specific embodiments that have been represented by way of example.

Claims

We claim:
1. A compound of Formula
Figure imgf000255_0001
I
or a harmaceutically acceptable salt thereof, wherein:
Figure imgf000255_0002
2a
R 2b
R is
R3a
-(-R3
R3 is R 3c and
each of Rla, Rl , Rlc, R2a, R2, R2c, R3a, R3 , R3c, R4, R4', R4", R5, R6, R6', R7, R7', R8a, R8a', R8,
R8 ', R9a, R9a', R9, R9 ', Rxa, Rx, Rx ', Rxc, Rya, Rya', Ry andRyybD' is independently selected from hydrogen or deuterium;
provided that at least one of Rla, Rl , Rlc, R2a, R2, R2c, R3a, R3 , R3c, R4, R4', R4", R5, R6, R6',
R', R' , R8a, R8a', R8, R8 ', R9a, R9a', R9, R9 ', Rxa, Rx, Rx ', Rxc, Rya, Rya', Ry andR yyt">' i .s deuterium. The compo compound is of Formula Il-a or Formula Ill-a:
Figure imgf000256_0001
Il-a in-a
harmaceutically acceptable salt thereof.
The compo Formula Ill-b:
Figure imgf000256_0002
harmaceutically acceptable salt thereof.
The compound of claim 1 , wherein the compound is of Formula II-c or Formula III-c:
Figure imgf000257_0001
The compound of claim 1, wherein the compound is of Formula Il-d or Formula Ill-d:
Figure imgf000257_0002
or a pharmaceutically acceptable salt thereof.
6 The compound of any one of claims 1-5, wherein the compound is selected from those compounds set forth in Tables 1-8.
7. The compound of claim 1 , wherein the compound is of Formula IV:
Figure imgf000258_0001
or a pharmaceutically acceptable salt thereof.
8. The compound of claim 7, wherein the compound is selected from those compounds set forth in Table 9 or Table 10.
9. A composition comprising a compound according to any of claims 1-8 and a pharmaceutically acceptable excipient.
10. A method for inhibiting the activity of JAK2, or a mutant thereof, in a patient or in a biological sample comprising the step of administering to said patient or contacting said biological sample with a compound according to any of claims 1-8.
11. A method for treating a JAK2-mediated disorder in a patient in need thereof, comprising the step of administering to said patient a compound according to any of claims 1-8.
12. The method according to claim 11, wherein the JAK2-mediated disorder is a myeloproliferative disorder.
13. The method according to claim 12, wherein the myeloproliferative disorder is selected from primary myelofibrosis, secondary myelofibrosis, polycythemia vera, essential thrombocythemia, post polycythemia vera and post essential thrombocythemia.
14. The method of claim 13, wherein the myelofibrosis is primary myelofibrosis.
15. The method of claim 13, wherein the myelofibrosis is secondary myelofibrosis.
PCT/IB2018/052089 2018-03-27 2018-03-27 Heteroaryl compounds and uses thereof WO2018096525A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IB2018/052089 WO2018096525A2 (en) 2018-03-27 2018-03-27 Heteroaryl compounds and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2018/052089 WO2018096525A2 (en) 2018-03-27 2018-03-27 Heteroaryl compounds and uses thereof

Publications (2)

Publication Number Publication Date
WO2018096525A2 true WO2018096525A2 (en) 2018-05-31
WO2018096525A3 WO2018096525A3 (en) 2018-09-27

Family

ID=62195457

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2018/052089 WO2018096525A2 (en) 2018-03-27 2018-03-27 Heteroaryl compounds and uses thereof

Country Status (1)

Country Link
WO (1) WO2018096525A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109232440A (en) * 2018-01-16 2019-01-18 深圳市塔吉瑞生物医药有限公司 For inhibiting the diphenylamino pyrimidines of kinase activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017504653A (en) * 2014-01-31 2017-02-09 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド Diaminopyrimidine benzenesulfone derivatives and uses thereof
CU20180059A7 (en) * 2015-12-17 2018-10-04 Gilead Sciences Inc INHIBITING COMPOUNDS OF THE QUINASA DE UNIÓN A TANK

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109232440A (en) * 2018-01-16 2019-01-18 深圳市塔吉瑞生物医药有限公司 For inhibiting the diphenylamino pyrimidines of kinase activity
WO2019140953A1 (en) * 2018-01-16 2019-07-25 深圳市塔吉瑞生物医药有限公司 Diphenylaminopyrimidine compound for inhibiting kinase activity
EP3578555A4 (en) * 2018-01-16 2019-12-11 Shenzhen Targetrx, Inc. Diphenylaminopyrimidine compound for inhibiting kinase activity
CN111892543A (en) * 2018-01-16 2020-11-06 深圳市塔吉瑞生物医药有限公司 Diphenylaminopyrimidine compounds for inhibiting kinase activity
JP2021510717A (en) * 2018-01-16 2021-04-30 深▲チェン▼市塔吉瑞生物医薬有限公司Shenzhen TargetRx, Inc. Diphenylaminopyrimidine compounds for inhibiting kinase activity
US11384069B2 (en) 2018-01-16 2022-07-12 Shenzhen Targetrx, Inc. Diphenylaminopyrimidine compound for inhibiting kinase activity
JP7169005B2 (en) 2018-01-16 2022-11-10 深▲チェン▼市塔吉瑞生物医薬有限公司 Diphenylaminopyrimidine compounds for inhibiting kinase activity

Also Published As

Publication number Publication date
WO2018096525A3 (en) 2018-09-27

Similar Documents

Publication Publication Date Title
USRE48731E1 (en) Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
CN100484934C (en) Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
Brasca et al. Identification of N, 1, 4, 4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl) phenyl] amino}-4, 5-dihydro-1 H-pyrazolo [4, 3-h] quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitor
CN102203079B (en) Picolinamide derivatives as kinase inhibitors
CN102137859B (en) Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
JP5841548B2 (en) Dihydropteridinone, process for its production and use
RU2305545C2 (en) Application of pyrazoline derivatives to produce pharmaceutical for prevention and/or treatment of diseases associated with cell proliferation
CN106565686B (en) Antitubulin
KR102598246B1 (en) Heterocyclic compounds as JAK inhibitors and salts thereof and therapeutic uses
MXPA03009925A (en) Novel 4-amino-5,6-substituted thiopheno[2,3-d]pyrimidines.
JP2010501593A (en) Isoquinoline, quinazoline and phthalazine derivatives
CN104066734B (en) Triazol [4,5 d] pyrimidine derivatives
KR20090130104A (en) Pyrido[2,3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
EP3212652B1 (en) Ripk2 inhibitors and method of treating cancer with same
EP3196194B1 (en) Pyrimidine derivatives useful as selective jak3 and/or jak1 inhibitors
KR101905295B1 (en) Naphthyridinedione derivatives
CN103097368B (en) Be used for the treatment of the tricyctic lactone of cancer
EP3371172A1 (en) Tetrahydroindazoles and medical uses thereof
WO2018096525A2 (en) Heteroaryl compounds and uses thereof
TWI691500B (en) Heterocycle compounds as tyro3, axl and mertk (tam) family of receptor tyrosine kinase inhibitors
CN109336829B (en) Aryl formamide compound containing 1,2, 3-triazole structure and application thereof
CN112979646B (en) Imidazopyridine derivative
EP4101468A1 (en) Anticancer agent composition
CN106831779B (en) The noval chemical compound of a kind of jak kinase inhibitor
KR102582097B1 (en) Janus kinase inhibitors and use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18726022

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2018726022

Country of ref document: EP

Effective date: 20201027

122 Ep: pct application non-entry in european phase

Ref document number: 18726022

Country of ref document: EP

Kind code of ref document: A2